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ABSTRACT 
During the establishment of pregnancy, uterine stromal cells differentiate into decidual 
cells and recruit natural killer (NK) cells. These NK cells are characterized by low cytotoxicity 
and distinct cytokine production. In rodent as well as in human pregnancy, the uterine NK cells 
peak in number around mid-gestation after which they decline. NK cells associate with uterine 
spiral arteries and are implicated in pregnancy associated vascular remodeling processes and 
potentially in modulating trophoblast invasion. Failure of trophoblast invasion and vascular 
remodeling has been shown to be associated with pathological conditions like preeclampsia 
syndrome, hypertension in mother and/or fetal growth restriction.  
We hypothesize that NK cells fundamentally contribute to the organization of the 
placentation site. In order to study the in vivo role of NK cells during pregnancy, gestation stage-
specific NK cell depletion was performed in rats using anti asialo GM1 antibodies.  Robust 
endovascular trophoblast invasion and vascular remodeling were observed in NK cell depleted 
animals. This depletion affected mesometrial vasculature, lowered relative oxygen 
concentrations at the placentation site and altered trophoblast lineage commitment at gestation 
d9.5. There was also a significant change in the organization of the chorioallantoic placenta on 
d13.5.  Delivery of oxygen appears to be a key signal influencing both trophoblast cell 
differentiation and organization of the placentation site.  
Hypoxia promotes development of the invasive trophoblast lineage. We next evaluated 
the impact of hypoxia on the trophoblast stem (TS) cell transcriptome. DNA microarray analysis 
was performed on rat TS cells exposed to atmospheric and low oxygen (0.5%). Upregulation of 
genes characteristic of an invasive phenotype and a marked downregulation of stem state-
associated genes were observed.  Matrix metalloproteinase 12 (Mmp12) and lysine demethylase 
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3A (Kdm3a) were markedly upregulated in response to low oxygen, while E-cadherin (Cdh1) 
expression was dramatically decreased. These responses were dependent upon hypoxia inducible 
factor (HIF) signaling.  Several of the HIF targets were identified to be Kdm3a targets. KDM3A 
acts on dimethyl and monomethyl histone H3K9 substrates, which prompted an examination of 
global histone H3K9 methylation status of trophoblast cells developing in vitro and in vivo. 
Hypoxia significantly impacted histone H3K9 methylation.  Knockdown of KDM3A in TS cells 
inhibited hypoxia-induced Mmp12 gene expression and disrupted histone H3K9 methylation 
status at the Mmp12 locus.  
 Ectopic expression of KDM3A stimulated MMP12 expression. KDM3A knockdown 
also significantly decreased hypoxia-activated TS cell invasion through Matrigel chambers. 
Finally, blastocysts transduced with Kdm3a shRNA expressing lentiviral particles showed 
reduced outgrowth when exposed to low oxygen tensions. In summary, NK cells impact oxygen 
delivery and uteroplacental adaptive responses, influencing critical lineage decisions affecting 
trophoblast differentiation and the ultimate structure and function of the chorioallantoic placenta. 
Hypoxia/HIF-directed epigenetic remodeling via KDM3A contributes to the control of TS cell 
adaptations during placentation modulating trophoblast lineage commitment and invasion.  
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The maternal –fetal interface                                                                                                                           
          The maternal fetal interface is a dynamic site undergoing pregnancy associated adaptations 
(Enders and Welsh, 1993). The most important adaptation is extensive vascular remodeling of 
the maternal spiral arteries to facilitate nutrient flow and gas exchange in the growing fetus 
(Adamson et al., 2002; Kaufmann et al., 2003; Red-Horse et al., 2004; Vercruysse et al., 2006). 
An elaborate arterial-venous network is established that supplies the placenta.  As gestation 
progresses, small uterine spiral arteries supplying the placenta are modified creating flaccid, low 
resistance blood vessels (Adamson et al., 2002; Christofferson, 1993; Pijnenborg et al., 2006; 
Takemori et al., 1984; Takemori et al., 1985). Uterine natural killer (NK) cells and invasive 
trophoblast cells have been identified as two key players mediating these pregnancy associated 
vascular changes (Croy et al., 2000; Moffett and Loke, 2006a, b; Vercruysse et al., 2006). 
The rat as a model for studying biology at the maternal-fetal interface 
          Animal model systems are essential tools for studying and manipulating molecular 
mechanisms that govern cellular development. The maternal-fetal interface is no exception.  The 
rat and the human both possess hemochorial placentation (Fig. 1.1). The idea of studying any 
animal model system is that if the process being studied is fundamental, most likely it will 
demonstrate conservation across species.  Although, there are some differences in the 
organization of the rodent versus the primate maternal-fetal interface, overriding similarities in 
the lineages of cells comprising the maternal-fetal interface and their functions exist.  Among 
these are the processes and changes taking place during the last week of gestation in the rat. 
During this latter phase, trophoblast cells move out of the chorioallantoic placenta and invade 
into the uterine endometrium, where they establish intimate relationships with the uterine  
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vasculature (Adamson et al., 2002; Ain et al., 2003a; Caluwaerts et al., 2005; Coan et al., 2006; 
Vercruysse et al., 2006). These invasive events in the rat are remarkably similar to invasive 
events taking place during the latter stages of the first trimester and throughout the second 
trimester of pregnancy in the human (Kaufmann et al., 2003; Red-Horse et al., 2004; Vercruysse 
et al., 2006).  
Placentation in the Rat 
          The placenta is an important organ during gestation, which functions as a conduit between 
the mother and the developing fetus. It is specialized to facilitate and coordinate maternal 
adaptations to pregnancy and fetal development. The placenta is primarily comprised of 
trophoblast cells, which perform a number of specialized functions. Implantation brings about 
differentiation of mural trophectoderm (trophectoderm not in contact with the inner cell mass) to 
post-mitotic trophoblast giant cells (TGC). These cells move anti mesometrially and surround the 
future parietal yolk sac. The polar trophectoderm (trophectoderm in direct contact with the inner 
cell mass) proliferates and expands to form the extraembryonic ectoderm and the ectoplacental 
cone (Gardner et al., 1973). Pluripotent trophoblast stem (TS) cells are found in the 
extraembryonic ectoderm and later on in the chorionic ectoderm (Tanaka et al., 1998; Uy et al., 
2002). They supply the ectoplacental cone with precursors for the spongiotrophoblast lineage 
and the secondary TGC.  During mid-gestation, the rodent placenta has a layer of TGC and the 
developing chorioallantoic placenta (Fig. 1.2 A&B). The developing chorioallantoic placenta 
further acquires distinct structural and functional specifications as pregnancy progresses. The 
mature placenta is comprised of two morphologically and functionally distinct layers : the 
junctional zone and the labyrinth zone. Progenitor cells, spongiotrophoblasts, glycogen cells, and 
an outer layer of TGCs comprise the junctional zone. 
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Fig. 1.1 Schematic representation of the general organization of the hemochorial placenta. 
In hemochorial placentation trophoblast cells invade into the uterus both interstitially and 
endovascularly. Uterine NK cells and invasive trophoblast cells are two key players at the 
maternal fetal interface. 
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The invasive trophoblast lineage is known to arise from progenitors within the junctional 
zone region (Wiemers et al., 2003). During the last week of gestation, these cells move out of the 
placenta and invade into the maternal uterine mesometrial compartment. The innermost layer of 
the placenta is the labyrinth zone which consists of trophoblast cells and fetal vasculature derived 
from the allantois. Progenitor trophoblast cells within the labyrinth zone fuse to form syncytia, 
which provide barriers between maternal and fetal compartments. The labyrinth zone consists of 
an elaborate branched structure, providing a large surface area for nutrient, waste and gas 
exchange with the fetus. 
Blastocyst derived rat trophoblast stem (TS) cell 
Rat trophoblast stem cells (Fig. 1.3) represent an excellent model system to study effects of low 
oxygen signaling in vitro. These cells were derived from d4.5 rat blastocysts cultured on rat 
embryonic fibroblasts (REFs) in RPMI-1640 culture medium supplemented with 20% FBS, 
FGF4, and heparin. Once cell lines were established, the REF feeder layers could be replaced 
with REF conditioned medium (Asanoma et al., 2012).  
In the proliferative state, cells express established markers of TS cells, including Cdx2 
and Eomes. Cells ceased proliferation and differentiated when FGF4, heparin, and REF 
conditioned medium were removed. Differentiation was characterized by the decline of Cdx2 
and Eomes expression, the appearance of large polyploid cells (trophoblast giant cells), and the 
expression of trophoblast differentiation-associated genes, including Prl3b1 (PL-II, trophoblast 
giant cells), Tpbpa (spongiotrophoblast), Cx31 (glycogen cells), Prl5a1 (PLP-L, invasive 
trophoblast), and Gcm1 (syncytial trophoblast). The capacity of rat TS cells to express different 
lineage associated genes which are also observed in vivo during trophoblast differentiation and  
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Fig 1.2A Multi-lineage trophoblast cell differentiation. In mouse and rat, trophoblast cells 
differentiate into several lineages. Junctional zone precursor cells can give rise to trophoblast 
giant cells, spongiotrophoblast and glycogen cells. Labyrinth zone precursor cells differentiate 
into syncytial trophoblast. Fig 1.2 B Organization of a mature rat placenta. Beginning 
midgestation the placenta is comprised of two distinct zones, the junctional zone harboring the 
precursors of invasive trophoblast lineage and the labyrinth zone composed of 
syncytiotrophoblast cells. 
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placenta formation, makes them an excellent tractable model to study hypoxia dependent 
adaptations in vitro. 
NK cells and the uterine vasculature 
          Pregnancy results in a highly regulated allocation of immune cells to the uterus (Bulmer 
and Lash, 2005; Croy et al., 2002; Croy et al., 2003; Head, 1996; Hunt et al., 2000; Kruse et al., 
1999; Kruse et al., 2002; Moffett-King, 2002). Following embryo implantation most leukocytes 
are excluded from the maternal uterus except for NK cells which constitute almost 70% of the 
leukocyte population in the uterus during pregnancy.  
NK cells are conspicuous cellular constituents of uteroplacental compartments from 
rodents and primates (Bulmer and Lash, 2005; Croy et al., 1996; Dosiou and Giudice, 2005; 
Hanna and Mandelboim, 2007; Head, 1996; Liu and Young, 2001; Moffett-King, 2002; Moffett 
and Loke, 2006a; Parham, 2004; Sargent et al., 2006). Implantation associated decidualization in 
the rat and mouse, results in expansion of NK cell numbers in the maternal uterine mesometrial 
decidua (Ain et al., 2003a; Croy et al., 1996; Head, 1996). The uterine mesometrial compartment 
receives the mesenteric blood flow and it is the region overlying the developing chorioallantoic 
placenta. By midgestation, NK cells migrate away from the decidual region and associate with 
the mesometrial vasculature (Fig. 1.4). The mesometrial vasculature is organized in a triangular 
shaped area between the mesometrial decidua and the mesometrial surface of the uterus and has 
been referred to as the metrial gland, and several other terms (Ain and Soares, 2004; Peel, 1989). 
These mesometrial blood vessels are responsible for the nutrient flow to the placenta and fetus. 
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Fig. 1.3. Overview of rat trophoblast stem cell model. The rat trophoblast stem (TS) cells can 
be maintained in a stem cell state or induced to differentiate by removal of FGF4 and rat 
embryonic fibroblast (REF) conditioned media. Differentiated cells have distinct cellular 
morphology comprising of  various lineages. 
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NK cells are implicated in uterine vascular development (Croy et al., 2002).  Lack of NK cells is 
associated with profound alterations in the uterine mesometrial vasculature. Several mouse 
models of NK cell deficiency (transgenic mice expressing a human CD3ε gene, Tgε26, 
recombinase activating gene-2 null/common cytokine receptor chain γ null double mutant mice, 
IL-15 null mice) have been studied during pregnancy.  Genetic deficiency of uterine NK cells 
causes a lack of remodeling of the uterine vasculature resulting in hypertrophied vascular media, 
swollen endothelial cells, and narrow vessel lumens (Ashkar and Croy, 2001; Barber and Pollard, 
2003; Croy et al., 2002; Guimond et al., 1997). NK cell-mediated effects on the uterine 
vasculature may be directed by NK cell production of an assortment of angiogenic growth 
factors, including vascular endothelial growth factor A (VEGF A) (Hanna et al., 2006; Lash et 
al., 2006b; Li et al., 2001; Wang et al., 2000)  nitric oxide (NO) (Ain and Soares, 2004; Burnett 
and Hunt, 2000; Burnett et al., 2002; Hunt et al., 1997; Hunt et al., 2000) and pro-inflammatory 
cytokine interferon γ (IFNγ) (Ashkar et al., 2003; Ashkar et al., 2000; Monk et al., 2005; Murphy 
et al., 2009). 
Uterine NK cell-invasive trophoblast cell interactions  
          The nature of the interaction between uterine NK cells and trophoblast cells is not clearly 
understood. At the onset of uterine NK cell recruitment, NK cells are positioned in close contact 
with growing trophoblast cells (gestation d7.5 to d 9.5; Fig. 1.4). As gestation proceeds, NK cells 
exit the decidua. By gestation d13.5 NK cells are numerous and are concentrated in the metrial 
gland region. As gestation proceeds further, uterine NK cell number decreases. The movement of 
invasive trophoblast cells into the metrial gland is initiated as NK cell numbers decrease. A 
reciprocal relationship exists in rat and mouse between the disappearance of the NK cells and 
initiation of trophoblast invasion (Ain et al., 2003a). 
13 
 
 
 
 
 
Fig. 1.4.  Natural killer cell, uterine spiral artery, and trophoblast cell dynamics within rat 
placentation sites throughout gestation. The schematic diagram highlights the reciprocal 
relationship between the uterine natural killer cells and the invasive trophoblast cells through 
different time-points of gestation. Two waves of uterine spiral artery remodeling are executed 
through the actions of natural killer cells (first wave) and invasive trophoblast cells (second 
wave). 
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This reciprocal relationship is also supported by observations with an NK deficient 
mouse model (Ain et al., 2003a). Trophoblast cell invasion has been investigated in wild type 
and in Tgε26 transgenic (deficient in NK cells) mice. Pregnant Tgε26 transgenic mice possess 
very few NK cells in their mesometrial decidua and metrial gland on gestation d12.5, in contrast 
to the large number of NK cells in these compartments of the wild type mouse. NK cell 
deficiency is correlated with an accelerated migration of cytokeratin-positive trophoblast cells 
into the mesometrial decidua.  This observation contrasted with minimal trophoblast cell 
invasion in wild type mice on gestation d12.5. 
          The reciprocal relationship between NK cells and invasive trophoblast cells is further 
demonstrated in the Brown Norway (BN) rat strain (Konno et al., 2007). The late gestation 
invasion of trophoblast cells into the metrial gland of BN rats is decreased in comparison to other 
strains. The decreased trophoblast invasion is associated with a prominent retention of NK cells.  
The retained NK cells are prominently arranged in close proximity to the uterine mesometrial 
vasculature of the late gestation stage placentation site.                                                                                                                                                                                    
            Evidence exists that human uterine NK cells may be the source of regulatory molecules 
that may promote (e.g.IL8, IP10) (Hanna et al., 2006; Hanna and Mandelboim, 2007) or inhibit 
(e.g. IFN γ) trophoblast cell invasion (Ain et al., 2003a; Hu et al., 2006b; Hu et al., 2008; Lash et 
al., 2006a). NK cells may have a direct effect on trophoblast cells or alternatively indirect effects 
via actions on other constituents of the uterine mesometrial compartment. The latter may include 
uterine NK cell products targeting the uterine mesometrial endothelium, which represent the 
guidance system for the movement of invasive endovascular trophoblast cells. 
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Hypoxia and HIF signaling 
          Hypoxia is defined as a condition of reduced oxygen pressure below a critical threshold 
which brings about restriction of proper functioning of organs, tissues or cells (Hockel and 
Vaupel, 2001). The concept of hypoxia is context dependent. Normoxic conditions for 
embryonic or adult cells vary between 2-9% of oxygen. Certain regions in thymus, medulla of 
kidney and bone marrow can exist in as low as 1% oxygen due to their specialized, atypical 
vascular networks (Simon and Keith, 2008). Early embryonic development takes place in low 
oxygen (1-2%). Balance in oxygen levels is maintained by cells primarily through induction of 
specialized transcription factors known as hypoxia inducible factors (HIFs).   
          HIFs are basic Per-Arnt/AhR-Sim basic helix loop helix (bHLH-PAS) transcription factors 
(Gu et al., 2000). The HIFs form heterodimers with aryl hydrocarbon receptor nuclear 
translocator (ARNT); also known as HIF1β and bind to specific DNA sequences known as 
hypoxia responsive elements (HREs) which are located in the promoter, introns and 3’ enhancers 
of a large number of oxygen regulated target genes (Wang et al., 1995; Wang and Semenza, 
1995). Three separate genes code for HIF1α, HIF2α and HIF3α. HIF1α is ubiquitously 
expressed, whereas HIF2α and HIF3α show more tissue specific expression (Wiesener et al., 
2003). HIF3α has multiple splice variants (Gu et al., 1998).  
          HIFα subunits are regulated by oxygen tension, whereas the ARNT subunit is insensitive 
to changes in oxygen concentration (Fig. 1.5). Under normoxic conditions HIFα subunits are 
hydroxylated on two conserved proline residues, P402 and P564 (Ivan et al., 2001; Jaakkola et 
al., 2001a) by a family of three prolyl hydroxylases (PHD1, PHD2 and PHD3) (Bruick and 
McKnight, 2001; Epstein et al., 2001). Hydroxylated HIFα proteins are degraded by mechanisms 
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involving von Hippel Lindau (pVHL) tumour suppressor proteins, which covalently tag HIF 
proteins with polyubiquitin and lead them to proteasome mediated degradation (Schofield and 
Ratcliffe, 2004). Under hypoxic conditions HIFα proteins are not hydroxylated and are therefore 
not degraded (Simon and Keith, 2008). The accumulated HIFα proteins translocate into the 
nucleus where they dimerize with ARNT and bind to the HREs (RCGTG motif where R is any 
purine residue). The heterodimer further binds to a transcriptional coactivator, CREB binding 
protein (CBP)/ p300, for full functional activation of HIF signaling (Ema et al., 1999). 
Downstream target genes of HIF signaling are stress response gene families such as glucose 
transporters, glycolytic enzymes, angiogenic factors, hematopoietic growth factors and gene 
families which affect cell growth, survival and motility (Schofield and Ratcliffe, 2004; Semenza, 
2000, 2001). 
Hypoxia signaling and trophoblast cell development 
          Oxygen is an essential nutrient for cells. Oxygen is delivered to tissues via red blood cells 
through the vasculature. Molecular mechanisms mediating cellular responses to low oxygen 
tension have been identified. HIFs are activated by low oxygen and promote transcriptional 
regulation of downstream effector genes, which lead to cellular adaptations to hypoxia (Wang et 
al., 1995; Wang and Semenza, 1995). 
          Placental and fetal development  rely on oxygen availability. Uterine oxygen 
concentrations are low (1-2%) before chorioallantoic placenta formation (Rodesch et al., 1992). 
Before gestation d9.5, the mouse embryo is heavily dependent on glycolysis for ATP generation 
(Simon and Keith, 2008). However, by gestation d10.5-d11.5, establishment of placental 
circulation increases intrauterine oxygen concentrations. Once the hemochorial placenta is 
18 
 
established, oxygen concentrations increase to approximately 8%. In vitro studies demonstrated 
that low oxygen tension can modulate trophoblast differentiation (Adelman et al., 2000; Alsat et 
al., 1996; Caniggia et al., 2000; Genbacev et al., 1996; James et al., 2006a, b; Jiang et al., 2000; 
Nelson et al., 1999). An oxygen gradient has also been proposed to be the primary effector 
regulating gestation dependent vascular remodeling (Burton and Jaunaiux, 2001; Caniggia et al., 
2000; Fryer and Simon, 2006; Genbacev et al., 1996).            Mutagenesis of components of HIF 
signaling in mice (Arnt, Vhl, Phd2, HIF1α and HIF2α) results in aberrant placental phenotypes 
and disruptions in trophoblast lineage commitment (Adelman et al., 2000; Cowden Dahl et al., 
2005; Gnarra et al., 1997; Maltepe et al., 2005; Takeda et al., 2006). An appropriate balance 
between trophoblast proliferation and differentiation is required to produce a functional placenta 
(Fryer and Simon, 2006).  
Oxygen concentration and trophoblast cell invasion 
          Low oxygen tension or exposure of trophoblast cells to gradients of oxygen concentrations 
have been shown to both activate and inhibit trophoblast invasion (Caniggia et al., 2000; Crocker 
et al., 2005; Genbacev et al., 1996; Graham et al., 2000; Hayashi et al., 2005; James et al., 2006a, 
b; Kadyrov et al., 2003; Kilburn et al., 2000; Robins et al., 2007; Rosario et al., 2008; Zhou et 
al., 1997). These studies have used different experimental procedures, cell types, duration and 
concentration of oxygen exposure. A study looked at the effects of low oxygen tension on four 
different transformed trophoblast cell lines; HTR-8/SVneo, SGHPL-4, JEG3 and JAR (Lash et 
al., 2007). These cell populations exhibited pronounced differences in the extent of invasiveness 
upon exposure to low oxygen tensions (3%). 
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Fig. 1.5. Schematic of the hypoxia inducible factor (HIF) signaling pathway. The HIFs form 
heterodimers with aryl hydrocarbon receptor nuclear translocator (ARNT); also known as HIF1β 
and bind to specific DNA sequences known as hypoxia responsive elements (HREs) which are 
located in the promoter, introns and 3’ enhancers of a large number of oxygen regulated target 
genes. HIFα subunits are regulated by oxygen tension, whereas the ARNT subunit is insensitive 
to changes in oxygen concentration. 
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The impact of oxygen tension on development of invasive trophoblast lineages from 
trophoblast stem cell populations has received little attention. Our laboratory has identified two 
reproducible in vivo methods for perturbing the development of the placentation site (Ain et al., 
2004; Alam et al., 2007; Ho-Chen et al., 2006; Ho-Chen et al., 2007; Rosario et al., 2008); see 
Preliminary Data). Exposure of pregnant rats to hypobaric-hypoxia during the establishment of 
the placenta ( gestation d6.5 to d13.5) or NK cell depletion during the same phase of pregnancy 
results in profound structural changes: 1) activation of intrauterine endovascular trophoblast 
invasion; 2) alteration in chorioallantoic placental organization (Rosario et al., 2008;summarized 
in Fig. 4).   
Hypoxia activation of epigenetic regulators 
Hypoxia signaling mediated by HIF transcription factors are known to modulate 
adaptations by epigenetic regulators. Regulation of histone methylation by low oxygen signaling 
is an area of active research. Although it has been observed that under low oxygen exposure 
(0.2%) hypoxia promotes increase in H3K9 trimethylation marks and global deacetylation, 
promoters of hypoxia regulated genes have been shown to have increased H3K4 tri-methylation 
and decreased H3K27 trimethylation (Johnson et al., 2008).  
Under low oxygen, stabilized HIF transcription factors increase their repertoire of 
downstream players by regulating chromatin modifiers which then are targeted to different 
regulatory regions and control cellular adaptations to low oxygen. So apart from transcriptional 
regulation, epigenetic regulation is another rapid regulatory device that the cells utilize to adapt 
to low oxygen environment. Histone lysine demethylases consists of two different groups: flavin 
adenine dinucleotide (FAD)-dependent enzyme and the Jmjc domain containing demethylases 
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(Mosammaparast and Shi, 2010).  Jmjc domain containing demethylases are dioxygenases whose 
activities require Fe(II), a-ketoglutarate, and oxygen. There are 30 known jmjc domain 
containing proteins out of which some are hypoxia responsive(Pollard et al., 2008). Based on 
gene expression analysis, it has been identified that JMJD1A, JMJD2B as well as JMJD1B, 
JMJD2C, JMJD6, PLU-1, SMCX, RBP2, and KIAA1718, could be upregulated by hypoxia 
(Yang et al., 2009). ChIP seq studies in human cell lines have identified several JmJc family 
members which are direct targets of HIF transcription factors which include PLU-1, JMJD1A, 
JMJD2B, JMJD2C(Yang et al., 2009). 
Epigenetics, Hypoxia and Cell invasion 
Hypoxia signaling through HIF transcription factors upregulate a number of JmJc domain 
containing proteins, out of a which a subset of them are involved in cell invasion particularly in 
cancer cell metastases. Jmjd2c or Kdm4c has long been shown to be amplified in different types 
of cancers like squamous cell carcinoma, medulloblastoma and in prostrate carcinomas. In 
colorectal cancer (CRC) cells, Jmjd2c is upregulated on hypoxia exposure and regulates cell 
proliferation, apoptosis, cell cycle arrest and invasion. JMJD2B was overexpressed in CRC 
tissues and had positive correlation with deeper depth of invasion and advanced clinical stages 
(Fu et al., 2012). 
Recently, the mechanism of Jmjd2c mediated regulation of invasion and metastasis has 
been shown in breast cancer cells (Luo et al., 2012). JMJD2C interact with HIF1A and is 
preferentially recruited to the response elements of a subset of hypoxia responsive genes 
involved in metabolic switch and metastatic invasion in lung cancer cells. Disruption of Jmjd2c 
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significantly downregulated metastasis and also caused reduction of tumor growth in a mouse 
model. 
Epigenetically altered VHL-HIF pathway has been implicated in metatstatic pathology of 
clear cell renal carcinoma (Vanharanta et al., 2013). Studying two pro metastatic VHL-HIF 
targets CXCR4 and CYTIP genes, the authors show that that loss of Polycomb repressive 
complex 2 (PRC2)-dependent histone H3 Lys27 trimethylation (H3K27me3) upregulates HIF-
driven chemokine (C-X-C motif) receptor 4 (CXCR4) expression, promoting chemotactic cell 
invasion. Loss of promoter DNA methylation resulted in upregulation of HIF target CYTIP gene. 
Results from the study elucidate a clear mechanism of HIF driven epigenetic amplification of 
tumor initiating pathways, resulting in tumor metastasis. 
Epigenetic regulation of trophoblast cell invasion 
Histone deacetylation has been linked to HIF mediated effector functions in other 
systems. ARNT null TS cells have been shown to have significantly lower HDAC activity 
characterized by differentiation  independent induction of H4acetylation and altered class 2 
HDAC subcellular localization. Inhibition of HDAC activity in TS cells mimics the trophoblast 
differentiation defects observed in ARNT null TS cells implying greater roles of HIF mediated 
signaling pathway and HDACs in the process of trophoblast differentiation and invasion 
(Maltepe et al., 2005). 
  Trophoblast cells show increased invasiveness on differentiation. They undergo epethilial 
to mesenchymal transition with a marked loss of e cadherin. Abell et al. very elegantly probe  
mechanisms underlying this epithelial mesenchymal transition (Abell et al., 2011). MAP3K4 
kinase deficient TS cells show increased invasiveness with loss of apical basal polarity, gain of 
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mesenchymal front-back polarity , significant loss of ecadherin expression  and concomitant gain 
of mesenchymal markers like N-Cadherin and Vimentin. However this acquisition of 
mesenchymal characteristics do not alter the “stemness” of the trophoblast cells as they can 
equally contribute to placentas when injected in blastocysts. Histone acetylation has been shown 
to be a regulator of gene activation. Global loss of histone acetylation has been observed when 
TS cells differentiate. MAP3K4 regulation of CBP acetyl transferase is pivotal in maintenance of  
the epithelial phenotype of the trophoblast stem cells. 
Research Objectives 
During pregnancy, the maternal fetal interface is a dynamic site undergoing pregnancy 
associated adaptations. Vascular remodeling of the maternal uterine spiral arteries facilitates 
nutrient flow and gas exchange in the growing fetus represents a critical event in the 
establishment of the hemochorial placenta. Failure in this process results in unmodified vessels 
and gives rise to a number of pregnancy associated diseases like preeclampsia  (affects 5-7% of 
all pregnancies), intra uterine growth restriction (IUGR) and pre-term birth. The rat and the 
human both possess hemochorial placentation and overriding similarities exist between the 
species, especially in the process wherein trophoblast cells move out of the chorioallantoic 
placenta and invade into the uterine endometrium and establish intimate relationships with the 
uterine vasculature (Harris, 2010; Pijnenborg et al., 1981b; Pijnenborg et al., 2006). Uterine NK 
cells and invasive trophoblast cells have been identified as two key players mediating pregnancy 
associated vascular changes. 
Disrupted oxygen delivery to the fetus retards somatic growth and brain development. In 
some situations it can also lead to fetal death. NK cells have been implicated in preeclampsia. 
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Aberrant NK cell number, activation and signaling have been related to failure of pregnancy 
associated vascular remodeling. Chronic placental hypoxia and altered hypoxia signaling have 
been proposed to be major players in the pathogenesis of preeclampsia. Thus, understanding the 
regulation of uterine vascular remodeling and trophoblast invasion is critical in deciphering the 
molecular mechanisms of the pathogenesis of pregnancy associated disorders.  
There are two specific aims in this research project (Fig. 1.6), they are: 
1. To investigate  NK cell regulation of hemochorial placentation 
2. To examine epigenetic regulation of TS cell adaptations to hypoxia through activation of 
KDM3A 
Experimental findings related to Specific Aim 1 are presented in Chapter 2 and those associated 
with Specific Aim 2 are presented in Chapter 3. 
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Fig. 1.6. Schematic diagram describing the objectives of the research. NK cells regulate 
uterine vascular development, which impacts oxygen delivery (ΔO2), activates HIF signaling, 
and modulates trophoblast lineage development. 
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CHAPTER 2: 
NATURAL KILLER CELL REGULATION OF HEMOCHORIAL PLACENTATION 
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ABSTRACT 
During the establishment of pregnancy, uterine stromal cells differentiate into decidual 
cells and recruit a population of lymphocytes called natural killer (NK) cells. This process is 
conserved in laboratory rodents, humans, and other species with hemochorial placentation.  NK 
cells associate with uterine spiral arteries, the conduit for nutrient delivery to the placenta and 
fetus, and are hypothesized to contribute to the regulation of pregnancy-dependent uterine spiral 
artery remodeling. Failures in uterine spiral artery remodeling are associated with diseases of 
pregnancy, such as preeclampsia and intrauterine growth restriction. This prompted an 
investigation of NK cells as potential regulators of hemochorial placentation.  NK cell depletion 
within the uterus decreased the delivery of pro-angiogenic factors and delayed uterine spiral 
artery development leading to decreased oxygen tension at the placentation site, stabilized 
hypoxia inducible factor (HIF) 1A protein within the primordial placenta, and re-directed 
trophoblast cell differentiation to junctional zone/invasive trophoblast cell lineages. Invasive 
endovascular trophoblast cells replaced the endothelium of uterine spiral arteries extending the 
depth of the placental vascular bed and accelerating vessel remodeling. Hypoxia-regulated 
trophoblast lineage decisions, including expansion of invasive trophoblast cells, could be 
reproduced in vitro using rat trophoblast stem cells; and were dependent on hypoxia-inducible 
factor signaling. We conclude that NK cells guide hemochorial placentation through controlling 
a hypoxia-sensitive adaptive reflex regulating trophoblast lineage decisions.    
 
 
 
30 
 
INTRODUCTION 
Hemochorial placentation is shared by many mammalian species, including humans, 
some nonhuman primates and rodents (Davies and Glasser, 1968; Enders and Welsh, 1993; 
Georgiades et al., 2002). The hemochorial placenta is organized into two distinct compartments.  
Each compartment provides a specialized function, which includes: i) delivery of maternal 
nutrients to the placenta; and ii) transfer of nutrients from the placenta to the developing fetus.  
These functionally distinct placental compartments are under different regulatory programs. The 
maternal-fetal interface is a dynamic site undergoing pregnancy-associated adaptations (Enders 
and Welsh, 1993). A critical adaptation is the extensive vascular remodeling of the maternal 
uterine spiral arteries, which facilitates nutrient flow and gas exchange with the growing fetus 
(Adamson et al., 2002; Kaufmann et al., 2003; Pijnenborg et al., 2006; Red-Horse et al., 2004).  
Failures in this process result in unmodified vessels and give rise to pregnancy-associated 
diseases such as preeclampsia, intrauterine growth restriction (IUGR), and pregnancy 
termination (Kaufmann et al., 2003; Pijnenborg et al., 2006; Redman and Sargent, 2005). The 
mechanisms controlling uterine vascular remodeling are poorly understood. Putative regulators 
include natural killer (NK) cells and a specialized lineage of trophoblast cells referred to as 
invasive or extravillous trophoblast (Croy et al., 2003; Moffett and Loke, 2006a; Pijnenborg et 
al., 2006).  
Uterine adaptations to pregnancy include highly regulated immune cell trafficking (Croy 
et al., 2003; Erlebacher, 2010; Hunt et al., 2000). Following embryo implantation most 
leukocytes are excluded from uterine tissue proximal to the placentation site except for NK cells, 
a process evident in rodents and primates (Bulmer et al., 2010; Croy et al., 2003; Moffett and 
Loke, 2006a; Zhang et al., 2011). Implantation associated decidualization in the rat and mouse, 
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results in the accumulation of NK cell numbers in the uterine mesometrial decidua (Ain et al., 
2003a; Croy et al., 2003; Zhang et al., 2011). NK cells have been implicated in pregnancy-
associated uterine vascular development (Croy et al., 2003; Lash et al., 2010; Smith et al., 2009; 
Zhang et al., 2011). Genetic deficiency of uterine NK cells results in a lack of remodeling of the 
uterine vasculature resulting in hypertrophied vascular media, swollen endothelial cells, and 
narrow vessel lumens(Ashkar and Croy, 2001; Barber and Pollard, 2003; Guimond et al., 1997).  
NK cell-mediated effects on the uterine vasculature may be directed by NK cell production of an 
assortment of angiogenic growth factors and vasoactive molecules (Hanna et al., 2006; Hunt et 
al., 2000; Kalkunte et al., 2009; Lash et al., 2006a; Li et al., 2001; Monk et al., 2005; Wang et 
al., 2003; Wang et al., 2000). Aberrant NK cell number, activation, and signaling have been 
implicated in pregnancy complications (Dosiou and Giudice, 2005; Lash and Bulmer, 2011; 
Trowsdale and Moffett, 2008; Zhang et al., 2011).    
                 The invasive trophoblast lineage arises from trophoblast stem (TS) cells through an as 
yet unknown differentiation process(Roberts and Fisher, 2011). This differentiated cell lineage 
possesses a unique gene expression profile and is specialized for adhesion, degradation, and 
migration through uterine stromal extracellular matrices and restructuring uterine spiral 
arteries(Ain et al., 2003a; Apps et al., 2011; Bilban et al., 2010; Harris, 2010; Red-Horse et al., 
2004).  Invasive trophoblast cells take two routes as they penetrate into the uterus. They move 
between spiral arteries (interstitial invasive trophoblast) or alternatively they move within spiral 
arteries, replacing the endothelium and in some instances acquiring a pseudo-endothelial 
phenotype as they proceed (Damsky and Fisher, 1998; Pijnenborg et al., 2006; Red-Horse et al., 
2004; Zhou et al., 1997). Rat and human placentation sites exhibit deep intrauterine trophoblast 
cell invasion (Ain et al., 2003a; Caluwaerts et al., 2005; Kaufmann et al., 2003; Pijnenborg et al., 
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2006; Vercruysse et al., 2006), which contrasts with mouse placentation(Adamson et al., 2002; 
Ain et al., 2003a; Coan et al., 2006).  Shallow trophoblast invasion is linked to poor spiral artery 
remodeling and diseases of pregnancy (Kaufmann et al., 2003; Red-Horse et al., 2004; Whitley 
and Cartwright, 2010). 
 A potential interaction between uterine NK cells and trophoblast cells is not clearly 
understood. A reciprocal relationship exists in rat and mouse regarding the presence of NK cells 
and invasive trophoblast cells within the uterine mesometrial compartment (Ain et al., 2003a; 
Konno et al., 2007). NK cells represent effectors directing the first wave of vascular 
modification.  Their disappearance after midgestation marks the entry of invasive trophoblast 
cells and initiation of the second wave of vascular modification.  The reciprocal relationship of 
NK cells and trophoblast cells is also supported by observations with an NK deficient mouse 
model (Ain et al., 2003a) and the Brown Norway rat (Konno et al., 2007). NK cells may directly 
act on trophoblast cells (Ain et al., 2003a; De Oliveira et al., 2010; Hanna et al., 2006; Hu et al., 
2006b; Hu et al., 2010) or alternatively they may possess indirect effects on trophoblast cells via 
actions on other constituents of the uterine mesometrial compartment(Hanna and Mandelboim, 
2007; Zhang et al., 2011). The latter may include uterine NK cell products targeting uterine 
spiral arteries and their delivery of nutrients, including oxygen to the developing placenta.   
Placental development is sensitive to oxygen availability. Oxygen tension at the 
maternal-fetal interface changes with gestation and is affected by placentation (Burton, 2009; 
Caniggia et al., 2000; Cartwright et al., 2007; Fryer and Simon, 2006; Genbacev et al., 1997). 
Oxygen tensions tend to be lower during early pregnancy and increase following the 
establishment of the hemochorial placenta (Fischer and Bavister, 1993; Rodesch et al., 1992; 
Zamudio, 2003).  Insights about the role of oxygen as an intrinsic regulator of placentation have 
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been derived from mutagenesis of genes in the mouse genome controlling cellular responses to 
hypoxia. Central to the cellular response to hypoxia is a transcription factor complex referred to 
as hypoxia inducible factor (HIF; (Dunwoodie, 2009; Majmundar et al., 2010; Semenza, 2010)).  
Phenotypes of placentas with null mutations for several genes encoding components of the HIF 
signaling pathway are associated with failures in placentation, including the HIF1A, HIF2A, 
HIF1B (dimerization partner for HIF1A and HIF2A), prolyl hydroxylase domain protein 2 
(PHD2; also known as EGLN1), and von Hippel-Lindau genes (Adelman et al., 2000; Cowden 
Dahl et al., 2005; Gnarra et al., 1997; Maltepe et al., 2005; Takeda et al., 2006).  Exposure of 
pregnant rats to a hypoxic environment leads to alterations in placentation, especially expansion 
of the invasive trophoblast lineage (Rosario et al., 2008).  This is a conserved adaptive response. 
Maternal anemia (human) and chronic constriction of the lower aorta (rhesus monkey), which 
lead to hypoxia at the maternal-fetal interface, are also triggers for increasing intrauterine 
trophoblast invasion (Kadyrov et al., 2003; Zhou et al., 1993).  
In this study, we investigated the role of NK cells on placentation in the rat.  Depletion of 
NK cells affected uterine spiral artery development, oxygen delivery, HIF-dependent trophoblast 
lineage decisions, and trophoblast-directed uterine spiral artery remodeling.  The results indicate 
that NK cells fundamentally contribute to the organization of the hemochorial placentation site. 
MATERIALS AND METHODS 
Animals and tissue collection 
Holtzman Sprague Dowley (HSD) and Dahl Salt Sensitive (DSS) rats were acquired from 
Harlan Laboratories (Indianapolis, IN).  Brown Norway (BN) and Fischer F344 (F344) rats were 
obtained from Charles River Laboratories (Wilmington, MA).  Transgenic rats expressing 
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enhanced green fluorescence protein (EGFP) driven by a chicken β-actin promoter (chbA-EGFP; 
(Ikawa et al., 1999)) were obtained from Masaru Okabe (Osaka University, Osaka, Japan) and 
used to establish a colony.  Animals were housed in an environmentally controlled facility with 
lights on from 0600-2000 h and allowed free access to food and water. Virgin female rats 8-10 
weeks of age were cohabited with adult males (>3 months of age) of the same strain.  Mating 
was assessed by inspection of vaginal lavages.  The presence of sperm in the vaginal lavage was 
considered d0.5 of pregnancy.  
An immunodepletion strategy was used to ablate NK cells (Barlozzari et al., 1987; 
Barlozzari et al., 1985; Murphy et al., 2005).  Pregnant rats received intraperitoneal injections of 
anti-asialo GM1 (0.5 ml/injection; Wako Chemicals, Richmond, VA) on gestation d4.5, d6.5, 
and d9.5.  Control pregnant rats received the same volume of normal rabbit serum.   
Some pregnant rats were placed in a hypoxic (8.5% oxygen) gas-regulated chamber 
(BioSpherix, Lacona, NY) from gestation d8.5 to d9.5. Pair-fed and ad libitum-fed pregnant rats 
exposed to ambient conditions (normoxia) served as controls.  
Oxygen tensions at placentation sites were estimated by pimonidazole-protein adduct 
formation (Pringle et al., 2007; Samoszuk et al., 2004). Gestation d9.5 animals were weighed and 
injected intraperitoneally with pimonidazole hydrochloride (Hypoxyprobe™-1, HPI Inc.; 
Burlington, MA) at a concentration of 60mg/kg of body weight and sacrificed 90 min later by 
cervical dislocation.  
Rat placental tissues were collected on gestation d9.5, d11.5, and d13.5.  The primordial 
placental structure at gestation d9.5 is referred to as the ectoplacental cone.  At gestation day 
13.5, the placenta is comprised of two distinct dissectible compartments:  the junctional zone, 
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which establishes the border with maternal uterine structures; and the labyrinth zone, which 
represents the interface with the fetus.  Placentation site dissections were performed as 
previously described (Ain et al., 2006). Tissues for histological analysis were frozen in dry-ice 
cooled heptane and stored at -80°C. Tissue samples for protein or RNA extraction were frozen in 
liquid nitrogen and stored at -80°C until processed.  
The University of Kansas Animal Care and Use Committee approved protocols for the 
care and use of animals. 
Flow cytometry  
Dissociated splenocytes were subjected to density gradient centrifugation with Ficoll 
Hypaque solution (GE Amersham, Piscataway, NJ) for enrichment of lymphocytes.  Enriched 
cell preparations (1x10
6
) were labeled with phycoerythrin (PE) conjugated mouse anti-CD161 
(BD Pharmingen, San Diego, CA; Cat. No. 555009) and fluorescein (FITC) conjugated mouse 
anti-CD3 (BD Pharmingen; Cat. No.554832). Cells were analyzed by flow cytometry with a BD 
LSRII (BD Biosciences San Jose, CA). 
Immunocytochemistry and histochemistry 
Immunocytochemical analyses were performed on 10 µm frozen tissue sections using 
Histostain-AEC-plus kits (Zymed, San Francisco, CA) or indirect immunofluorescence detection 
using goat anti-mouse IgG tagged with Alexa 488 (Invitrogen, Carlsbad, CA, Cat. No. A11029; 
1:1000 dilution), goat anti-mouse IgG tagged with Alexa 568 (Invitrogen, Cat. No. A11031; 
1:400 dilution), or goat anti-rabbit IgG tagged with cyanine 3 (Cy3; Jackson ImmunoResearch 
Laboratories, West Grove, PA, Cat. No. 111-165-003; 1:250 dilution). Nuclei were visualized 
with 4',6-diamidino-2-phenylindole (DAPI, Molecular Probes, Carlsbad, CA).  Negative controls 
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were performed with normal rabbit serum or isotype-specfic control mouse IgG and did not 
exhibit positive reactivity in the tissue sections.  Processed tissue sections were inspected and 
images recorded with a Leica MZFLIII stereomicroscope equipped with a charge-coupled device 
(CCD) camera (Leica, Welzlar, Germany). 
Trophoblast cells.  Trophoblast cells were detected using a mouse anti-pan cytokeratin 
antibody (Sigma-Aldrich, St.Louis, MO; Cat. No. C2931) at a dilution of 1:400 (Konno et al., 
2007). Immunofluorescence detection was performed with a mouse monoclonal antibody to pan 
cytokeratin tagged with FITC (Sigma-Aldrich; Cat. No. F3418); and used at a dilution of 1:200.  
NK cells. NK cells were detected with antibodies against Perforin (PRF1) and ANK61 
antigen.  Rabbit anti-rat PRF1 antibodies (Torrey Pines Biolabs, Houston, TX; Cat. No. TP251) 
were used at a concentration of 2.5 µg/ml. Immunoreactivity was visualized using alkaline 
phosphatase conjugated goat anti-rabbit immunoglobulin (Sigma-Aldrich; Cat. No. A3687) and 
nitro blue tetrazolium/bromochloroindoyl phosphate (Hu et al., 2006b). Mouse anti rat ANK61 
antibodies (Santa Cruz Biotechnology, Santa Cruz, CA; Cat. No. sc-59340) were used at 1:100 
dilution. Uterine NK cells present in the uterine mesometrial compartment specifically bind 
prolactin-like protein-A (PLP-A; (Muller et al., 1999)).  Consequently, we also used a fusion 
protein containing human placental alkaline phosphatase (AP) and PLP-A (AP-PLP-A) as a 
ligand for detection of PLP-A binding to uterine NK cells, as previously described (Muller et al., 
1999).  AP was used as a negative control.   
Endothelial cells.  Mouse antibodies to a rat platelet/ endothelial cell adhesion molecule1 
(PECAM1)  (Serotec, Oxford, UK; Cat. No. MCA970) were used to identify endothelial cells 
(1:20 dilution). 
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Smooth muscle cells.  Smooth muscle cells were monitored with a mouse smooth muscle 
α actin (ACTA2) antibody (Sigma-Aldrich; Cat. No. A2547) using a dilution of 1:400. 
Immunofluorescence detection was performed with mouse monoclonal antibody to ACTA2 
tagged with Cy3 (Sigma-Aldrich; Cat. No. C6198); and used at a dilution of 1:300.   
Junctional zone trophoblast lineages.  TPBPA localizes to junctional zone progenitor cell 
population and some of its differentiated derivatives (77).  Rabbit polyclonal antibodies were 
generously provided by Dr. Kunio Shiota (University of Tokyo, Japan) and used at a dilution of 
1:1000. 
Placental compartments.  Regions of the placentation sites were determined by vimentin 
immunostaining.  A mouse monoclonal antibody to vimentin (Sigma-Aldrich; Cat. No. V6389) 
was used at a dilution of 1:500. 
  HIF1A.  HIF1A stabilization was monitored with a mouse anti-HIF1A antibody (BD 
Biosciences; Cat. No. 610959) and used at a dilution of 1:200. 
        Pimonidazole-protein adducts.  Oxygen tension within placentation sites was estimated by 
detection of pimonidazole-protein adducts.  The 4.3.11.3 mouse monoclonal antibody supplied 
with the Hypoxyprobe kit (HPI Inc.) was used at a dilution of 1:50. 
Western blot analysis 
HIF1B and β-actin (ACTB) protein levels were evaluated by western blot analysis. Rat 
TS cell lysates were prepared in radioimmunoprecipitation assay (RIPA) buffer (10 mM Tris-
HCl, pH 7.2, 1% Triton X-100 or 1% Nonidet P-40, 1% sodium deoxycholate, 0.1% SDS, 150 
mM NaCl, 5 mM EDTA, 1 mM sodium orthovanadate, 1 mM  phenylmethylsulfonyl fluoride, 10 
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μg/ml aprotinin).  Protein concentrations were determined by the DC protein assay (Bio-Rad, 
Hercules, CA). Proteins were separated by SDS-PAGE and transferred onto nitrocellulose 
membranes. Immunoreactive proteins were detected with mouse antibodies to HIF1B (BD 
Pharmingen; Cat. No. 611079; 1:1000 dilution) and ACTB (Sigma-Aldrich; Cat. No. A5228; 
1:5000 dilution). Immunoreactive proteins were visualized by enhanced chemiluminescence 
according to the manufacturer’s instructions (Amersham Biosciences, Piscataway, NJ). 
qRT-PCR 
Total RNA was extracted from cells and tissues using TRIzol reagent (Invitrogen).  
cDNAs were synthesized from total RNA (1 µg) for each sample using Superscript 2 reverse 
transcriptase (Invitrogen), diluted five times with water, and subjected to qRT-PCR to estimate 
mRNA levels. Primers were designed using Beacon primer designer (Applied Biosystems, Foster 
City,CA).  Primer sequences can be found in Table 1. Real-time PCR amplification of cDNAs 
was carried out in a reaction mixture (20 µl) containing SYBR GREEN PCR Master Mix 
(Applied Biosystems) and primers (250 nM each).  Amplification and fluorescence detection 
were carried out using the ABI Prism 7500 real time PCR system (Applied Biosystems).  
Cycling conditions included an initial hold step (95 °C for 10 min) and 40 cycles of a two-step 
PCR (92 °C for 15 sec, then 60 °C for 1 min), followed by a dissociation step (95 °C for 15 sec, 
60 °C for 15 sec, and then 95 °C for 15 sec). The comparative cycle threshold method was used 
for relative quantification of the amount of mRNA for each sample normalized to 18S RNA. 
In situ hybridization 
Transcripts were localized at placentation sites using nonradioactive in situ hybridization 
as previously described (Ain et al., 2003a). Ten μm cryosections were prepared and stored at 
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Table2.1. Primer sequences used for qRT-PCR 
 
Symbol Accession no. Forward primer Reverse primer 
Prf1 NM_017330 ATCAGGACCAATACAACT CCATAGGAAGAGATGAGT 
Prl7b1 NM_153738 AACAATGCCTCTGGCCACTGC AGGCCATTGATGTGCTGAGACAGT 
Vegfa NM_0001110334 GCTCTGGGATTTGATATTC TCTTTCCTCTGCTGATTT 
Vegfb NM_053549 GGCTTTACACGATAGATATF TCACTATGGAACAGAGAA 
Vegfc NM_053653 GAAATTACAGTGCCTCTCTC CGTCTAATAATTGAATGAACTTG 
Tpbpa NM_172073 GCAAGAGCAGAAGGGTAAAGAAGG TTTCTATGTCGAGCTCCTCCTCCT 
Gjb3 NM_019240 TGTGAACCAGTACTCCACCGCATT GCTGCCTGGTGTTACAGTCAAAGT 
Prl5a1 NM_138527 TCCACACCAGACATTCCAGA TTTCCAGGAAGCCAACATTC 
Prl3d1 NM_017363 TCGCGCCTCTGGTATGCAAC TGGACACAATGGCAGTTGGTTTGG 
Tfeb NM_001025707 ACTCAGTTTCTCCTTATGC AGACAGGTCCATGAAGTA 
Hif1b NM_012780 GTCCAGAGGGCTATTAAG CTCATCGTCACATCTCAA 
Ankrd37 NM_001108400 TGAGACAGAAGCGGAGTT   TGCCCAACAAGACATCATC 
Egln1 BC081694 GACCTGTCACCTAACTGAG AATAGCATGAAGAGGTTTACAAA 
Bhlhe40 NM_053328 CTTAGAAACCAAAGACTA CTATAAACACACATACAAG 
Cdh1 NM_031334 AAGATCACGTATCGGATT CAATGATGAGAGCTGTATA 
Mmp9 NM_031055 TACTGCTGGTCCTTCTGA CCGTCCTTGAAGAAATGC 
Mmp12 NM_053963 GCTGGTTCGGTTGTTAGG GTAGTTACACCCTGAGCATAC 
18S rRNA M11188 GCAATTATTCCCCATGAACG GGCCTCACTAAACCATCCAA 
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-80°C until used. A plasmid containing a cDNA for Prl7b1(Wiemers et al., 2003) was used as a 
template to synthesize sense and antisense digoxigenin-labeled riboprobes according to the 
manufacturer’s instructions (Roche Molecular Biochemicals, Indianapolis, IN). Tissue sections 
were air dried and fixed in ice cold 4% paraformaldehyde in phosphate buffered saline. 
Prehybridization, hybridization, and detection of alkaline phosphatase conjugated anti-
digoxigenin were performed as previously reported (Ain et al., 2003b).  Images were captured 
using a Leica MZFLIII stereomicroscope equipped with a Leica CCD camera. 
Morphological measurements of placentation sites  
Measurements of the depth of trophoblast invasion, the sizes of placental compartments, 
and blood vessel and uterine mesometrial compartment cross-sectional areas were performed 
with National Institutes of Health Image J software as previously described (Konno et al., 2007; 
Rosario et al., 2008). Definitions of each compartment within the rat placentation site (uterine 
mesometrial compartment, metrial gland, mesometrial deciduum, junctional zone, and labyrinth 
zone) have been described (Ain et al., 2006).   
VEGFA protein measurements 
VEGFA was measured in decidual lysates by enzyme-linked immunosorbent assay 
(ELISA) according to the manufacturer’s (RayBiotech Inc., Norcross, GA) instructions.  
Gestation d9.5 mesometrial decidua samples were dissected and lysates prepared in extraction 
buffer provided by the manufacturer.  Measurements were normalized to protein concentration. 
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Rat TS cell culture 
Blastocyst-derived rat TS cells (Asanoma et al., 2011) were used to evaluate the effects 
of low oxygen on trophoblast lineage decisions. TS cells were cultured in Basal Culture Medium 
[RPMI 1640 (Cellgro, Herndon, VA), 20% fetal bovine serum (FBS; Atlanta Biologicals, 
Norcross, GA), 100 µM 2-mercaptoethanol (Sigma), 1 mM sodium pyruvate (Cellgro), 50 µM 
penicillin and 50 U/ml streptomycin (Cellgro)] supplemented with 70% rat embryonic fibroblast 
(REF) conditioned medium, FGF4 (25 ng/ml; Sigma) and heparin (1 mg/ml; Sigma).  TS cells 
maintained in the basal culture medium (stem cell/proliferative state) were exposed to a range of 
oxygen tensions (0.5 to 2%) and 5% CO2 using a NAPCO Series 8000WJ incubator (Thermo 
Scientific, Pittsburgh, PA) for 24 h and then harvested for cell and molecular analyses.   
Matrigel invasion assay 
The invasive ability of rat TS cells was measured as previously described (Peters et al., 
1999).  Rat TS cells were placed in Matrigel invasion chambers (BD Biosciences) at a density of 
2 x 10
4
 cells per chamber.  Cells were allowed to invade for 24 h.  Membranes were collected 
and stained with Diff-Quick (Dade Behring, Newark, DE).  Invading cells were visualized by 
light microscopy and counted.  
Short- hairpin RNA (shRNA) constructs and production of lentivirus  
Hif1b shRNA constructs in the pLKO.1 vector were obtained from Open Biosystems (Huntsville, 
AL).  Several shRNAs were tested for each gene.  The Hif1b shRNA sequences used in this 
analysis are as follows:  i) Hif1b shRNA-1: 
5’GAGAAGTCAGAAGGTCTCTTTTCTCGAGTAAAGAGACCTTCTGACTTCTC3’; ii) 
Hif1b shRNA-2: 
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5’CCAGACAAGCTAACCATCTTACTCGAGTAAGATGGTTAGCTTGTCTGG3’.  The 
control shRNA, which targets no known mammalian gene, pLKO.1-shSCR (Plasmid 1864), was 
obtained from Addgene (Cambridge, MA) and has the following sequence 
5’CCTAAGGTTAAGTCGCCCTCGCTCTAGCGAGGGCGACTTAACCTTAGG3’ (Sarbassov 
et al., 2005b).  Third generation lentiviral packaging vectors were purchased from Addgene and 
included: pMDLg/pRRE (Plasmid 12251), pRSV-Rev (Plasmid 12253) and pMD2.G (Plasmid 
12259). Lentiviral particles were produced as previously reported (Lee et al., 2009).  In brief, 
293FT cells (Invitrogen) were transiently transfected using Lipofectamine 2000 (Invitrogen) with 
the following plasmids: shRNA containing transducing vector, third-generation packaging 
system plasmids (pMDLg/pRRE and pRSV-Rev; 104), and a VSVG envelope plasmid 
(pMD2.G).  After transfection, cells were maintained in 50% DMEM with high glucose 
(Cellgro), 45% Opti-MEM I (Invitrogen) and 5% FBS. Culture supernatants containing lentiviral 
particles were harvested every 24 h for two to three days.  Supernatants were centrifuged to 
remove cell debris, filter sterilized, concentrated by ultracentrifugation, and stored at -80°C until 
used.  
Statistical analyses   
Data analyses were performed using SigmaPlot 11.2 statistical software package (Systat 
Software, Inc, San Jose, CA).  Specific details of the analyses are presented in the figure legends. 
RESULTS 
Depletion of uterine NK cells  
In vivo depletion of NK cells can be achieved by treatment with anti-asialo GM1 
antibodies (Barlozzari et al., 1987; Barlozzari et al., 1985; Murphy et al., 2005). HSD rats were 
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injected intraperitoneally with 500 µl of anti-asialo GM1 antibodies (Wako Chemicals, 
Richmond, VA) or normal rabbit serum (control) on gestation d4.5 or gestation d4.5 and d9.5. 
Placentation sites were collected on gestation d9.5 or d13.5 and examined for the presence of NK 
cells using PRF1 immunostaining.  A single injection of anti-asialo GM1 at gestation d4.5 
depleted NK cells from placentation sites at gestation day 9.5 (Fig. 2.1 A-F) and decreased 
uterine NK cell numbers on gestation d13.5, indicating evidence of recovery (Fig. 2.2 A). A 
combination of two injections of anti-asialo GM1 (one at gestation d4.5 and the second at d9.5) 
was effective in depleting uterine NK cells at gestation d13.5 (Fig. 2G-L).  qRT-PCR analysis of 
d9.5 uterine mesometrial decidua for Prf1 mRNA verified the depletion of NK cells (Fig. 1.2 B).  
Successful NK cell depletion was confirmed through the use of other strategies to detect NK 
cells (ANK61 immunostaining and AP-PLP-A binding; Fig. 2.3). The immunodepletion 
treatment was also effective in depleting systemic NK cells as assessed by flow cytometric 
analysis of splenocytes with NK1.1 antibodies (also known as NKRP1 or CD161; Fig. 2.4).  
Controls exhibited the expected full complement of systemic and uterine NK cells.  Delaying the 
initiation of anti-asialo GM1 antibody treatment until gestation d6.5 was less effective in 
depleting NK cells (Fig. 1.5).  Thus, we have a protocol for preventing the colonization of the 
placentation site with NK cells and a tool for investigating the role of NK cells on hemochorial 
placentation.   
NK cells, endovascular trophoblast invasion, and uterine spiral artery remodeling 
The placentation site at gestation d13.5 is well defined but lacks penetration of invasive 
trophoblast cells beyond the decidual compartment (Ain et al., 2003a).  In contrast, gestation 
d13.5 placentation sites from NK cell depleted rats exhibited distinct changes in their placental  
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Fig. 2.1  NK cell depletion from d9.5 and d13.5 placentation sites. A) Rats were treated on 
gestation d4.5 with normal rabbit serum (Control) or anti-asialo GM1 on gestation d4.5 (Anti-
aGM1-1(4.5)) and sacrificed on gestation d9.5. This treatment strategy effectively depleted NK 
cells from placentation sites on gestation d9.5 (B-F). D and E are high magnification images of 
boxed regions in B and C, respectively. G) Rats were treated on gestation d4.5 and d9.5 with 
normal rabbit serum (Control) or anti-asialo GM1 (Anti-aGM1-2(4.5, 9.5)) and sacrificed on 
gestation d13.5. This treatment strategy effectively depleted NK cells from placentation sites on 
gestation d13.5 (H-L). J and K are high magnification images of boxed regions in H and I, 
respectively. NK cells were identified using PRF1 immunocytochemistry. Quantification of 
relative depletion (% of control) is shown in panels F (n=6 per group, P<0.02; Mann-Whitney 
Rank Sum Test) and L (n=5 per group, P<0.001; Student’s t-test). Scale bars=0.25mm. 
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Fig. 2.2.  NK cell numbers in gestation d13.5 placentation sites following a 
single injection of anti-asialo GM1 on gestation d4.5. A) Rats were treated on gestation d4.5 
with a single dose of normal rabbit serum (Control) or antiasialo GM1 (Anti-aGM1-1(4.5)) and 
sacrificed on gestation d13.5. This treatment strategy significantly decreased NK cell numbers 
but did not eliminate them from the placentation site on gestation d13.5 (B-F). D and E are high 
magnification images of boxed regions in B and C, respectively. NK cells were identified using 
PRF1 immunocytochemistry. F) Quantification of PRF1 positive cells (number/mm2; n=5 per 
group). Asterisks indicate significant differences from controls (n=5 per group, P<0.01; Mann-
Whitney Rank Sum Test). Scale bars=0.25 mm. G) Prf1 transcript levels in gestation d9.5 
decidual tissues dissected from rats treated on gestation d4.5 with normal rabbit serum (Control) 
or anti-asialo GM-1 (anti-aGM1-1(4.5)). Prf1 transcript levels were measured by qRT-PCR 
(SYBR Green, ΔΔCT method). 18S rRNA served as an internal control. Asterisks indicate 
significant differences (Control, n=5 and anti-aGM1- 1(4.5), n=5; P<0.05, Mann-Whitney Rank 
Sum Test). 
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Fig.2.3 Assessment of NK cell depletion in gestation d9.5 and d13.5 placentation sites using 
PRF1 and ANK61 immunoreactivity and AP-PLP-A binding. A) Schematic representation of 
treatment on gestation d4.5 and sacrifice on gestation d9.5. Rats were treated with a single dose 
of normal rabbit serum (Control: B-E) or anti-asialo GM1 (Anti-aGM1-1(4.5): F-I). J) Schematic 
representation of treatment on d4.5 and d9.5 and sacrifice on gestation d13.5. Rats were treated 
with two doses of normal rabbit serum (Control: K-N) or antiasialo GM1 (Anti-aGM1-2(4.5,9.5): 
O-R). NK cells were identified using PRF1 immunocytochemistry (B, C, F, G, K, L, O, and P), 
ANK61 immunocytochemistry (D, H, M, and Q), or AP-PLP-A binding (E, I, N, and R). C, G, 
L, and P are high magnification images of boxed regions in B, F, K, and O, respectively. Please 
note that these treatment regimens effectively depleted NK cells as determined by each of the 
three NK cell detection methods. Scale bars=0.25 mm. 
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Fig. 2.4. Splenic NK cell depletion. A) Schematic representation of treatment on gestation d4.5 
and sacrifice on gestation d9.5. Rats were treated with a single dose of normal rabbit serum 
(Control, B) or anti-asialoGM1 (Anti-aGM1-1(4.5), C).Spleens were dissected, mechanically 
dissociated, and processed for flow cytometry using CD3-FITC and CD161-PE antibodies. 
Please note that the antiasialoGM1 treatment effectively depleted NK cells from the spleen. 
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Fig. 2.5. NK cell numbers in gestation d9.5 placentation sites following a single injection of 
anti-asialo GM1 on gestation d6.5. A) Rats were treated on gestation d6.5 with a single dose of 
normal rabbit serum (Control) or antiasialoGM1 (Anti-aGM1-1(6.5)) and sacrificed on gestation 
d9.5. This treatment strategy significantly decreased NK cell numbers but did not eliminate them 
from the placentation site on gestation d9.5 (B-F). D and E are high magnificationMimages of 
boxed regions in B and C, respectively. Controls were treated with normal rabbit serum. NK 
cells were identified using PRF1 immunohistochemistry. F) Quantification of PRF1 positive 
cells (number/mm2; n=5 per group). The asterisk indicates a significant difference between 
Control and Anti-aGM1-1(6.5) groups (n=5; P<0.05). Scale bars=0.5 mm. G) Prf1 transcript levels 
in decidual tissues dissected from gestation d9.5 decidual tissue following treatment with normal 
rabbit serum (Control) or anti-asialo GM-1 on gestation day 6.5 (anti-aGM1-1(6.5)). Prf1 
transcript levels were measured by qRT-PCR (SYBR Green, ΔΔCT method). 18S rRNA served 
as an internal control. 
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vascular beds, including deep intrauterine endovascular trophoblast invasion (Fig. 2.6). Uterine 
spiral arteries were lined with cuboidal-shaped cells, which stained positive for cytokeratin (Fig. 
2.6 B and D) and expressed prolactin family 7, subfamily b, member 1 (Prl7b1; also known as 
prolactin-like protein-N) mRNA (Fig. 2.6 F and G).  Prl7b1 transcripts are restricted to the 
invasive trophoblast cell lineage (Konno et al., 2007; Rosario et al., 2008; Wiemers et al., 2003).  
The effects of NK cell depletion on placentation were not unique to the HSD rat.  Three 
additional inbred strains (BN; DSS; F344) showed similar increases in endovascular trophoblast 
invasion following NK cell depletion (Fig. 2.7).  We also verified the extraembryonic origin of 
the endovascular invasive trophoblast cells using a transgenic rat model expressing enhanced 
green fluorescent protein (EGFP) under the control of the chicken β-actin promoter (chbA-
EGFP; (Ikawa et al., 1999; Rosario et al., 2008).  NK cell depletion similarly stimulated EGFP-
expressing extraembryonic cells to invade into the uterine vasculature of wild-type HSD females 
(Fig. 2.6 J).  As indicated above, a single injection of anti-asialo GM1 on gestation d4.5 depleted 
NK cells at d9.5 with some recovery by d13.5 (Fig. 2.2).  This treatment strategy was effective in 
stimulating endovascular trophoblast cell invasion on d13.5 (Fig. 2.8), suggesting that NK cell 
depletion was not required throughout the eight-day interval.   Delaying the initiation of anti-
asialo GM1 treatment until gestation d6.5 did not effectively deplete uterine NK cells (Fig. 2.5) 
nor did it promote endovascular trophoblast invasion (Fig. 2.8).   
Additional insights into the role of NK cells and endovascular trophoblast in uterine 
spiral artery remodeling were obtained through immunohistological analysis.  Three types of 
centrally located uterine spiral arteries were observed at gestation d13.5:  i) vessels surrounded 
by NK cells; ii) vessels devoid of NK cells; iii) vessels devoid of NK cells but containing 
endovascular trophoblast cells. The presence of NK cells led to disruptions in the integrity of the  
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Fig 2.6 NK cell depletion leads to activation of endovascular trophoblast invasion 
on gestation d13.5. Rats were treated on gestation d4.5 and d9.5 with normalrabbit serum 
(Control) or anti-asialo GM1 (NK cell depleted) and sacrificed on gestation d13.5. Invasive 
endovasacular trophoblast cells were identified by pan cytokeratin immunocytochemistry (A-D). 
E) Quantification of the depth ofcytokeratin positive cell penetration into the uterine mesometrial 
vasculature.Values are means ± the standard error of each mean. Invasion index = Distanceof 
endovascular cytokeratin positive cell location relative relative to the trophoblast giant cell layer 
of the chorioallantoic placenta ÷ Total distance from the trophoblast giant cell layer to the 
mesometrial surface of the uterus. The asterisk indicates a significant difference between Control 
and NK cell depleted (n=5 per group; P<0.001; Student’s t-test). F and G) In situ hybridization 
of Prl7b1 mRNA incontrol and NK cell depleted d13.5 placentation sites. H) Prl7b1 transcript 
levels in gestation d13.5 metrial gland tissues dissected from control and NK cell depleted rats. 
Prl7b1 transcript levels were measured by qRT-PCR (SYBR Green, ΔΔCT method). 18S rRNA 
served as an internal control. The asterisk indicates a significant difference between Control and 
NK cell depleted (n=4; P<0.001; Student’s t-test). I and J) Representative images showing 
EGFP expressing endovascular trophoblast cells at gestation d13.5 placentation sites of Control 
(I) and NK cell depleted (J) wild-type female rats mated to chβA-EGFP transgenic male rats. 
Please note that NK cell depletion stimulated the invasion of EGFP-positive trophoblast cells 
into the maternal uterine vasculature. Scale bars=0.25 mm. 
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Fig. 2.7. NK cell depletion leads to activation of endovascular trophoblast 
invasion on gestation d13.5 in F344, DSS, and BN inbred rat strains. A) Schematic 
representation of treatments on gestation d4.5 and d9.5 and sacrifice on gestation d13.5. Rats 
were treated with normal rabbit serum (Control: B, F344; D, DSS; F, BN) or anti-asialo GM1 
(NK cell depleted: C, F344; E, DSS; G,BN). Invasive endovascular trophoblast cells were 
identified by pan-cytokeratin immunocytochemistry. H-J) Quantification of the depth of 
cytokeratin positive cell penetration into the uterine mesometrial vasculature (H, F344; I, DSS; 
J, BN). Values are means ± the standard error of each mean. Asterisks indicate significant 
differences between Control and NK cell depleted (P<0.001; Student’s t-test). 
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Fig 2.8 Effects of single injections of anti-asialo GM1 on endovascular trophoblast invasion 
on gestation d13.5. A) Schematic representation of treatment on gestation d4.5 and sacrifice on 
gestation d13.5. B) Schematic representation of treatment on gestation d6.5 and sacrifice on 
gestation d13.5.Rats were treated with normal rabbit serum (Control: C) or anti-asialo GM1 
(AntiaGM1-1(4.5): D; Anti-aGM1-1(6.5): E). Invasive endovascular trophoblast cells were 
identified by pan-cytokeratin immunocytochemistry. F) Quantification of the depth of 
cytokeratin positive cell penetration into the uterine mesometrial vasculature. Values are means 
± the standard error of each mean. The Invasion Index is described in Fig. 2. Asterisks indicate 
significant differences between Control and anti GM1 treated rats (n=5 per group; P<0.001; 
analysis of variance with Holm-Sidak method for comparisons). 
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smooth muscle layer surrounding spiral arteries (Fig. 2.9A and C). These modifications were not 
observed in spiral arteries devoid of NK cells (Fig. 2.9B).  The endovascular trophoblast-bearing  
(cytokeratin positive) uterine spiral arteries of NK cell depleted rats exhibited additional changes 
(Fig. 2.9 D).  These vessels contained diminished ACTA2 and in many instances complete loss 
of the smooth muscle layer. PECAM 1 immunostaining was absent from some modified uterine 
spiral arteries, reflecting the disappearance of the endothelium (Fig. 2.9F), but present in others 
containing endovascular trophoblast (Fig. 2.9 G) indicative of their acquisition of a pseudo-
endothelial phenotype (Damsky and Fisher, 1998; Zhou et al., 1997). Trophoblast cells are 
proposed to activate endothelial cell apoptosis (Ashton et al., 2005; Red-Horse et al., 2006).  NK 
cells reappear in the uterine mesometrial compartment in rats receiving a single injection of anti-
asialo GM1 on gestation d4.5 but not in rats receiving injections on both gestation d4.5 and d9.5 
(Fig. 2.1, Fig. 2.2).  The pseudo-endothelial trophoblast phenotype was much easier to identify 
following the latter treatment (Fig. 2.9 G).  Partial and complete NK cell depletion result in 
distinct endovascular trophoblast phenotypes on gestation d13.5 and suggest that NK cells may 
modulate the appearance of the pseudo-endothelial phenotype.    
Collectively, the results indicate that NK cells regulate uterine spiral artery remodeling 
through several mechanisms, including:  i) through direct actions on the smooth muscle tunica 
media; ii) via restraining endovascular trophoblast invasion; iii) by modulating the endovascular 
trophoblast cell phenotype.   
NK cells modulate uterine spiral arteries and oxygen delivery 
The effects of NK cell depletion on placentation closely resembled our earlier 
observations on the effects of maternal hypoxia on placentation (Rosario et al., 2008).  Maternal  
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Fig. 2.9. NK cells and endovascular trophoblast cells contribute to remodeling uterine 
spiral artery structure. Rats were treated on gestation d4.5 and d9.5 with normal rabbit serum 
(Control) or anti-asialo GM1 (NK cell depleted) and sacrificed on gestation d13.5. Double 
immunofluorescence staining for ANK61 and ACTA (A and B) and cytokeratin and ACTA2 (C 
and D) on representative uterine mesometrial regions are shown. A and C) Asterisks demarcate 
blood vessels possessing interruptions (arrowheads) in the tunica media. B) Asterisks identify 
blood vessels with intact tunica media. In panels E-G, rats were treated on d4.5 and d9.5 with 
normal rabbit serum (Control, E) or anti-asialo GM1 (Anti aGM1-1(4.5), F; aGM1-2(4.5,9.5), G). 
Double immunofluorescence staining for cytokeratin and PECAM1 (E-G) on representative 
uterine mesometrial regions are shown. G) The asterisk indicates the location of a blood vessel 
lined by cells doubly positive for cytokeratin and PECAM1 (yellow). Scale bars=0.25 mm. 
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hypoxia activates endovascular trophoblast invasion, uterine spiral artery remodeling, and 
placental reorganization.  A 24 h interval of sensitivity to maternal hypoxia was noted between 
gestation d8.5 and d9.5 (Rosario et al., 2008).  This prompted an investigation of NK cell 
depleted and control placentation sites at gestation d9.5.  A prominent difference in the 
distribution of uterine spiral arteries (detected by ACTA2 and PECAM1 immunostaining) was 
observed at gestation d9.5 (Fig. 2.10 A-D). NK cell depleted placentation sites showed 
significantly less development of uterine spiral arteries, especially their progression toward 
developing trophoblast (ectoplacental cone).  The difference in vascular development between 
control and NK cell depleted was not evident by gestation d11.5 (Fig. 2.11).  Since uterine NK 
cells are potential sources of angiogenic factors such as vascular/endothelial growth factors 
(VEGFs; (Kalkunte et al., 2009; Lash et al., 2006b; Li et al., 2001; Wang et al., 2003; Wang et 
al., 2000)), we investigated Vegf transcript and VEGFA protein concentrations in the 
mesometrial compartment where NK cells normally reside.  Transcript levels for Vegfa, Vegfb, 
and Vegfc and VEGFA protein concentrations were all significantly lower in the NK cell 
depleted rats.  Decreases in Vegf transcripts and VEGFA protein are consistent with poor uterine 
spiral artery development.   
We next investigated whether the attenuated uterine spiral artery development impacted 
oxygen delivery to the placentation site.  Pimonidazole hydrochloride forms adducts with 
proteins in tissues experiencing low oxygen tensions (<10 mm of Hg). Pimonidazole-protein 
adducts can be immunohistochemically detected and used for assessment of relative tissue 
oxygen concentrations (Samoszuk et al., 2004), including murine placentation sites (Pringle et 
al., 2007).  NK cell depletion at the placentation site was associated with an increase in the 
accumulation of pimonidazole-protein adduct formation and thus indicative of oxygen tensions  
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Fig. 2.10. NK cells and uterine spiral artery development. Rats were treated on gestation d4.5 
with normal rabbit serum (Control) or anti-asialo GM1 (NK cell depleted) and sacrificed on 
gestation day 9.5. Blood vessels were identified by PECAM1 (A and B) and ACTA2 (C and D) 
immunocytochemistry. E) Numbers of ACTA2 positive vessels within the uterine mesometrial 
compartment were quantified. The asterisk indicates significant differences between Control and 
NK cell depleted (n=5; P<0.001; Student’s t-test). F-H) Transcript levels for Vegfa (F), Vegfb 
(G), and Vegfc (H) were measured in gestation d9.5 mesometrial decidual tissue dissected from 
Control and NK cell depleted rats. Transcript levels were measured by qRT-PCR (SYBR Green, 
ΔΔCT method). 18S rRNA served as an internal control. Asterisks indicate significant 
differences between Control and NK cell depleted (n=5; P<0.02 for each gene; Mann-Whitney 
Rank Sum Test). I) VEGFA protein levels were measured in gestation d9.5 mesometrial decidual 
tissue dissected from Control and NK cell depleted rats by ELISA and normalized to protein 
concentration. The asterisk indicates a significant difference between Control and NK cell 
depleted tissues (n=10; P<0.05; Mann-Whitney Rank Sum Test). 
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Fig. 2.11. Role of NK cells on uterine spiral artery development at gestation d11.5. A) 
Schematic representation of treatment on gestation d4.5 and d9.5 and sacrifice on gestation 
d11.5. Rats were treated with normal rabbit serum (Control: B) or anti-asialo GM1 (NK cell 
depleted: C). Blood vessels were identified by PECAM1 immunocytochemistry. Please note that 
uterine spiral arteries are well developed in both Control and NK cell depleted tissues. Scale 
bars=0.25 mm. 
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below 10 mm of Hg (Fig. 2.12 A and B).  These results were suggestive of a local hypoxia but 
contrary to an earlier report, which failed to observe increased pimonidazole-protein adduct 
formation at the maternal-fetal interface in mice possessing genetic NK cell deficiencies (Leno-
Duran et al., 2010).   
Cellular responses to low oxygen are regulated by activation of a hypoxia signaling 
pathway controlled by specialized transcription factors known as HIFs (Semenza, 2010). HIFs 
are basic helix-loop-helix Per-Arnt/AhR-Sim (bHLH-PAS) transcription factors (Zhang et al., 
2011) and consist of an oxygen-labile α subunit and the aryl hydrocarbon receptor nuclear 
translocator (ARNT, also known as HIF1B).  This heterodimer acts to regulate a number of 
hypoxia-sensitive target genes (Kanasaki et al., 2008).  Activation of a cellular response to low 
oxygen is associated with stabilization of the HIF1A subunit protein, formation of a heterodimers 
with HIF1B, and modulation of gene transcription.  Consequently, we assessed HIF1A protein in 
NK cell depleted and control placentation sites on gestation d9.5 using immunocytochemistry.  
NK cell depletion was associated with stabilization of the HIF1A protein within cells of the 
ectoplacental cone (Fig. 2.12 E-H).  These results support the idea that NK cell depletion is 
leading to activation of the hypoxia-signaling pathway within trophoblast cells of the 
ectoplacental cone.     
Collectively, these experiments indicate that NK cells regulate development of uterine 
spiral arteries and oxygen delivery to the developing placenta. 
NK cells, hypoxia, and trophoblast lineage decisions within the placenta                    
Maternal hypoxia during the labile period of placental morphogenesis activates invasive 
trophoblast cells, resulting in formation of a placenta that is adept at uterine vascular  
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Fig. 2.12 NK cells regulate oxygen tension and stabilization of HIF1A at the d9.5 
placentation site. Representative images are presented of pimonidazole protein adduct (PIM) 
immunostaining within d9.5 placentation sites from Control (A) and NK cell depleted (B) rats. 
Staining was consistently greater in NK cell depleted rat placentation sites (n=5 per group). 
Representative images are shown of cytokeratin (C and D) and HIF1A (E-H) 
immunolocalization. Ectoplacental cone regions react positively with antibodies to pan-
cytokeratin (C and D). The boxed areas in panels C and D are shown in E and G and F and 
H,respectively. Panels G and H contain a counterstain with DAPI. HIF1A immunofluorescence 
was consistently stronger in NK cell depleted rat ectoplacental cone areas (n=5 per group). Scale 
bars=0.25 mm.  
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modification; whereas later exposure to hypoxia is entirely ineffective (Rosario et al., 2008).  
This infers a critical developmental window of sensitivity to low oxygen that impacts trophoblast 
cell lineage decisions.  In the next series of experiments, we compared the effects of NK cell 
depletion (as described above; Fig. 2.13A) and maternal hypoxia (exposure to 8.5% oxygen from 
gestation d8.5 to d9.5; Fig. 2.13B) on the expression of trophoblast cell lineage markers within 
ectoplacental cone tissues isolated on gestation d9.5.  Transcripts for a series of junctional zone-
specific trophoblast markers (Prl3d1: trophoblast giant cells; Tpbpa: junctional zone precursor 
and differentiated trophoblast; Prl5a1 and Prl7b1:  invasive trophoblast) were significantly 
upregulated, whereas a glycogen cell marker (Gjb3) and a labyrinthine trophoblast-specific 
transcript (Tfeb) were not affected (Fig. 2.13 A and B).  The response was similar in the NK cell 
depleted and hypoxia exposed tissues.  Tpbpa is expressed in the earliest cell populations 
committed to junctional zone trophoblast lineages and many of their descendants (Iwatsuki et al., 
2000; Simmons and Cross, 2005).  TPBPA protein expressing cells in the ectoplacental cone 
were also upregulated following NK cell depletion or exposure to maternal hypoxia (Fig. 2.14).  
The hemochorial placenta is organized into two compartments, which reflect trophoblast 
interactions with two vascular beds. Trophoblast cells connected to the maternal vasculature 
specialize in facilitating nutrient flow to the placenta. This compartment is referred to as the 
junctional zone in the rat and extravillous trophoblast in the human. Invasive trophoblast cells of 
the rat arise from the junctional zone (Ain et al., 2006; Simmons and Cross, 2005). Trophoblast 
cells developing in proximity to the fetal vasculature promote nutrient transfer to the fetus and 
constitute the labyrinth zone in the rat and villous trophoblast in the human. We investigated the 
organization of gestation d13.5 placentation sites in control and NK cell depleted rats using 
vimentin immunostaining.  This technique permits effective demarcation of junctional (negative)  
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Fig. 2.13. In vivo analysis of the role of NK cells and oxygen on trophoblast cell 
lineage allocation. A) Rats were treated on gestation d4.5 with normal rabbit serum (Control) or 
anti asialo GM1 (NK cell depleted) and sacrificed on gestation d9.5. B) Rats were exposed to 
8.5% oxygen for 24 h beginning on d8.5 and sacrificed on gestation d9.5. Gestation d9.5 
ectoplacental cone tissues were dissected, RNA extracted, and trophoblast lineage-associated 
transcripts measured by qRT-PCR. qRT-PCR measurements (SYBR Green) were performed 
using the ΔΔCT method). 18S rRNA served as an internal control. Asterisks indicate significant 
differences among groups (n=5; P<0.01 for each gene; Mann-Whitney Rank Sum Test). C and 
D) Effects of NK cells on the organization of the gestation d13.5 chorioallantoic placenta. Rats 
were treated on gestation d4.5 and d9.5 with normal rabbit serum (Control) or anti-asialo GM1 
(NK cell depleted) and sacrificed on gestation d13.5. Placentation sites were sectioned and 
immunostained for vimentin (labyrinth zone and uterine mesometrial compartment positive, 
junctional zone negative). C) Representative localization of vimentin in placentation sites from 
controls. D) Representative localization of vimentin in placentation sites of NK cell depleted rats. 
Scale bar = 1 mm. The dashed black lines on panels C and D demarcate the positioning of the 
junctional zone, relative the underlying labyrinth zone. E) Ratio of cross sectional areas for 
junctional zone versus labyrinth zone from Control (n=5) and NK cell depleted (n=5) 
placentation sites. Values are means ± the standard error of each mean. Please note the relative 
enlargement of the JZ from NK cell depleted placentation sites (asterisk; P<0.001; Student’s t-
test). 
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Fig.2.14. Role of NK cells and hypoxia on TPBPA protein-positive cell distribution within 
the ectoplacental cone. A) Rats were treated on gestation d4.5 with normal rabbit serum 
(Control) or anti asialo GM1 (NK cell depleted), or B) exposed to 8.5% oxygen for 24 h 
beginning on d8.5. All animals were sacrificed on gestation d9.5. Representative sections 
through ectoplacental cones immunostained for cytokeratin (C-E), TPBPA (F-H), or TPBPA 
counterstained with DAPI (I-K). Sections from ectoplacental cones of Control (C, F, and I), NK 
cell depleted (D, G, and J), or 8.5% hypoxia exposed (E, H, and K) rats. Scale bars=0.125 mm. 
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and labyrinth (positive) zones.  NK cell depletion resulted in an expansion of the junctional zone 
(Fig. 2.13D).  A similar placental response occurs following maternal hypoxia exposure (Rosario 
et al., 2008).  Although the junctional zone expanded following NK cell depletion, junctional 
zone and labyrinth zone-specific gene expression patterns were similar between NK cell depleted 
and controls (Fig. 2.15).  
We conclude from these experiments that NK cells and hypoxia modulate trophoblast cell 
lineage decisions and organization of the developing placenta.    
Hypoxia signaling regulates trophoblast cell lineage decisions 
We next determined whether the impact of hypoxia on development of junctional zone-
specific trophoblast cell lineages was a direct action on the TS cell population and whether the 
response was dependent on HIF1B signaling.  For these experiments, we utilized TS cells 
derived from rat blastocysts (Asanoma et al., 2011).  We first evaluated the effects of a range of 
oxygen concentrations (0.5 to 2%) on Tpbpa gene expression by TS cells maintained in the stem 
cell state.  A 24 h interval was selected since it is sufficient to elicit in vivo trophoblast responses 
(Fig.2.13).  An oxygen concentration of 0.5% was a reliable activator of Tpbpa gene expression 
and TPBPA protein accumulation (Fig.2.17) and was used in all subsequent experiments.  TS 
cells were exposed to low oxygen for 24 h, harvested, and cellular phenotypes assessed.  HIF 
signaling was disrupted through targeting HIF1B, the binding partner for HIF1A, with specific 
shRNAs.  shRNAs were delivered to TS cells in lentiviral vectors. Hif1b shRNAs significantly 
decreased Hif1b mRNA and HIF1B protein levels, whereas control shRNAs showed no 
significant disruption of HIF1B expression (Fig. 2.18 A and B). Transcript concentrations for 
known hypoxia responsive genes (Ankrd37, Egln1, and Bhlhe40; Benita et al., 2009; Semenza,  
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Fig. 2.15. Effects of NK cell depletion on gestation d13.5 placental zonespecific 
gene expression. A) Rats were treated on gestation d4.5 and d9.5 with normal rabbit serum 
(Control) or anti asialo GM1 (NK cell depleted) and sacrificed on gestation d13.5. Junctional and 
labyrinth zones were dissected, RNA extracted, and qRT-PCR analyses (B) performed on genes 
expressed in the junctional zone (Tpbpa, Gjb3, Prl5a1, Prl7b1) and labyrinth zone (Tfeb). 
Sample size: n=4 per group. Transcript levels were measured by qRT-PCR (SYBR Green, ΔΔCT 
method). 18S rRNA served as an internal control. 
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Fig. 2.16. Effects of low oxygen on TS cell responses. TS cells maintained in stem cell 
conditions were exposed to low oxygen (0.5%) for 24 h. A) qRT-PCR analyses for selected 
trophoblast cell lineage markers (Tpbpa, Prl3d1, and Tfeb) in TS cells exposed to ambient or low 
oxygen. qRT-PCR measurements (SYBR Green) were performed using the ΔΔCT method). 18S 
rRNA served as an internal control. Asterisks indicate significant differences among groups 
(P<0.05 for each gene; Mann Whitney Rank Sum Test). All experiments were performed in 
triplicate. B-E) Immunofluorescence staining for TPBPA in TS cells exposed to ambient or low 
oxygen. F, G) Assessment of the effects of oxygen tension on TS cell invasion. Cells penetrating 
Matrigel-coated filters were counted after staining with Diff Quick. Representative images of TS 
cells from the following conditions are shown: F) exposure to ambient oxygen, G) exposure to 
low oxygen. Arrowheads show the location of cells penetrating through the Matrigel. H) 
Quantification of TS cell invasion. All experiments were performed in triplicate. Asterisks 
indicate significant differences among groups (P<0.05; analysis of variance with Tukey’s Test 
for comparisons).  
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2010)  and trophoblast lineage-specific transcripts were evaluated.  Ankrd37, Egln1, and Bhlhe40 
transcript concentrations were increased in response to low oxygen (Fig. 2.18C), as was Tpbpa, a 
transcript expressed by junctional zone precursors and some of their derivatives (Fig. 2.18D).  In 
contrast, concentrations of Prl3d1 transcripts, a trophoblast giant cell-specific transcript, and 
Tfeb, a labyrinthine trophoblast-specific transcript, were significantly decreased (Fig. 2.18D).  
All low oxygen-sensitive cellular measures were dependent upon HIF1B except for the Tfeb 
response (Fig. 2.18C and D).  Hypoxia-mediated inhibition of gene expression is more 
frequently associated with HIF-independence (Semenza, 2010).  Concentrations of other 
trophoblast-associated transcripts (Gjb3, Prl5a1, Prl7b1) were not reproducibly affected by low 
oxygen. The number of TS cells expressing TPBPA protein was increased by exposure to low 
oxygen and reversed by knockdown of HIF1B (Fig. 1.18E).  Similar results were observed with a 
second independent Hif1b shRNA (Fig. 2.19).  Mouse TS cells exposed to low oxygen also show 
an upregulation of Tpbpa gene expression (Adelman et al., 2000; Cowden Dahl et al., 2005; 
Zhang et al., 2011). 
Oxygen tension also promoted the invasive phenotype of TS cells.  Expression of mRNA 
for proteins implicated in trophoblast invasion and trophoblast-directed spiral artery remodeling 
(Cdh1, Mmp9, and Mmp12; Harris et al., 2010; Librach et al., 1991; Peters et al., 1999; Vicovac 
and Aplin, 1996) and trophoblast movement through Matrigel were evaluated. Cdh1 transcript 
levels were decreased in response to low oxygen (Fig. 2.20F), while Mmp9 and Mmp12 
transcript levels were stimulated by low oxygen.  Low oxygen stimulated trophoblast invasion 
through Matrigel (Fig. 2.20G).  Each of these TS cell responses to low oxygen was dependent on 
HIF1B (Fig. 2.20F and G).  
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Fig. 2.17. Oxygen tension, HIF1B signaling, and trophoblast cell lineage decisions. 
TS cells maintained in stem cell conditions were exposed to low oxygen (0.5%) for 24 h in the 
presence of Control (Cntrl) shRNA or Hif1b shRNA-1. A) qRT-PCR analysis for Hif1b in TS 
cells exposed to ambient or low oxygen and control shRNA or Hif1b shRNA-1. B) Western blot 
analysis for TS cells exposed to ambient or low oxygen and control shRNA or Hif1b shRNA-1. 
C) qRT-PCR analyses for known hypoxia responsive genes (Ankrd37, Egln1, and Bhlhe40) TS 
cells exposed to ambient or low oxygen and control shRNA or Hif1b shRNA-1. All experiments 
were performed in triplicate. Asterisks indicate significant differences among groups (P<0.01 for 
Ankrd37 and Egln1, P<0.05 for Bhlhe40; analysis of variance with Tukey’s Test for 
comparisons). D) qRT-PCR analyses for trophoblast cell lineage markers (Tpbpa, Prl3d1, and 
Tfeb) in TS cells exposed to ambient or low oxygen and control shRNA or Hif1b shRNA-1. A, 
C, and D) qRT-PCR measurements (SYBR Green) were performed using the ΔΔCTmethod). 
18S rRNA served as an internal control. All experiments were performed in triplicate. Asterisks 
indicate significant differences among groups (P<0.01 for each gene; analysis of variance with 
Tukey’s Test for comparisons).E-G) Immunofluorescence staining for TPBPA in TS cells 
exposed to ambient or low oxygen and control shRNA or Hif1b shRNA-1. 
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Fig 2.18 Examination of the effects of Hif1b shRNA-2 on TS cell responses to low oxygen. 
TS cells maintained in stem cell conditions were exposed to low oxygen (0.5%) for 24 h in the 
presence of Control (Cntrl) shRNA or Hif1b shRNA-2. A) qRT-PCR analysis for Hif1b in TS 
cells exposed to ambient or low oxygen and control shRNA or Hif1b shRNA-2. B) Western blot 
analysis for TS cells exposed to ambient or low oxygen and control shRNA or Hif1b shRNA-2. 
C). qRT-PCR analyses for Ankrd37, a known hypoxia responsive gene. D) qRTPCR analysis for 
Tpbpa, a junctional zone lineage marker, in TS cells exposed to ambient or low oxygen and 
control shRNA or Hif1b shRNA-2. A, C, and D) qRTPCR measurements (SYBR Green) were 
performed using the ΔΔCT method).18S rRNA served as an internal control. Asterisks indicate 
significant differences among groups (Hif1b transcript measurements: *P<0.05, control shRNA 
vs Hif1b shRNA-2 in ambient conditions; **P<0.01, control shRNA vs Hif1b shRNA in low 
oxygen conditions; Ankrd37 and Tpbpa transcript measurements: control shRNA vs Hif1b 
shRNA-2, *P<0.05). All experiments were performed in triplicate.Analysis of variance and the 
Holm-Sidak method for multiple comparisons were used for all data analyses. 
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Fig. 2.19. Oxygen tension, HIF1B signaling, and trophoblast cell invasion. TS cells 
maintained in stem cell conditions were exposed to low oxygen (0.5%) for 24 h in the presence 
of Control (Cntrl) or Hif1b shRNA-1. A) qRT-PCR analyses for known hypoxia responsive 
genes (Cdh1, Mmp9, Mmp12) in TS cells exposed to ambient or low oxygen and control shRNA 
or Hif1b shRNA-1. qRT-PCR measurements (SYBR Green) were performed using the ΔΔCT 
method). 18S rRNA served as an internal control. All experiments were performed in triplicate. 
Asterisks indicate significant differences among groups (P<0.05 for each gene; analysis of 
variance with Tukey’s Test). B-D) Assessment of the effects of oxygen tension and HIF1B 
signaling on TS cell invasion. Cells penetrating Matrigel-coated filters were counted after 
staining with Diff  Quick. Representative images of TS cells from the following conditions are 
shown: B) control shRNA and exposure to ambient oxygen, C) control shRNA and exposure to 
low oxygen, and D) Hif1b shRNA-1 and exposure to low oxygen. Arrows in B and D show the 
locations of invaded cells. E) Quantification of TS cell invasion. All experiments were 
performed in triplicate. Asterisks indicate significant differences among groups (P<0.05; analysis 
of variance with Tukey’s Test for comparisons). F) Schematic representation of the effects of 
NK cells on uterine spiral artery development, oxygen delivery to trophoblast stem cells, and 
HIF-dependenttrophoblast differentiation. 
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Collectively, the results indicate that trophoblast lineage decisions are sensitive to oxygen 
tension.  Hypoxia exposed TS cells are directed to differentiate towards a unique invasive and 
non-giant cell and non-labyrinthine trophoblast phenotype.  This process is regulated by HIF1B.   
DISCUSSION 
The accumulation of NK cells in the uterus during pregnancy is a well-conserved 
biological event (Zhang et al., 2011). In this report, we investigated the role of uterine NK cells 
in the rat, a species with hemochorial placentation and deep intrauterine trophoblast invasion 
(Ain et al., 2003a). Our research demonstrates that NK cells act as regulators of hemochorial 
placentation. NK cells influence the development of uterine spiral arteries, at least in part, 
through their production of proangiogenic factors, such as VEGFs. Uterine spiral arteries deliver 
nutrients including oxygen to the developing placenta. Oxygen tension at the placentation site 
influences adaptive responses, which include trophoblast lineage decisions. Depending upon the 
internal milieu, trophoblast cells are differentially allocated to the uteroplacental vascular bed 
versus the placental–fetal interface, resulting in the creation of placentas with specialized 
properties for acclimation to specific environmental challenges. These experimental findings 
provide an important physiological link between the work of Croy and her colleagues 
demonstrating a role for NK cells in uterine spiral artery remodeling (Guimond et al., 1997; 
Zhang et al., 2011) and the efforts of Simon and coworkers elucidating the involvement of HIF 
signaling in the regulation of placentation (Adelman et al., 2000; Fryer and Simon, 2006).  
There are temporal and quantitative features associated with the activities of NK cells and 
invasive trophoblast cells in uterine spiral artery maturation. NK cells promote uterine spiral 
artery growth toward the ectoplacental cone, a key event in the establishment of the hemochorial 
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placenta, and cause at least a partial disruption of spiral artery tunica media integrity. All NK 
cells are not the same and differentially contribute to the establishment of the maternal–fetal 
interface (Madeja et al., 2011). In the absence of NK cells, spiral artery extension is delayed and 
the tunica media initially remains intact. These observations are consistent with an angiogenic/ 
vascular remodeling role for NK cells. The actions of NK cells on uterine spiral artery and 
stromal cell compartments are not a prerequisite for endovascular trophoblast invasion. This 
process is actually accelerated and more robust in the absence of NK cells. Although NK cell and 
invasive trophoblast cell populations are each sufficient to facilitate establishment of the 
hemochorial placenta, there are quantitative differences in the extent of spiral artery remodeling 
achieved by each cell population. NK cell actions on spiral arteries can be viewed as modest, 
especially in comparison with the substantial actions of endovascular invasive trophoblast cells 
on uterine spiral artery structure and nutrient delivery to the placenta. The latter actions are 
exaggerated in the absence of NK cells. By promoting spiral artery development, oxygen 
delivery, and establishing the hemochorial placenta, NK cells effectively delay endovascular 
trophoblast invasion. Delaying trophoblast entry into spiral arteries and the concomitant 
enhanced flow of maternal resources to the placenta is protective to the mother and can be 
viewed as a maternal adaptive strategy.  
How do NK cells communicate with the developing placenta? Previous in vitro 
experimentation indicated that NK cells produce factors that directly affect the behavior of 
trophoblast cells, including the invasive trophoblast lineage (Hanna et al., 2006; Lash et al., 
2010; Zhang et al., 2011). Some reports suggested that NK cell secretory products stimulate 
trophoblast invasion, whereas others concluded the opposite action. Differences in the findings 
are probably related to methodological issues, such as the origin of NK cell and trophoblast cell 
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preparations used in the analyses and/or other procedural considerations; however, they belie the 
most relevant mode of communication between NK cells and trophoblast cells, which is the 
delivery of oxygen. This view is supported by the similar placentation responses observed with 
two distinct in vivo manipulations: (i) NK cell depletion and (ii) maternal hypoxia(Rosario et al., 
2008). Our results indicate that the direct actions of NK cells on trophoblast cells are of 
secondary consideration to the fundamental role of NK cells in the development of the 
vasculature and oxygen delivery.  
Oxygen tension is a regulator of trophoblast cell function (Burton, 2009; Fryer and 
Simon, 2006; Genbacev et al., 1996; Zhou et al., 2011). A number of reports have demonstrated 
that trophoblast cells respond to oxygen restriction (Tuuli et al., 2011). In vitro experimentation 
has yielded a range of responses, some of which are contradictory, but, again, methodological 
differences are the likely cause for the discrepancies. Our in vivo findings led us to a critical 
window during placental morphogenesis (E8.5–E9.5 in the rat) that is especially sensitive to 
oxygen tension (Rosario et al., 2008). This is an interval where critical trophoblast lineage 
decisions are being finalized. These decisions impact morphogenesis of the placenta. Low 
oxygen favors TS cell and/or trophoblast precursor cell allocation to the junctional zone, a 
structure that establishes the placental interface with the uterus, including maternal vascular 
connectivity. Placentation sites are constructed to meet proximal challenges presented during the 
critical phase of their development, with the expectation that these challenges will continue 
throughout pregnancy and into postnatal extrauterine life. Problems and potentially disease arise 
when adaptations are ineffective and/or mismatches occur with the original environmental 
challenge directing placentation and subsequent prenatal and postnatal exposures. These 
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postulates are consistent with central roles for the placenta in fetal programming and the 
development of adult health and disease (Myatt, 2006).  
In vivo placental adaptive responses can be simulated in vitro and include oxygen-
sensitive lineage decisions. TS cell lineage responses are dependent upon HIF1B signaling 
pathways. HIF1B can interact with oxygen-sensitive HIF1A or HIF2A subunits or alternatively 
with other members of the bHLH-PAS family (Semenza, 2010). The HIF1A–HIF1B heterodimer 
is a transcription factor complex controlling expression of genes that are vital to cell survival 
under conditions of oxygen deprivation (Semenza, 2010). HIF1B binding partners and 
transcriptional targets in TS cells are unknown. Presumably, HIF1B is participating in 
transcriptional regulation of genes required for metabolic adaptations and also those controlling 
lineage decisions. The latter are keys to understanding how the invasive trophoblast cell lineage 
develops and potentially gaining insights about disorders that adversely affect placentation. In 
conclusion, hypoxia-activated trophoblast invasion/uterine spiral artery remodeling is an 
adaptive response regulated by NK cells that ensures appropriate placentation and protects 
pregnancy. 
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CHAPTER 3: 
EPIGENETIC INVOLVEMENT OF THE HISTONE H3K9 DEMETHYLASE KDM3A 
IN TROPHOBLAST STEM CELL ADAPTATIONS TO HYPOXIA 
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ABSTRACT 
Delivery of oxygen is a key signal influencing both trophoblast cell differentiation and 
organization of the placentation site. Hypoxia promotes development of the invasive trophoblast 
lineage. In this study, we evaluated the impact of hypoxia on trophoblast stem (TS) cell 
differentiation.  Initially, DNA microarray analyses were performed in rat TS cells exposed to 
ambient or low oxygen (0.5%). Hypoxia stimulated an upregulation of genes characteristic of an 
invasive/vascular remodeling phenotype, including matrix metalloproteinases (Mmp9, Mmp12) 
and a histone H3K9 demethylase (Kdm3a) transcript levels and a marked downregulation of 
stem state-associated genes, including E-cadherin (Cdh1). These responses were dependent upon 
hypoxia inducible factor (HIF) signaling. Hypoxia also induced global changes in trophoblast 
cell histone H3K9 methylation marks. A subset of the HIF targets was further shown to be 
KDM3A targets. Knockdown of KDM3A in rat TS cells inhibited Mmp12 gene expression and 
disrupted histone H3K9 methylation status at the Mmp12 locus. Conversely, ectopic expression 
of KDM3A in rat TS cells upregulated Mmp12 expression in ambient conditions. KDM3A 
knockdown also decreased hypoxia-induced blastocyst outgrowth and reduced invasion through 
Matrigel-coated transwell chambers. In summary, hypoxia/HIF-directed epigenetic remodeling 
contributes to the control of TS cell adaptations, modulating trophoblast cell lineage 
development. 
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INTRODUCTION 
Vascular remodeling in an important pregnancy associated adaptation in hemochorial 
placentation wherein the specialized trophoblast cell population called the invasive trophoblast 
lineage or alternatively extravillous trophoblast invade into the maternal spiral arterioles turning 
them into flaccid low resistance vessels (Georgiades et al., 2002; Red-Horse et al., 2004). Failure 
of trophoblast invasion and vascular remodeling is associated with pathological conditions like 
preeclampsia and intrauterine growth restriction (Kaufmann et al., 2003; Pijnenborg et al., 2006). 
The invasive trophoblast lineage arises from the trophoblast stem (TS) cells. The regulation of 
the differentiation program for this cell lineage is not well understood. Invasive trophoblast cells 
can be classified based on their route of invasion. In the rat, an initial wave of invasion consists 
of the endovascular invasive cell lineage, which moves within the spiral arteries, removes 
endothelium and often acquires a vascular endothelial phenotype known as 
pseudovasculogenesis (Harris, 2010; Harris et al., 2010; Pijnenborg et al., 1981b; Pijnenborg et 
al., 2006; Wiemers et al., 2003; Zhou et al., 1997). A second wave consists of the interstitial 
invasive cell lineage, which moves into the decidua and is situated between the uterine spiral 
arteries (Ain et al., 2003a; Pijnenborg et al., 1981a).  
Oxygen tension is an important cue for placental development. During early gestation, 
oxygen tension at the placentation sites is low and then progressively increases with the 
establishment of functional placental compartments and vascular remodeling (Burton, 2009; 
Fryer and Simon, 2006; Genbacev et al., 1997; Rodesch et al., 1992). Cellular responses to low 
oxygen signaling are mediated by hypoxia inducible factor (HIF) transcription factors (Semenza, 
2010). HIF transcription factors consist of heterodimer composed of oxygen sensitive HIF1A or 
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HIF2A and a constitutively active HIF1B (also known as aryl hydrocarbon receptor nuclear 
translocator, ARNT).  
Under oxygen replete conditions HIFA proteins is hydroxylated by prolyl hydroxylases and 
targeted for degradation by the ubiquitin ligase Von Hippel Lindau protein (Ivan et al., 2001; 
Jaakkola et al., 2001b). Under low oxygen tensions, HIFA proteins are stabilized, dimerize with 
HIF1B, and bind hypoxia response elements (Wang et al., 1995). HIF1A and HIF2A are known 
to have unique as well as overlapping targets (Bracken et al., 2006; Hu et al., 2006a; Raval et al., 
2005). Mutagenesis of genes encoding components of the HIF pathway including the Hif1a, 
Hif2a, Hif1b, prolyl hydroxylase domain protein 2 (Phd2; also known as Egln1), and Von 
Hippel-Lindau (Vhl) genes, are associated with failures in placentation (Adelman et al., 2000; 
Fryer and Simon, 2006). Hypoxia exposure can redirect placental organization and promote 
development of the invasive trophoblast cell lineage (Chakraborty et al., 2011; Rosario et al., 
2008).  
Cellular adaptations to hypoxia include epigenetic reorganization.  Hypoxia leads to a range 
of histone modifications at target genes (Johnson et al., 2008; Melvin and Rocha, 2012) and 
specifically regulates a number of JmJc domain containing histone demethylases (Beyer et al., 
2008; Krieg et al., 2010; Pollard et al., 2008; Wellmann et al., 2008). KDM3A  (also known as 
JMJD1A) is a hypoxia responsive JmJc containing histone H3K9 demethylase, specifically 
acting on histone H3K9 monomethyl and dimethyl substrates (Yamane et al., 2006). KDM3A is 
implicated in the regulation of cell differentiation (Herzog et al., 2012; Lockman et al., 2007), 
maintenance of embryonic stem cell stem state (Ko et al., 2006; Loh et al., 2007), in cancer cell 
invasion (Guo et al., 2011; Yamada et al., 2012; Yamane et al., 2006) as well as in vivo tumor 
cell growth (Krieg et al., 2010). Targeted in vivo Kdm3a mutagenesis in mice is associated with 
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failures in male germ cell development and metabolic syndrome (Liu et al., 2010; Okada et al., 
2007; Tateishi et al., 2009). 
In this chapter, we examine the actions of hypoxia signaling on development of the 
invasive trophoblast cell lineage. Hypoxia-responsive gene expression in TS cells is elucidated 
and the contributions of HIF and KDM3A to hypoxia-dependent changes in TS cell biology were 
determined. Hypoxia exposure upregulates a signature set of genes involved in cellular 
movement and invasion. HIF regulated KDM3A appears to be at the center of global and 
genespecific epigenetic changes. In summary, HIF-directed epigenetic remodeling contributes to 
the control of TS cell adaptations to low oxygen and development of the invasive trophoblast cell 
lineage. 
MATERIALS AND METHODS 
Animals and tissue collection 
HSD rats were acquired from Harlan Laboratories (Indianapolis, IN).  Animals were housed in 
an environmentally controlled facility with lights on from 0600-2000 h and allowed free access 
to food and water. Virgin female rats 8-10 weeks of age were cohabited with adult males (>3 
months of age) of the same strain.  Mating was assessed by inspection of vaginal lavages.  The 
presence of sperm in the vaginal lavage was considered gestation day (E)0.5.  Rat embryos were 
collected by flushing uteri with M2 medium (Millipore, Temecula, CA) at E4.5.   
Pregnant rats were placed in a hypoxic (8.5% oxygen) gas-regulated chamber (BioSpherix, 
Lacona, NY) from E8.5 to E9.5. Pair-fed and ad libitum-fed pregnant rats exposed to ambient 
conditions (normoxia) served as controls. Rat placental tissues were collected on E9.5.  The E9.5  
primordial placental structure is referred to as the ectoplacental cone. Placentation site 
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dissections were performed as previously described (Ain et al., 2006). Tissues for histological 
analysis were frozen in dry-ice cooled heptane and stored at -80°C. Tissue samples for protein or 
RNA extraction were frozen in liquid nitrogen and stored at -80°C until processed.  The 
University of Kansas Animal Care and Use Committee approved protocols for the care and use 
of animals. 
Rat TS cell culture 
Blastocyst-derived rat TS cells (Asanoma et al., 2012) were used to evaluate the effects 
of low oxygen on trophoblast lineage decisions. TS cells were cultured in Basal Culture Medium 
[RPMI 1640 (Cellgro, Herndon, VA), 20% fetal bovine serum (FBS; Atlanta Biologicals, 
Norcross, GA), 100 µM 2-mercaptoethanol (Sigma-Aldrich, St. Louis, MO), 1 mM sodium 
pyruvate (Cellgro), 50 µM penicillin and 50 U/ml streptomycin (Cellgro)] supplemented with 
70% rat embryonic fibroblast (REF) conditioned medium, FGF4 (25 ng/ml; Sigma-Aldrich) and 
heparin (1 µg/ml; Sigma-Aldrich).  TS cells maintained in the stem cell/proliferative state were 
exposed to a range of oxygen tensions (0.5 to 2%) and 5% CO2 using a NAPCO Series 8000WJ 
incubator (Thermo Scientific, Pittsburgh, PA) for 24 h and then harvested for cell and molecular 
analyses.   
Immunocytochemistry  
Immunocytochemical analyses were performed on 10 µm frozen tissue sections using 
indirect immunofluorescence detection using goat anti-mouse IgG tagged with Alexa 488 
(Invitrogen, Carlsbad, CA, Cat. No. A11029; 1:1000 dilution), goat anti-mouse IgG tagged with 
Alexa 568 (Invitrogen, Cat. No. A11031; 1:400 dilution), or goat anti-rabbit IgG tagged with 
cyanine 3 (Cy3; Jackson ImmunoResearch Laboratories, West Grove, PA, Cat. No. 111-165-
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003; 1:250 dilution). Nuclei were visualized with 4',6-diamidino-2-phenylindole (DAPI, 
Molecular Probes, Carlsbad, CA).  Negative controls were performed with normal rabbit serum 
or isotype-specfic control mouse IgG and did not exhibit positive reactivity in the tissue sections.  
Processed tissue sections were inspected and images recorded with a Leica MZFLIII 
stereomicroscope equipped with a charge-coupled device (CCD) camera (Leica, Welzlar, 
Germany).   
Western blot analysis 
KDM3A, ACTB, histone H3, and histone H3K9 methylation modifications 
(monomethylated: H3K9me1, dimethylated: H3K9me2, trimethylated: H3K9me3) were 
monitored by western blot analysis. Rat TS cell lysates were prepared in 
radioimmunoprecipitation assay (RIPA) buffer (10 mM Tris-HCl, pH 7.2, 1% Triton X-100 or 
1% Nonidet P-40, 1% sodium deoxycholate, 0.1% SDS, 150 mM NaCl, 5 mM EDTA, 1 mM 
sodium orthovanadate, 1 mM  phenylmethylsulfonyl fluoride, 10 μg/ml aprotinin).  Protein 
concentrations were determined by the DC protein assay (Bio-Rad, Hercules, CA). Proteins were 
separated by SDS-PAGE and transferred onto nitrocellulose membranes. Immunoreactive 
proteins were detected with rabbit antibodies to KDM3A (Sigma-Aldrich, Catalog No. 
SAB3500093) and ACTB (Sigma-Aldrich, Catalog No. A1978).  Antibodies to histone H3 and 
histone H3K9 methylated isoforms were obtained from (Abcam, Cambridge, MA; histone H3, 
Catalog No. ab1791; H3K9me1, Catalog No.ab9045; H3K9me2, Catalog No. ab1220; 
H3K9me3, Catalog No.ab8898). Immunoreactive proteins were visualized by enhanced 
chemiluminescence according to the manufacturer’s instructions (Amersham Biosciences, 
Piscataway, NJ). 
 
100 
 
DNA microarray 
Affymetrix 230 2.0 DNA microarray chips (Affymetrix, Santa Clara, CA) were probed with 
cDNAs generated from rat trophoblast stem cells grown under oxygen replete conditions or low 
(0.5%) oxygen exposure. Each treatment group was repeated in triplicate. RNA samples were 
hybridized to the Affymetrix 230 2.0 DNA microarray chip using the GeneChip® Hybridization 
Oven 640 (Affymetrix). Washing and staining of hybridized chips were conducted using the 
GeneChip® Fluidics Station 450 (Affymetrix).Chips were scanned using the Affymetrix 
GeneChip® Scanner 3000 (Affymetrix) with autoloader by the KUMC Biotechnology Support 
Facility. Hybridization signals were normalized with internal controls using the Mas5 algorithm 
in Expression Console (Affymetrix) and fold change computed. Significant differences were 
determined by paired two-tailed Student t-tests. Microarray data was processed for functional 
analysis using Ingenuity Pathway Analysis (Redwood City, CA). Probe sets included in the 
analysis were restricted to those changing at least 1.5 fold between group comparisons with 
signal strengths of ≥ 500 for the maximal value. 
Quantitative RT-PCR (qRT-PCR) 
Total RNA was extracted from cells and tissues using TRIzol reagent (Invitrogen).  
cDNAs were synthesized from total RNA (1 µg) for each sample using Superscript 2 reverse 
transcriptase (Invitrogen), diluted five times with water, and subjected to qRT-PCR to estimate 
mRNA levels. Primers were designed using Beacon primer designer (Applied Biosystems, Foster 
City, CA).  Primer sequences can be found in Table 3.1.1 and 3.1.2.  Real-time PCR 
amplification of cDNAs was carried out in a reaction mixture (20 µl) containing SYBR GREEN 
PCR Master Mix  (Applied Biosystems,) and primers (250 nM each).  Amplification and 
fluorescence detection were carried out using the ABI Prism 7500 real time PCR system  
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Table 3.1.1 Primer sequences of the upregulated genes used for qRT-PCR 
Gene 
Symbol 
GenBank 
Accession  
Number 
Forward 
Primer 
Reverse Primer 
Ppp1r3c NM_001012072 TACCTGAACGACCATCTA AAAGTGTGGCAGAAAGTT 
Mmp12 NM_053963 GCTGGTTCGGTTGTTAGG GTAGTTACACCCTGAGCATAC 
Plod2 NM_175869 TGAGAAGACGAGAGGAATA TAAACAAGATGACCAGAT 
Bhlhe40 NM_053328 ACAATGAGTACAGTTCCTTA ACCGTGATTCCATAACAG 
Kdm3a NM_175764 CTGAGATTCCTGAGCAAGTTATTC AGCCGAAGACTGTTTACATCC 
Ndrg1 NM_001011991 CCCACTAAACTCATTCCT TCAGCATTCAGAACTCTAA 
Il33 NM_001014166 CCAACATATCCGTAACAG GCTTGTAACCAGTAAGTC 
Cd200 NM_031518  TTCTCTATGTGCTTCTATGA AGATGTGAACTACTTGCTA 
Vegfa NM_031836 GCTCTGGGATTTGATATTC TCTTTCCTCTGCTGATTT 
Dpp3 NM_053748 AGAGTTACATTGGCTTCA CTTTGCACTCATGTCTTT 
Mmp9 NM_031055 TACTGCTGGTCCTTCTGA CCGTCCTTGAAGAAATGC 
Slc2a1 NM_138827 GCTCAGTGTCATCTTCATC ACCCTCTTCTTTCATCTCC 
Comt NM_012531 CTGACTTCCTGGCGTATG TTCTCCAAGCCGTCTACA 
Plau NM_013085 TTGGTTCAGACTGTGAGAT GCACTGTTCGTGAGAAAT 
Loxl2 NM_001106047 GCAGAGAAGACTTACAACC AGATGTGTGCTTCAGTTC 
LOC680835 
similar to 
Cullin 7  
XM_002727163 CAAGTCATCAGACCTTCC TTCACATCCGTTTCCATC 
Ankrd37 NM_001108400 TGAGACAGAAGCGGAGTT   TGCCCAACAAGACATCATC 
18S rRNA M11188 GCAATTATTCCCCATGAACG GGCCTCACTAAACCATCCAA 
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Table 3.1.2: Primer sequences of the downregulated genes used for qRT-PCR 
Gene 
Symbol 
GenBank 
Accession  
Number 
Forward 
Primer 
Reverse Primer 
Cdh1 NM_031334 TTCTGAAGACTCCCGATT ATGGACGAGAAAACTGGT 
Ccdc86 NM_001006974 CAACGAGAGCAGTCATCCA TGGGATCACCTCCTCCTTAG 
Rbm3 NM_053696 TCTAGAGGTGGTGGAGAC TCTCTAGACCGCCCATAC 
Id1 NM_012797 CTACCCTGCCTCAGAACC GCGACTTCAGACTCAGAG 
Ncoa3 XM_215947 AGTGTATCGTTTCTCATT TACATCCATTCTGTTCTC 
Kat6a NM_001100570 AATCTTGTATGCTATGGTTA TTATCCTGATGCTGAGTA 
Lin28 NM_001109269 AAACAAGTGTCAAACCAAGATTA GCCCTGTGGAAATAACCT 
Satb1 NM_001012129 GCCACTGGTATTTCCTAC TCCTTCTGACTTCCTGTT 
Hand1 NM_021592 CTCTTTGGAAATCCGAACC CTGGAGATGACACGAAGG 
Cdx2 NM_023963 CAGGAGGAAAGCTGAGTTGG TGCTGCTGTTGCAACTTCTT 
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(Applied Biosystems).  Cycling conditions included an initial hold step (95 °C for 10 min) and 
40 cycles of a two-step PCR (92 °C for 15 sec, then 60 °C for 1 min), followed by a dissociation 
step (95 °C for 15 sec, 60 °C for 15 sec, and then 95 °C for 15 sec). The comparative cycle 
threshold method was used for relative quantification of the amount of mRNA for each sample 
normalized to 18S RNA. 
Chromatin immunoprecipitation (ChIP)  
ChIP analysis was performed according to a previously published procedure (Krieg et al. 
2010). Briefly, TS cells were grown in 150-mm dishes for two days in ambient conditions and 
then exposed to 0.5% oxygen for 24 hours. Cells were then fixed with 1% formaldehyde, and 
purified nuclear lysates were sonicated using a Diagenode Bioruptor (Diagenode, Denville, NJ) 
to prepare DNA fragments at a size of approximately 500 bp. Lysates were immunoprecipitated 
with 3µg of appropriate antibody (H3K9me1, Catalog No.ab9045; H3K9me2, Catalog No. 
ab1220, ABCAM) or with rabbit or mouse IgG (BD Biosciences). Immunoprecipitated 
chromatin fragments were eluted from agarose beads. DNA-protein interactions were reverse 
cross-linked and purified using a QiaQuick PCR purification kit (Qiagen). Purified DNA 
fragments were assessed by quantitative PCR (qPCR) using Mmp12 promoter-specific primers 
(Table 3.1) and SYBRgreen PCR master mix (Applied Biosystems).  Specific primers were used 
for qPCR measurements of H3K9me1 and H3K9me2 enrichment site A (−459 to −322) 
occupancy (forward, AAGGATTCGTGTATTCTAGCA; reverse, 
ACGCCATTAGCAGAGTTT; 138-bp product ) and site B (−207 to −10) occupancy (forward, 
TGAGTGATGACTTAGACAATG; reverse, TCCTTTCAGCAACAGAGT; 197-bp product) at 
Mmp12 locus. Relative occupancy/enrichment was normalized to input samples by use of the 
CT method. 
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Short hairpin RNA (shRNA) constructs and production of lentivirus  
Hif1bshRNA constructs cloned into the pLKO.1 vector were obtained from Open 
Biosystems (Huntsville, AL).  Several shRNAs were tested for each gene evaluated.  The Hif1b 
shRNA sequences used in this analysis are as follows:  i) Hif1b shRNA-1: 
5’GAGAAGTCAGAAGGTCTCTTTTCTCGAGTAAAGAGACCTTCTGACTTCTC3’; ii) 
Hif1b shRNA-2: 
5’CCAGACAAGCTAACCATCTTACTCGAGTAAGATGGTTAGCTTGTCTGG3’.  The 
Kdm3a shRNA sequences used in the analysis are as follows:  i) Kdm3a shRNA-1: 
5’CCGGTGCGGGTAGAAGGCTTCTTAACTCGAGTTAAGAAGCCTTCTACCCGCATTTT
TG3’; ii) Kdm3a shRNA-2: 
5’CCGGGAAGTTCCTGAGCAAGTTATTCTCGAGAATAACTTGCTCAGGAACTTCTTTT
TG3’. 
The control shRNA, which targets no known mammalian gene, pLKO.1-shSCR (Plasmid 1864), 
was obtained from Addgene (Cambridge, MA) and has the following sequence 
5’CCTAAGGTTAAGTCGCCCTCGCTCTAGCGAGGGCGACTTAACCTTAGG3’ (Sarbassov 
et al., 2005a).  Third generation lentiviral packaging vectors were purchased from Addgene and 
included: pMDLg/pRRE (Plasmid 12251), pRSV-Rev (Plasmid 12253) and pMD2.G (Plasmid 
12259). Lentiviral particles were produced as previously reported (Lee et al., 2009).  In brief, 
293FT cells (Invitrogen) were transiently transfected using Lipofectamine 2000 (Invitrogen) with 
the following plasmids: shRNA containing transducing vector, third-generation packaging 
system plasmids (pMDLg/pRRE and pRSV-Rev; 104), and a VSVG envelope plasmid 
(pMD2.G).  After transfection, cells were maintained in 50% DMEM with high glucose 
(Cellgro), 45% Opti-MEM I (Invitrogen) and 5% FBS. Culture supernatants containing lentiviral 
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particles were harvested every 24 h for two to three days.  Supernatants were centrifuged to 
remove cell debris, filter sterilized, concentrated by ultracentrifugation, and stored at -80°C until 
used. 
Ectopic expression of Kdm3a 
Full length mouse Kdm3a expression vector was kindly provided by Dr. Christopher 
Mack, University of North Carolina, Chapel Hill, NC. Flag-tagged pcDNA3 vector expressing 
Kdm3a was transfected into rat TS cells using Lipofectamine 2000 (Lifetechnologies, NY) 
transfection reagent according to manufacturer’s instructions. Cells were selected with Geneticin 
(Lifetechnologies, NY) for 5 days before experiments. 
Matrigel invasion assay 
The invasive ability of rat TS cells was measured as previously described (Peters et al., 
1999).  Rat TS cells were placed in Matrigel invasion chambers (BD Biosciences) at a density of 
2 x 104 cells per chamber.  Cells were allowed to invade for 24 h.  Membranes were collected 
and stained with Diff-Quick (Dade Behring, Newark, DE).  Invading cells were visualized by 
light microscopy and counted. 
Blastocyst outgrowth assay 
The blastocyst outgrowth assay was performed as reported before (Armant et al., 1986). 
Blastocysts were obtained from d4.5 pregnant rats by flushing them from the uterine horns with 
0.1 ml DMEM medium (Lifetechnology). The embryos were cultured at 37°C in a 5% CO2 
incubator for 48 hours to allow hatching from the zona pellucida. They were cultured in rat TS 
Basal Culture Medium. The attached blastocysts were exposed to 0.5 % oxygen for 24 hours in a 
NAPCO Series 8000WJ incubator (Thermo Scientific, Pittsburgh, PA) and then fixed in 4% 
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paraformaldehyde solution. The surface area of outgrowth was visualized using light microscopy 
and measured using Image J software. 
Statistical analyses   
Data analyses were performed using SigmaPlot 11.2 statistical software package (Systat 
Software, Inc, San Jose, CA).  Specific details of the analyses are presented in the figure legends. 
RESULTS 
TS cell transcriptome responses to low oxygen 
 Hypoxia signaling regulates the development of the invasive trophoblast cell lineage 
(Chakraborty et al., 2011; Rosario et al., 2008), which can be effectively modeled in vitro using 
rat TS cells (Chakraborty et al., 2011).  As a first step to identify potential regulatory 
mechanisms downstream of hypoxia exposure, we profiled the transcriptomes of TS cells 
exposed to ambient and 0.5% oxygen for 24 h using DNA microarray analysis (Fig. 3.1A).  This 
culture condition activates HIF signaling pathways and promotes development of the invasive 
trophoblast cell lineage (Chakraborty et al., 2011).  All DNA microarray data will be deposited 
in the Gene Expression Omnibus (GEO) repository. Appendix Tables A 2.1 and A 2.2 show 
abbreviated lists of hypoxia-regulated transcripts.  Genes listed in these tables are those with 
arbitrary expression signal strengths of ≥ 500, a fold change of ≥ 1.5, and a P value ≤ 0.05. 
Similar numbers of transcripts were significantly upregulated (n=786) or downregulated (n=838) 
by low oxygen exposure (Fig. 3.1B). We utilized Ingenuity Pathway Analysis software 
(Ingenuity Systems, Redwood City, CA) to evaluate signaling pathways affected by exposure to 
low oxygen. Functions associated with general cellular movement and survival were upregulated  
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Fig3.1. Analysis of microarray data. A) Schematic showing the experimental plan of hypoxia 
exposure of rat TS cells. B) Scatter graph showing the signal intensity probe sets.  
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Fig3.2. Ingenuity Pathway Analysis of microarray data. Functional analysis of ambient 
oxygen exposed rat TS cell genes and 0.5% oxygen exposed rat TS cell genes using Ingenuity 
Pathway Analysis software. 
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following exposure to low oxygen exposure, whereas cell-to-cell association and stem cell 
maintenance pathways were downregulated (Fig. 3.2). A subset of differentially regulated 
transcripts was further analyzed and validated using qRT-PCR.  The transcripts upregulated by 
low oxygen included transcripts encoding extracellular matrix remodeling enzymes (Mmp12, 
Mmp9, Plau, Dpp3), a histone demethylase (Kdm3a), key regulators of glycogen and glucose 
metabolism (Ppp1r3c), and a number of transcripts known to be regulated by hypoxia and the 
HIF signaling pathway (Benita et al., 2009; Semenza, 2010) (Table 3.2.1).  In contrast, the 
downregulated group included cell-cell adhesion (Cdh1), TS cell-associated (Cdx2, Bmp4, Id2, 
Satb1), cell proliferation-associated (Rbm3, Lin28), and trophoblast giant cell-associated 
(Hand1) transcripts (Table 3.2.2).  In summary gene expression analysis is consistent with rat 
TS cells adapting to low oxygen by differentiation into an invasive trophoblast cell lineage.   
HIF dependence of TS cell responses to low oxygen 
Many cellular adaptations to hypoxia are mediated by the HIF signaling pathway 
(Semenza, 2010).  Since hypoxia-activated TS cell differentiation towards an invasive 
trophoblast cell lineage is dependent on HIF signaling (Chakraborty et al., 2011), we next 
focused on identification of hypoxia-responsive TS cell transcripts, which were dependent on 
HIF signaling.   In order to determine the involvement of the HIF signaling pathway in the 
regulation of TS cell adaptations to low oxygen, HIF1B (the common transcriptional partner for 
HIF1A and HIF2A) was silenced using lentiviral transduction of HIF1B-specific shRNAs 
(Chakraborty et al., 2011). Knockdown of HIF1B attenuated the hypoxia-dependent upregulation 
of several transcripts, such as: Mmp12, Mmp9, Kdm3a, Ppp1r3c, Il33 and Bhlhe40 (Fig. 3.3 A). 
In contrast, the HIF dependence of TS cell transcripts downregulated by low oxygen was not as  
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   Table 3.2.1 Genes upregulated by hypoxia exposure 
 
 
 
 
 
 
 
 
 
 
 
 
       
          (Experiment performed in triplicate; * indicates P<0.05, Student’s t Test) 
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        Table 3.2.2. Genes downregulated by hypoxia exposure 
 
 
 
 
 
 
 
 
 
         (Experiment performed in triplicate; * indicates P<0.05, Student’s t Test) 
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Fig. 3.3. Validation of  hypoxia responsive genes. A) qRT-PCR analyses for hypoxia 
responsive  upregulated genes  . TS cells exposed to ambient or low oxygen and 1control shRNA 
or Hif1b shRNA-1. All experiments were performed in triplicate. Asterisks indicate significant 
differences among groups (P<0.05 analysis of variance with Student-Newman-Keuls method for 
comparisons). B) qRT-PCR analyses for hypoxia responsive downregulated genes  . TS cells 
exposed to ambient or low oxygen and 1control shRNA or Hif1b shRNA-1. All experiments 
were performed in triplicate. Asterisks indicate significant differences among groups (P<0.05 
analysis of variance with Student-Newman-Keuls method for comparisons; ** indicates P,0.05 
between  control shRNA group in ambient conditions and control shRNA group in hypoxic 
conditions). 
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uniform. Cdh1, Hand1 and Rbm3 transcript decreases in response to hypoxia were dependent 
upon HIF signaling but other transcripts like Id1, Lin28, and Satb1 which downregulated in 
response to low oxygen were not significantly affected by HIF1B knockdown (Fig. 3.3 B). 
Similar patterns of HIF-dependence of hypoxia upregulated versus downregulated genes have 
been described (Semenza, 2010).  The results demonstrate that HIF controls oxygen tension-
sensitive genes potentially involved in regulating development of the invasive trophoblast cell 
lineage. 
Role of KDM3A in TS cell adaptations to low oxygen 
Among the candidate mediators of HIF action on trophoblast development identified by 
transcriptome profiling (see above), the discovery of KDM3A was compelling.  Kdm3a is a 
known hypoxia responsive gene and is a direct target of HIF action (Beyer et al., 2008; Krieg et 
al., 2010; Pollard et al., 2008; Wellmann et al., 2008; Yang et al., 2009).  Additionally, histone 
H3K9 demethylases, including KDM3A, are known regulators of differentiation of a range of 
cell lineages, such as embryonic stem cells, extraembryonic endoderm, neural crest, neuronal 
cells, mammary epithelium, and muscle (Kawazu et al., 2011; Ko et al., 2006; Lockman et al., 
2007; Loh et al., 2007; Nottke et al., 2009; Pedersen and Helin, 2010; Qi et al., 2010; Strobl-
Mazzulla et al., 2010; Verrier et al., 2011; Wen et al., 2009).   
Hypoxia and trophoblast differentiation modulate KDM3A expression.  Initially, we 
examined KDM3A mRNA and protein responses to hypoxia using in vitro and in vivo models.  
Exposure of rat TS cells to 0.5% oxygen was an effective stimulus to increase KDM3A transcript 
and protein levels (Fig. 3.4 A,B &C).  KDM3A protein peaked at 16 h following initiation of the 
exposure to low oxygen.  Two related histone H3K9 demethylases, Kdm3b and Kdm3c, were not  
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Fig. 3.4. KDM3A is upregulated on hypoxia  exposure . TS cells maintained in stem cell 
conditions were exposed to low oxygen (0.5%) for 24 h. A) qRT-PCR analyses for Kdm3a  in TS 
cells exposed to ambient or low oxygen. qRT-PCR measurements (SYBR Green) were 
performed using the ΔΔCT method). 18S rRNA served as an internal control. Asterisks indicate 
significant differences among groups (P<0.05 for each gene; Student’s tTest). All experiments 
were performed in triplicate. B) Western blot analysis of KDM3A on rat TS cell exposed to 
ambient or low oxygen (collected every four hour interval upto 24 hours) conditions. C) 
Immunofluorescence staining for KDM3A in TS cells exposed to ambient or low oxygen. D) 
qRT-PCR analyses for Kdm3b and Kdm3c in TS cells exposed to ambient or low oxygen.  
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upregulated following rat TS cell exposure to low oxygen (Fig. 3.4D).  KDM3A transcript and 
protein levels were also upregulated in the ectoplacental cone following exposure of E8.5 
pregnant rats to hypoxic conditions for 24 h (Fig. 3.5).  These in vivo conditions were also 
associated with increases in the expression of other hypoxia responsive genes, including Mmp12 
and Ppp1r3c (Fig. 3.6).  Increased KDM3A expression also accompanies in vitro trophoblast 
differentiation induced by mitogen withdrawal and in vivo trophoblast development (Fig. 3.7 A, 
B, C, D and E). We utilized BeWo trophoblast cells as a human trophoblast cell model. BeWo 
trophoblast cells also respond to hypoxic conditions with increased KDM3A expression (Fig. 
3.8. A&B).  KDM3A could be localized on human placentation sites (Fig. 3.8. C) prominently in 
the first trimester extra villous trophoblast (EVT) columns. A marked decrease in expression of 
KDM3A is observed at term placentation sites. The cytokeratin positive interstitial trophoblast 
cells continue to express KDM3A at term.  Collectively, the results indicate that KDM3A 
expression is regulated by hypoxia and by developmental events leading to trophoblast cell 
specialization.   
Identification of KDM3A responsive genes.   
Since KDM3A exhibited a pronounced increase accompanying hypoxia exposure, we 
postulated that KDM3A might contribute to the regulation of a subset of the genes differentially 
regulated by exposure to low oxygen.  We utilized shRNAs to disrupt KDM3A expression (Fig. 
3.9). Knockdown of KDM3A interfered with TS cell gene expression responses to low oxygen 
(Fig. 3.10).  The hypoxia responsiveness of Mmp12, Ppp1r3c, Il33, Cd200, Plod2 and 
LOC580835 like Cullin 7gene expression was attenuated by knockdown of KDM3A, whereas 
other hypoxia-responsive genes like Bhlhe40, Plau, Dpp3, Ankrd37, Cdh1 and Rbm3 were  
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Fig. 3.5. KDM3A is upregulated on hypoxia  exposure in vivo . A) Rats were exposed to 8.5% 
oxygen for 24 h beginning on d8.5 and sacrificed on gestation d9.5. Gestation d9.5 ectoplacental 
cone tissues were dissected, RNA extracted, and Kdm3a was measured by qRT-PCR. qRT-PCR 
measurements (SYBR Green) were performed using the ΔΔCT method). 18S rRNA served as an 
internal control. Asterisks indicate significant differences among groups (n=5; P<0.05; Mann-
Whitney Rank Sum Test). B) Western blot analysis of KDM3A on rat TS cell exposed to 
ambient or low oxygen (collected every four hour interval upto 24 hours) conditions. C) Rats 
were exposed to 8.5% oxygen or kept at ambient housing conditions for 24 h beginning on d8.5. 
All animals were sacrificed on gestation d9.5. Representative sections through ectoplacental 
cones immunostained for KDM3A counterstained with DAPI. Scale bars=0.125 mm. 
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Fig. 3.6. Hypoxia exposure upregulates Mmp12, Ppp1r3c  in vivo. Rats were exposed to 8.5% 
oxygen for 24 h beginning on d8.5 and sacrificed on gestation d9.5. Gestation d9.5 ectoplacental 
cone tissues were dissected, RNA extracted, and hypoxia responsive genes Mmp12 and Ppp1r3c 
were measured by qRT-PCR. qRT-PCR measurements (SYBR Green) were performed using the 
ΔΔCT method). 18S rRNA served as an internal control. Asterisks indicate significant 
differences among groups (n=5; P<0.05; Mann-Whitney Rank Sum Test). 
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Fig. 3.7. Regulation of KDM3A expression during trophoblast differentiation. A) In vitro 
Kdm3a  expression in rat TS cells during the course of differentiation induced by mitogen 
withdrawal. qRT-PCR measurements (SYBR Green) were performed using the ΔΔCT method). 
18S rRNA served as an internal control. Asterisks indicate significant differences among groups 
(n=5; P<0.05; Student’s t Test). B) Western blot analysis of in vitro KDM3A expression in rat 
TS cells during the course of differentiation induced by mitogen withdrawl. C) In vivo 
developmental expression of KDM3A in placenta from gestation d9.5 to d13.5.  qRT-PCR – 
representative experiments performed in triplicate and evaluated by analysis of variance and 
Tukey’s Test (*P<0.05, comparisons with d9.5). D) Western blot analysis of KDM3A during 
placental development. E) Immunolocalisation of KDM3A on placentation sites from gestation 
d9.5 to d13.5. Scale bar: 0.125 mm. 
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unaffected by KDM3A manipulation (Fig. 3.10).  A complementary experiment was performed 
to examine the regulatory role of KDM3A on gene expression independent of hypoxia.  Ectopic 
expression of KDM3A significantly upregulated Mmp12 and Ppp1r3c gene expression in TS 
cells grown in ambient conditions; however, this treatment was ineffective in altering Il33 
transcript levels (Fig 3.11). Thus, KDM3A is an effective intermediary controlling the 
expression of a subset of TS cell genes regulated by hypoxia/HIF signaling.  The dependence on 
KDM3A is not the same for all KDM3A responsive genes. 
KDM3A regulates hypoxia-activated trophoblast cell invasion.   
Hypoxia is an effective activator of invasive trophoblast lineage development 
(Chakraborty et al., 2011; Rosario et al., 2008).  We next explored whether KDM3A was 
involved in development of the hypoxia-activated invasive trophoblast lineage. Two model 
systems were evaluated:  i) TS cell invasion through Matrigel chambers; ii) blastocyst 
outgrowths (Ain et al., 2003b; Armant et al., 1986; Chakraborty et al., 2011; Peters et al., 1999).  
Exposure to low oxygen stimulates TS cell acquisition of an invasive phenotype and penetration 
through the extracellular matrix and the outward migration and spreading of trophoblast cells 
from attached blastocysts.  KDM3A knockdown significantly decreased hypoxia-stimulated 
trophoblast invasion through Matrigel chambers and blastocyst outgrowth (Fig. 3.12 A &B).  
Ectopic expression of KDM3A in TS cells grown under ambient conditions significantly 
increased their movement through Matrigel chambers (Fig. 3.12 C). Collectively, these results 
indicate that KDM3A is a key regulator of TS cell adaptations to hypoxia, including gene 
expression and their acquisition of an invasive phenotype.   
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Fig. 3.8. KDM3A expression in human placentation. A) Hypoxia stimulates KDM3A 
expression in human trophoblast. BeWo trophoblast cells were incubated for 24 h in ambient O2 
(21%) or low O2 (0.5%). qRT-PCR for KDM3A, representative experiment performed in 
triplicate and evaluated by Student’s t test.  B) Western blot analysis for KDM3A expression.  C) 
Immunolocalization of KDM3A on human placentation sites. Scale bar: 100µm. 
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Fig. 3.9. Knockdown of KDM3A in rat TS cells. TS cells maintained in stem cell conditions 
were exposed to low oxygen (0.5%) for 24 h in the presence of Control (Cntrl) shRNA or Kdm3a 
shRNA-1& 2. A) qRT-PCR analysis for Kdm3a  in TS cells exposed to ambient or low oxygen 
and control shRNA or Kdm3a shRNAs. qRT-PCR measurements (SYBR Green) were performed 
using the ΔΔCTmethod). 18S rRNA served as an internal control. All experiments were 
performed in triplicate. Asterisks indicate significant differences among groups (P<0.05; analysis 
of variance with Tukey’s Test for comparisons). B) Western blot analysis for TS cells exposed to 
ambient or low oxygen and control shRNA or Kdm3a  shRNAs.  
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Fig. 3.10. Expression of hypoxia dependent KDM3A responsive genes. . A) qRT-PCR 
analyses for Kdm3a responsive  upregulated genes . TS cells exposed to ambient or low oxygen 
and control shRNA or Kdm3a shRNA-1. All experiments were performed in triplicate. Asterisks 
indicate significant differences among groups (P<0.05 analysis of variance with Student-
Newman-Keuls method for comparisons). B) qRT-PCR analyses for Kdm3a responsive 
downregulated genes . TS cells exposed to ambient or low oxygen and control shRNA or Kdm3a 
shRNA-1. All experiments were performed in triplicate. Asterisks indicate significant differences 
among groups (P<0.05 analysis of variance with Student-Newman-Keuls method for 
comparisons; # indicates P<,0.05 between  control shRNA group in ambient conditions and 
control shRNA group in hypoxic conditions). 
 
 
 
 
 
 
136 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A 
B 
137 
 
 
 
 
 
Fig. 3.11.Ectopic expression of  KDM3A in rat TS cells. A) TS cells were transfected with 
pcDNA3 or pcDNA3 expressing flag tagged Kdm3a. qRT-PCR analysis for Kdm3a  in TS cells 
transfected with pcCDNA3 vector only or pcDNA3-Kdm3a. qRT-PCR measurements (SYBR 
Green) were performed using the ΔΔCTmethod. 18S rRNA served as an internal control. All 
experiments were performed in triplicate. Asterisks indicate significant differences among 
groups (P<0.05; Student’s t Test for comparisons). B) Westren blot analysis for flag and 
KDM3A expression. C) qRT-PCR analysis for Ppp1r3c and Mmp12 in TS cells transfected with 
pcCDNA3 vector only or pcDNA3-Kdm3a. qRT-PCR measurements (SYBR Green) were 
performed using the ΔΔCTmethod. 18S rRNA served as an internal control. All experiments 
were performed in triplicate. Asterisks indicate significant differences among groups (P<0.05; 
Student’s t Test for comparisons). 
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Hypoxia-dependent histone modifications at the Mmp12 locus 
Several genes upregulated in low oxygen exposed TS cells are sensitive to KDM3A 
manipulation, including, Mmp12.  MMP12 is a matrix metalloelastase that has been implicated in 
trophoblast-directed uterine spiral artery remodeling (Harris, 2010).  KDM3A is a lysine 
demethylase with specificity for histone H3K9me1 and H3K9me2 (Yamane et al., 2006).  
Consequently, we next examined histone H3K9 methylation status within the proximal Mmp12 
promoter region and its susceptibility to regulation by hypoxia using a ChIP assay. Under low 
oxygen tensions, there was significant loss of enrichment of H3K9 mono and dimethyl groups at 
the proximal promoter region of Mmp12 (Fig. 3.13). Such a change in the methylation landscape 
of histone H3K9 at the Mmp12 locus is consistent with hypoxia-induced KDM3A expression and 
its known lysine demethylase activity.    
Hypoxia-dependent global TS cell histone H3K9 methylation modifications 
In other cell types, it has been shown that hypoxia exposure can influence H3K9 
methylation status (Chen et al., 2006; Johnson et al., 2008).  Such observations prompted us to 
evaluate the effects of hypoxia on global H3K9 methylation in TS cells.  Western blots for H3K9 
methylation modifications were performed using lysates harvested from TS cells exposed to 
ambient or hypoxic (0.5% oxygen for 24 h) conditions.  Low oxygen exposure was associated 
with prominent decreases in global H3K9me1 and H3K9me2, whereas modest changes were 
observed for H3K9me3 (Fig. 3.14 A).  Immunocytochemistry in TS cell populations was 
consistent with a hypoxia-driven global down regulation of H3K9me1 (Fig 3.14 C). Disruption 
of KDM3A partly obviated the global effects of hypoxia on H3K9me1 (Fig. 3.14 B).  
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Fig 3.12. KDM3A regulates hypoxia activated trophoblast invasion. A)Assessment of the 
effects of oxygen tension and KDM3A expression on TS cell invasion. Cells penetrating 
Matrigel-coated filters were counted after staining with Diff  Quick. Representative images of TS 
cells from the following conditions are shown: control shRNA and exposure to ambient oxygen,  
control shRNA and exposure to low oxygen, and Kdm3ashRNA-1 &2 and exposure to low 
oxygen. The bar graph shows  quantification of TS cell invasion. All experiments were 
performed in triplicate. Asterisks indicate significant differences among groups (P<0.05; analysis 
of variance with Tukey’s Test for comparisons). B) Effects of oxygen tension and KDM3A 
expression on blastocyst outgrowth assay . The area of the outgrowth was measured using Image 
J software. Representative images of blastocyst outgrowths  from the following conditions: 
control shRNA and exposure to ambient oxygen,  control shRNA and exposure to low oxygen, 
and Kdm3ashRNA-1 &2 and exposure to low oxygen. The bar graph shows  quantification of 
outgrowth area in mm
2 
 (P<0.05; analysis of variance with Tukey’s Test for comparisons).. C) 
Assessment of the effects of ectopic KDM3A expression on TS cell invasion. Cells penetrating 
Matrigel-coated filters were counted after staining with Diff  Quick. Representative images of TS 
cells from the following conditions are shown:  pcDNA3 and pcDNA3 expressing flag tagged 
Kdma3a in ambient oxygen tensions.  The bar graph shows quantification of TS cell invasion. 
Asterisks indicate significant differences among groups (P<0.05;Student’s t Test). 
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Complementary experiments were performed on E9.5 placentation sites of control and 
hypoxia exposed (8.5% O2 for 24 h) rats.  The in vivo findings are consistent with hypoxia-
driven global changes in H3K9 methylation, especially H3K9me1 (Fig. 3.14 D& E).  
In summary, our findings indicate that hypoxia has a global impact on chromatin 
reorganization in TS cells leading to the development of the invasive trophoblast cell lineage and 
places KDM3A within regulatory pathways controlling these events.   
DISCUSSION 
During development, the hemochorial placenta is constructed in response to stimuli 
present in the maternal environment and optimized to facilitate nutrient delivery to the fetus.  
Plasticity in placental organization is achieved via differential regulation of TS cell proliferation 
and differentiation.  Among the myriad of potential signals emanating from the maternal 
environment, oxygen delivery plays a significant role.  Eukaryotic ells have evolved mechanisms 
for adapting to exposure to low oxygen (Semenza, 2010).  TS cells utilize these conserved 
hypoxia-signaling pathways to control placentation (Adelman et al., 2000; Cowden Dahl et al., 
2005; Maltepe et al., 2005; Xie et al., 2011; Zhou et al., 2011).  The proximal response of TS 
cells to hypoxia is differentiation into invasive trophoblast capable of targeting uterine spiral 
arteries with the goal of expanding nutrient flow to the placenta and fetus (Chakraborty et al., 
2011; Rosario et al., 2008).   
 
TS cell adaptations to hypoxia are hierarchically regulated.  Low oxygen exposure elicits 
a broad spectrum of changes in the TS cell transcriptome highlighted by activation of genes  
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Fig. 3.13. ChIP analysis at Mmp12 locus.ChIP analysis of H3K9me1 and H3K9me2 
enrichment at rat Mmp12 proximal promoter region (-500 to +1 bp) on sites A and B (described 
in materials and methods section) in rat TS cells exposed to ambient O2 or 0.5% O2. IgG was 
included as a negative control. Values significantly different are indicated (*, P<0.05). 
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associated with cellular movement, invasion, and vascular remodeling.  A subset of the hypoxia-
induced changes in gene expression is dependent on HIF signaling, especially those genes 
activated by hypoxia.  A subset of HIF-dependent genes is linked to the actions of KDM3A. 
Thus a path can be constructed from hypoxia to HIF activation to increases in KDM3A 
expression to alterations in the histone methylation status of genes promoting development of the  
invasive trophoblast lineage.  
 
 Hypoxia, HIF, and KDM3A have been implicated in regulating epithelial mesenchymal 
transition and cell invasion in disease states, including cancers (Guo et al., 2011; Krieg et al., 
2010; Semenza, 2010; Yamada et al., 2012; Yamane et al., 2006; Yang et al., 2009).   HIF binds 
to hypoxia response elements (HREs) at the Kdm3a locus and stimulates Kdm3a transcription 
(Krieg et al., 2010; Mimura et al., 2012).   KDM3A targets histone H3K9me1 and H3K9me2 for 
demethylation and thus extending and amplifying HIF signaling (Krieg et al., 2010; Mimura et 
al., 2012).   Histone H3K9me2 marks are associated with gene repression, and thus their removal 
is linked to gene activation (Li et al., 2007). Loss of the histone H3K9me2 and H3K9me1 
modifications at the Mmp12 locus correlate with increased Mmp12 expression.  MMP12 is a 
matrix metalloelastase expressed by invasive trophoblast and situated downstream of hypoxia, 
HIF, and KDM3A regulation, with actions on uterine spiral arteries facilitating nutrient delivery 
to extraembryonic and embryonic tissues (Harris, 2010).   
 
KDM3A is specifically targeted to its sites of action within the genome.  HIF1A can 
recruit KDM3A to some of its target genes, including the Glut3 locus, resulting in H3K9me2 
demethylation and transcriptional upregulation (Mimura et al., 2012).  OCT1 is also linked to  
146 
 
 
 
 
 
 
Fig. 3.14. Effect of hypoxia signaling on global H3K9methylation status. A) Western blot 
analysis of rat TS cell exposed to ambient or 0.5% O2 for H3K9me1, H3K9me2 and H3K9me3. 
B) Western blot analysis of  TS cells under following conditions: Control shRNA and ambient 
O2, Control shRNA and 0.5% O2, Kdm3a shRNA1 or Kdm3a shRNA2 and ambient O2, and 
Kdm3a shRNA-1 or Kdm3a shRNA-2  and 0.5% O2 for  H3K9me1, H3K9me2 and H3K9me3. 
C) Immunolocalisation of H3K9me1, H3K9me2 and H3K9me3 on cells exposed to ambient O2 
or 0.5%O2. Cells are counterstained with pan cytokeratin. D) Rats were exposed to 8.5% oxygen 
for 24 h beginning on d8.5 and sacrificed on gestation d9.5. Gestation d9.5 ectoplacental cone 
tissues were dissected, protein lysates were prepared and used for western blot analyses of 
H3K9me1, H3K9me2 and H3K9me3.  Total H3 and ACTB was used to detect equal protein 
loading. E) Immunolocalization of H3K9me1 and H3K9me2 on d9.5 placentation sites from 
animals housed in ambient O2 tension or exposed to 8.5% O2 for 24h. 
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KDM3A recruitment to target genes where KDM3A acts to remove repressive histone marks 
(Shakya et al., 2011).  OCT1 has also been identified as a participant in the regulation of 
trophoblast lineage development (Sebastiano et al., 2010).  KDM3A is also known to interact 
with nuclear receptors, including the androgen receptor, through an LXXLL motif (Yamane et 
al., 2006), providing a method of targeting to relevant loci.  Although the androgen receptor does 
not appear to contribute to the regulation of trophoblast biology, other nuclear receptors such as  
PPARG and ESRRB have been linked to both trophoblast and hypoxia regulation (Ao et al., 
2008; Parast et al., 2009; Rielland et al., 2008). In hypoxic TS cells, KDM3A may be delivered 
by HIF transcription factors to its gene targets in some instances, whereas arrival at other loci 
may be entirely independent of HIF (Mmp12, Ppp1r3c).  This conclusion is based on the 
observed differential outcomes of loss-of-function and gain-of-function KDM3A manipulations 
in TS cells shown in this report.  Elucidation of mechanisms controlling KDM3A arrival at its 
appropriate targets in the TS cell genome is an important future task.   
 
Cells respond to hypoxia with global changes in histone modifications (Johnson et al., 
2008; Melvin and Rocha, 2012).  This epigenetic reorganization is postulated to establish a less 
compact chromatin environment, facilitating rapid transcriptional activation of genes and 
adaptations to hypoxic conditions. Consistent with such observations TS cells respond to 
hypoxia with global changes in histone H3K9me1 and H3K9me2. Recently H3K9me1 has 
achieved some prominence.  Histone H3K9 methylation is a progressive event, wherein H3K9 
monomethyl transferases deposit methyl groups on unmethylated histone H3K9 yielding 
H3K9me1 and H3K9me2 states.  The H3K9 monomethylation mark serves as a recognition 
signal for SUV39H, an H3K9 methyl transferase, which can convert H3K9me1to a more 
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repressive H3K9me3 and bring about heterochromatic silencing (Towbin et al., 2012). Changes 
in histone H3K9 methylation, particularly H3K9 monomethylation, are also observed during 
chromatin assembly implicating its role in maintaining chromatin architecture (Jasencakova and 
Groth, 2010; Loyola et al., 2009).  H3K9 methylation status and SUV39H have also been linked 
to development of the trophoblast lineage (Alder et al., 2010; Rugg-Gunn et al., 2010). 
A role for KDM3A under hypoxic conditions may seem contradictory based on its known 
enzymatic properties.  KDM3A is a α ketoglutarate-dependent dioxygenase and requires oxygen 
for enzymatic activity (Chen et al., 2006; Johnson et al., 2008).  Our findings are consistent with 
Beyer and coworkers who observed the preservation of  KDM3A  histone demethylase activity 
in cells exposed to 0.5% oxygen (Beyer et al., 2008).  Another α ketoglutarate-dependent 
dioxygenase and known regulator of HIF, HIF-asparaginyl hydroxylase, also retains its 
enzymatic function under low oxygen tensions (Stolze et al., 2004).  Distribution of oxygen 
within intracellular compartments may be preserved to maintain enzymes that are critical for 
adaptations to hypoxia.   
  
In summary, our observations connect hypoxia-dependent establishment of the invasive 
trophoblast lineage to an epigenetic modulator called KDM3A.  HIF signaling serves as an 
essential intermediary in the process and key regulator of KDM3A expression.  KDM3A acts on 
the epigenetic landscape of target loci controlling development of the invasive trophoblast 
lineage.  
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CHAPTER 4: 
GENERAL DISCUSSION 
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I. Model 
A summary of our research findings is presented in Figs. 4.1 and 4.2. Fig 4.1 illustrates 
the role of natural killer cells and hypoxia signaling in trophoblast lineage development.  Uterine 
NK cells regulate vascular development, which impacts oxygen delivery and trophoblast lineage 
development, ultimately impacting the structural and functional organization of the 
chorioallantoic placenta. 
Fig 4.2 depicts mechanisms of low oxygen signaling in trophoblast invasion. Low oxygen 
tensions stabilize HIF transcription factors which regulates expression of a number of genes 
involved in hypoxic adaptations. HIF mediated upregulation of histone demethylase KDM3A 
epigenetically regulates a subset of hypoxia responsive genes controlling development of the 
invasive trophoblast lineage. 
II. NK Cells Modulate the Timing of Critical Events During Hemochorial Placentation  
Strategies have been employed to investigate roles for NK cells during the establishment 
of pregnancy.  These have included genetic mouse models possessing NK cell deficiencies (Croy 
et al., 2002) and systemic immunodepletion of NK cells using administration of antibodies to 
asialo GM1 during rat gestation (Chapter 2). The success of the immunodepletion approach is 
gestation-stage dependent and most effective when administered immediately prior to or 
concurrent with embryo implantation.  From the mouse genetic models we learned that NK cells 
promote uterine spiral artery remodeling, including decreasing arterial smooth muscle wall 
thickness and increasing vessel lumen diameter(Guimond et al., 1997). NK cell 
immunodepletion in the rat results in striking changes in uterine spiral arteries, characterized  
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Fig. 4.1. Schematic diagram showing the role of NK cells and hypoxia/HIF signaling in the 
regulation of trophoblast cell differentiation. NK cells regulate uterine vascular development, 
which impacts oxygen delivery ( O2) and trophoblast lineage decisions, regulating the 
organisation of the chorioallantoic placenta. Differentiated trophoblast lineages in the labyrinth 
zone include syncytial trophoblast. Differentiated trophoblast lineages in the junctional zone 
include trophoblast giant cells, spongiotrophoblast cells, glycogen cells and precursors for 
invasive trophoblast cells. 
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Fig4.2. Schematic showing the mechanism of hypoxia signaling mediated KDM3A action 
and trophoblast invasion. Hypoxia signaling activates KDM3A expression which brings about 
epigenetic modifications of H3K9 methylation status affecting the invasive behavior of the rat 
trophoblast cells.  
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initially by a delay in uterine spiral artery development and progression toward the placenta and 
subsequently by an acceleration of endovascular invasive trophoblast cell movement and 
extensive uterine spiral artery remodeling. These physical changes include replacement of the 
endothelium with endovascular trophoblast cells, their acquisition of a pseudo-endothelial 
phenotype, the disappearance of smooth muscle cells in the tunica media of the modified uterine 
spiral artery, distention of uterine spiral artery lumen, and an increased capacity for blood 
delivery to the placenta.  Thus, NK cells possess two apparently contradictory actions in 
establishing the hemochorial placenta:  1) they promote uterine spiral artery development and 
remodeling; and 2) they restrain trophoblast-directed uterine spiral artery remodeling. The 
relative impact of each action on uterine spiral artery remodeling is not equivalent.  Invasive 
trophoblast-directed uterine spiral artery restructuring is far more extensive than NK cell-
directed uterine spiral artery restructuring.  It is apparent that these opposing efforts are 
interconnected in an important way.  The presence of NK cells delays and reduces the magnitude 
of trophoblast-directed uterine spiral arterial modifications, which is viewed as a maternally 
protective adaptation. 
Oxygen tension is a key mediator of NK cell actions at the placentation site 
NK cells have profound effects on the organization of the placentation site, including the 
development and function of the invasive trophoblast cell lineage.  These cells have been 
proposed to affect invasive trophoblast cells through their secretion of an assortment of 
cytokines/chemokines and via direct cell-cell interactions (Lash et al., 2010; Trowsdale and 
Moffett, 2008; Zhang et al., 2011). Some factors produced by NK cells stimulate invasive 
properties of trophoblast cells, whereas other NK cell-derived factors inhibit trophoblast 
invasion.  These observations are based exclusively on in vitro experimentation and are difficult 
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to reconcile.  A compelling hypothesis has also been proposed for direct NK cell-invasive 
trophoblast cell engagement (Chazara et al., 2011; Trowsdale and Moffett, 2008). NK cells 
possess surface receptors termed killer inhibitory receptors (KIRs), which specifically recognize 
histocompatibility antigens on the surface of trophoblast located at the maternal-fetal interface.  
This cell-cell interaction modifies NK cell and trophoblast cell function.  Two observations 
support an involvement of NK cell-invasive trophoblast cell adhesion in hemochorial 
placentation:  i) the existence of specific NK cell KIR receptor and histocompatibility antigen 
isoform combinations in successful pregnancies versus pregnancies afflicted with 
preeclampsia;(Chazara et al., 2011; Hiby et al., 2010; Hiby et al., 2004) and ii) the observation 
that endovascular trophoblast invasion and uterine spiral artery remodeling is affected by 
maternal and paternal histocompatibility antigen combinations (Madeja et al., 2011). These 
paracrine and cell-cell modes of NK cell action on trophoblast cells may be operative during the 
establishment of the hemochorial placenta; however, they are probably secondary to the more 
fundamental action of NK cells on uterine spiral artery development.  The latter activities are 
likely mediated by a myriad of angiogenic and vasoactive factors secreted by NK cells (Zhang et 
al., 2011). 
NK cells regulate uterine spiral artery development and in doing so control oxygen 
tension at the early placentation site.  The absence of NK cells at the maternal-fetal interface 
results in a transient hypoxia. The effects of NK cell depletion on invasive trophoblast-directed 
uterine spiral artery remodeling can be mimicked by appropriately timed in vivo hypoxia 
exposure (Rosario et al., 2008). A critical developmental window of sensitivity to in vivo 
hypoxia exposure exists between E8.5 and E9.5 of rat pregnancy.  This gestational interval 
represents a key developmental phase associated with commitment of trophoblast stem 
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(TS)/precursor cells to differentiated trophoblast cell lineages of the junctional zone versus the 
labyrinth zone.  In addition to the robust extension of endovascular trophoblast invasion deep 
into the uterine spiral arteries in both NK cell depleted and maternal hypoxia in vivo models, the 
junctional zone also undergoes an expansion relative to the labyrinth zone (Rosario et al., 2008). 
III. Hypoxia signaling in trophoblast invasion 
TS cell populations are an excellent in vitro model system for elucidating mechanisms 
regulating differentiation (Asanoma et al., 2011; Tanaka et al., 1998).  TS cell exposure to a 
range of oxygen tensions can differentially influence cell proliferation and differentiation 
(Adelman et al., 2000; Xie et al., 2011; Zhou et al., 2011). The impact of oxygen tension on 
development of invasive trophoblast lineages from TS cell populations has received little 
attention.  Low oxygen tensions can promote differentiation of TS cells towards junctional zone 
trophoblast cell lineages. At least some of these hypoxia-stimulated actions are mediated by the 
HIF transcription factor complex (Adelman et al., 2000). Disruption of HIF signaling impairs TS 
cell responses to low oxygen and acquisition of an invasive phenotype. Whether these HIF 
actions are at specific gene loci controlling the invasive trophoblast cell lineage or are indirect 
through more widespread epigenetic modifications and how they differentially affect TS cell 
proliferation versus differentiation remain to be determined (Maltepe et al., 2005). Identifying 
the biology of specific hypoxia-sensitive and HIF target genes should provide insight into the 
regulatory machinery controlling the invasive trophoblast cell lineage. 
Oxygen tension is an important stimulus for placentation. Oxygen tension at the maternal 
fetal interface changes throughout gestation and is dependent on placental development. 
Availability of oxygen and developmental variations of oxygen tension can have different 
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consequences depending on the stage of gestation. Low oxygen tension can be a developmental 
cue for placental organization and adaptive responses associated with placental development. 
Alternatively, it can also be a consequence of defective, pathological placentation wherein 
improper vascular remodeling results in poor placental perfusion and inefficient nutrient 
delivery. We utilized low oxygen tension as a developmental trigger to study hemochorial 
placentation and performed global TS cell gene expression analysis to identify targets of low 
oxygen exposure. We determined that hypoxia promotes a unique differentiated invasive 
trophoblast lineage, which is characterized by downregulation of trophoblast stem cell associated 
genes, loss of expression of genes involved cell contacts, upregulation of genes involved in 
extracellular matrix remodeling, cell movement, and vascular restructuring. 
In this study we identified several genes regulated by HIF signaling. Knockdown of the 
HIF1B, the common binding partner for HIF1A and HIF2A affected hypoxia responses in TS 
cells. HIF1B has other binding partners so further studies should be conducted to study roles of 
HIF1A or HIF2A in TS cell adaptations to hypoxia. We envisage modest effects on disruption of 
HIF1A or HIF2A since it is known that they act on an overlapping set of target genes (Bracken et 
al., 2006; Hu et al., 2006a; Raval et al., 2005) . This conclusion is further supported from 
analysis of mouse placentation following mutation of HIF1A, HIF2A, or both HIF1A and HIF2A 
(Cowden Dahl et al., 2005). ChIP  analysis with antibodies specific to HIF1A or HIF2 at known 
hypoxia responsive target genes such as Kdm3a and Bhlhe40 or alternatively at a genome-wide 
view using ChIP seq.  
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Significance of the HIF targets 
We have identified hypoxia signature of gene expression in rat TS cells. These genes are 
reflective of hypoxic adaptations and their functional roles in the process of invasion need to be 
evaluated. An emerging pattern of gene function in a subset of genes was related to various 
aspects of invasion. Mmp12 (Harris, 2010), Plod2 (Evens et al., 2010; Noda et al., 2012), Mmp9 
(Peters et al., 1999), Loxl2 (Luo et al., 2012; Wong et al., 2012), Cul7 (Fu et al., 2010) are 
known have prominent function of extra cellular matrix remodeling, invasion and metastses. We 
have observed significant downregulation of expression Cdh1 which is a hallmark of epithelial 
mesenchymal transition reported in a number of different cell types (Vicovac and Aplin, 1996). 
Bhlhe40 (Hughes et al., 2004; Xie et al., 2011) and Hand1 (Martindill et al., 2007) are 
trophoblast differentiation markers and are upregulated and downregulated, respectively  in 
hypoxia exposed TS cells. Hand1 is a key transcription factor involved in the differentiation of 
trophoblast giant cell lineage (Hughes et al., 2004; Martindill et al., 2007). Consistent with the 
known function of HAND1, our results demonstrate that hypoxia drives TS cells toward a unique 
non-giant cell invasive lineage. 
 The significance of changes in the expression level of each of the genes listed above to 
acquisition of the invasive trophoblast lineage should be evaluated. Mouse models are potentially 
available; however, mouse and rat placentation are not equivalent processes. The mouse exhibits 
shallow trophoblast invasion, which differs dramatically from the extensive trophoblast invasion 
occurring in the human. Our research shows the importance of utilizing rat models to study 
trophoblast invasion and uterine spiral artery restructuring.Gene targeting of rat ES cells is a 
recent technique for generating rat models with a modest success rate (Tong et al., 2011). Other 
techniques include trophoblast specific knockdown of genes utilizing lentiviral shRNA 
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delivery(Lee et al., 2009), gene targeting via zinc finger nucleases (Geurts et al., 2009) and use 
of transposon systems to disrupt gene function (Lu et al., 2007).  
Hypoxia dependent global epigenetic changes in rat TS cells 
Our approach in trying to understand the molecular mechanisms underlying hypoxia 
signaling in trophoblast cells is built on the premise that TS cells developmentally experience 
low oxygen tensions, differentiate and move toward correcting the oxygen deficit. Thus transient 
exposures to low oxygen, especially in vitro, are potentially more physiologically relevant. 
Chronic exposure to extremely low oxygen tensions can generate pathological responses which 
will not be reflective of the adaptive response. In our experiments 0.5% oxygen tensions caused 
a unique differentiated lineage of trophoblast cells possessing an invasive phenotype. Along with 
the increased invasiveness, we also observed global changes in H3K9 methylation patterns. 
Biological significance associated with these dramatic global changes in histone marks needs to 
be deciphered. Genome wide locations of H3K9me1 and H3K9me2 methylation in ambient and 
hypoxia exposed TS cells will provide information regarding the possible regulatory roles of 
these histone marks. ChIP sequencing (seq) studies with antibodies to each histone mark will 
facilitate localization of relevant genomic regions and their correlation with potential regulatory 
mechanisms controlling adaptations to hypoxia and invasive trophoblast lineage development. A 
similar strategy has been used to dissect hippocampal gene networks controlling responses to 
stressors. Hippocampal H3 histone methylation, especially H3K9me3 is regulated by acute and 
chronic stress in the rat (Hunter et al., 2009). ChIP seq localized stress induced H3K9me3 
enrichment to sites responsible for silencing endogenous retroviral elements (Hunter et al., 
2012). 
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In our analysis we observed global changes in histone H3K9 methylation.  Others have 
observed that hypoxia exposure results in global epigenetic changes in histone methylation and 
acetylation (Johnson et al., 2008).  Expansions of repressive H3K27 trimethylation marks and 
activating H3K4 trimethylation marks following hypoxia have been observed.  Parameters of 
hypoxia exposure (duration and concentration) and cell type should be considered in further 
investigations. 
KDM3A as a mediator of hypoxia dependent adaptations in rat TS cells 
Low oxygen tension stabilizes HIF transcription factors, which control cellular 
adaptations at a transcriptional level and through regulation of epigenetic modifiers. The latter 
represents a global mechanism of regulation extending the breadth of HIF influence.  In TS cells 
KDM3A is rapidly upregulated in response to hypoxia in a HIF-dependent manner.  KDM3A is a 
histone H3K9 demethylase and controls the expression of a subset of hypoxia/HIF responsive 
genes and development of the invasive trophoblast lineage.  We expect that KDM3A directs 
differentiation through its actions at specific loci throughout the genome.  Again a ChIP seq 
approach for identifying enrichment of KDM3A at specific genomic sites will be informative.    
Histone H3K9me1 and H3K9me2 enrichment at the Mmp12 locus in TS cells was 
influenced by hypoxia exposure.  Whether this event is dependent upon the activities of KDM3A 
is unknown.  Additionally, the breadth of KDM3A action on the distribution of genome-wide 
changes in H3K9me1 and H3K9me2 marks is unknown.  Combining a ChIP seq analysis of 
histone H3K9 methylation with genome-wide KDM3A localization will help address this 
uncertainty.   
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Activation of HIF signaling pathways under low oxygen tensions upregulate a variety of 
other JmJc domain containing demethylases which include Kdm4b, Kdm4c, Jarid1b (Krieg et al., 
2010; Pollard et al., 2008). These demethylases act on different histone methylation marks. 
Kdm4 family of demethylases act on H3K93me/2me and H3k363me/2me and Jarid1b acts on 
H3K4-2me/3me (Mosammaparast and Shi, 2010). Presumably these different JmJc domain 
containing demethylases possess unique as well as overlapping targets and contribute to a 
complex histone H3 methylome characteristic of cells undergoing adaptations to hypoxia.  The 
conditions of our experimentation were not associated with dramatic changes in KDM4 or 
JARID1B demethylases.  
 
IV.    Relevance of our research to human placentation and human pregnancy 
disorders 
Pregnancy associated disorders 
There are a number of pregnancy associated disorders in humans which are associated 
with improper trophoblast development and differentiation leading to inadequate trophoblast 
invasion and vascular remodeling. Preclampsia syndrome is one of the most common placental 
pathology occurring in 3-5% of first pregnancies (Kanasaki and Kalluri, 2009). It is 
characterized by mild to severe maternal hypertension and proteinuria around midgestation 
and/or mild to severe intrauterine fetal growth restriction. Preeclampsia is one of the leading 
causes of maternal and fetal death during pregnancy. Poor traophoblast invasion leads to 
insufficient prefusion of the placenta which triggers placental hypoxia. This causes upregulation 
of placental anti-angiogenic factors like soluble Flt1 (Levine et al., 2004; Maynard et al., 2003) 
which results in the angiogenic factor imbalance and subsequent disruption of vascular 
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endothelium and maternal cardiovascular system (Maynard and Karumanchi, 2011; Powe et al., 
2011). Possible cures include premature delivery of the baby and the placenta. 
IUGR is another pregnancy associated disorder which is characterized by small for 
gestational age babies (Scifres and Nelson, 2009). Causes of the disease can be traced back to 
improper placental development as well as shallow trophoblast invasion leading to inefficient 
vascular remodeling.  IUGR can result in developmentally growth retarded babies, disability and 
even fetal death. Research has shown that placental environment can play a huge role in 
determining adult life health disorders like hypertension, cardiovascular disease, renal diseases 
and diabetes to name a few (Barker, 2007; Thornburg et al., 2010a; Thornburg et al., 2010b). 
Uterine NK cells and pregnancy associated disorders: 
Recent studies have implicated role of decidual NK cells in vascular smooth muscle cell 
apoptosis(Fraser et al., 2012). Studies show in a co-culture in vitro model that decidual NK cells 
from normal pregnancies can initiate trophoblast invasion disrupting vascular endothelium, 
however when decidual NK cells obtained from high resistance pregnancies are co-cultured with 
trophoblast cells, impaired vascular remodeling and reduced invasiveness is observed. (Fraser et 
al.,2012). Peripheral NK cell number has been shown to stay unchanged in preeclamptic 
pregnancies, aberrant NK cell expression and increased NKG2A- and NKG2C surface receptors 
have been observed in preeclampsia (Bachmayer et al., 2009) . 
NK cells exhibit a polarity in their production of cytokines during pregnancy. Similar to 
other types of immune cells, NK cells also shift from Th1 to Th2 cytokines as pregnancy 
progresses. Persistence of NK cell Th1 production (e.g. Tumor Necrosis Factor α) is associated 
with a higher incidence of abortions.  
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Elevated NK cell cytotoxicity is also associated with implantation failure after in vitro 
fertilization and embryo transfer and in women experiencing recurrent pregnancy loss(Fukui et 
al., 2011) . Correlations have been made between cell surface expression of receptors in 
peripheral NK cells and pregnancy outcomes. A significant decrease in the percentage of 
CD56bright/NKp46+ cells is detected in preeclamptic patients 3-4 months before the onset of 
preelampsia (Fukui et al., 2012). 
  Finally, increased numbers of uterine NK cells have been observed at the placental 
interface in preeclamptic (Reister et al., 2006) and IUGR (Williams et al., 2009) pregnancies. 
Furthermore, excessive LIF production by NK cells in preeclamptic pregnancies has been 
associated with reductions in matrix metalloprotease synthesis by extravillous trophoblast 
(Reister et al., 2006). 
Hypoxia signaling and pregnancy associated disorders: 
Role of HIF transcription factors in preeclampsia remains debatable. This is largely due 
to the fact that hypoxia signaling seems to be playing instructive role in shaping of the placenta 
during early gestation. The placenta develops under low oxygen tensions until the uterine 
maternal vasculature is remodeled by invading trophoblast cells (Rodesch et al., 1992). HIFA is 
highly expressed in early gestation trophoblast cells and is subsequently downregulated around 9 
weeks of gestation (Caniggia et al., 2000). However this issue is complex. Failures in 
placentation caused by shallow trophoblast invasion result in impaired placental perfusion, and 
trigger chronic hypoxia signaling, which leads to pathogenesis.  
HIF1A expression may be upregulated in preeclampsia. HIF-1A RNA expression in 
maternal plasma is increased in pregnant women with preeclampsia and IUGR (Ashur-Fabian et 
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al., 2012). A role for HIF-1A in the pathogenesis of preeclampsia has also been determined from 
investigation of placentation in women residing at high altitudes experiencing chronic hypoxia 
(Zamudio et al., 2007). Preelampsia incidence is higher in these women and their placentas show 
elevated HIF1A expression (Zamudio et al., 2007). A number of downstream effectors of HIF 
signaling involved in the pathogenesis of preeclampsia have been identified. Anti-angiogenic 
factors  like Endothelin (Yamashita et al., 2001), sFlt1(Nevo et al., 2008; Nevo et al., 2006), 
Endoglin (Yinon et al., 2008) are hypoxia responsive and significantly upregulated in IUGR and 
preeclamptic placentas. Urocortin peptides are also HIF targets and elevated in preeclampsia 
(Imperatore et al., 2010). Urocortin peptides are known to be local regulators of myometrial 
contractility (Florio et al., 2004).  
Stabilization is a key process regulating HIF activities. Early onset preeclamptic 
placentas exhibit decreased proteosomal degradation of HIF-1A (Rajakumar et al., 2006; 
Rajakumar et al., 2008). PHD2 and FIH are involved in stabilization and activation of HIF 
transcription factors and have been shown to be downregulated in early onset preeclampsia 
syndrome (Rolfo et al., 2010). Manifestation of the pathological features of preeclamptic disease 
is linked to an impaired ability of the trophoblast cells to respond and adapt to gestation 
dependent variations in oxygen tensions (Tal, 2012).  
Hypoxia responsive invasion and vascular remodeling related genes in preeclampsia 
and IUGR 
Several of the hypoxia responsive genes have been investigated in preeclampsia, 
including Plau, Mmp9,  Comt, Cul7, Cdh1,Fasl,Glut1, Vegfa. PLAU is an established biomarker 
of Preeclampsia and complicated hypertensive pregnancies. Plasma concentrations of PLAU are 
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downregulated in severe preeclamptic pregnancies and IUGR (Koh et al., 1993; Lindoff and 
Astedt, 1994), as is cell surface PLAU activity (Graham and McCrae, 1996). Although the 
significance of MMP9 in the etiology of preeclampsia syndrome is unknown, increased MMP9 
levels have been observed in preeclamptic placentas (Wang et al., 2010). Two methoxy estradiol 
(2ME) is generated by the enzymatic activities of COMT. Plasma concentrations of 2ME are low 
in preeclamptic pregnancies (Perez-Sepulveda et al., 2012; Seol et al., 2012). The Val158Met 
COMT polymorphism is associated with increased COMT activity and a decreased risk to 
develop preeclampsia, suggesting a protective role against preeclampsia. Conversely, a low 
COMT activity haplotype has been linked to higher risk of recurrent preeclampsia (Kanasaki et 
al., 2008; Roten et al., 2011). 
The CUL7 gene is upregulated in IUGR and preeclampsia associated with IUGR, with 
extensive promoter hypomethylation observed in IUGR placentae (Gascoin-Lachambre et al., 
2010). CDH1 plays an important role in cell-cell adhesion and epithelial to mesenchymal 
transitions. Variations in the expression of CDH1 and its repressor SNAIL are observed in 
preeclamptic placentas (Brown et al., 2005). FASL, a regulator of apoptosis, is significantly 
down regulated in placental villi of preeclamptia patients (Neale and Mor, 2005). Serum FASL 
concentrations have also been used as biomarker of the preeclampsia (Laskowska et al., 2006). 
IUGR is also associated with reduced glucose transport to the fetus and decreased expression of 
placental GLUT1 (Zamudio et al., 2010). In pregnancies with adverse outcomes, (gestational 
hypertension, small for gestational age and pre-term birth) reduced VEGF family of angiogenic 
factor mRNAs is observed (Andraweera et al., 2013). In a recent bioinformatics study accessing 
publicly available preeclampsia databases, VEGF family along with its receptors have found 
significant correlation with the disease (Tejera et al., 2012). Numerous polymorphisms 
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associated with VEGFA are correlated to pregnancies complicated with adverse outcomes 
(Andraweera et al., 2013; Andraweera et al., 2011). 
KDM3A in the human placenta 
Knowledge of the role of KDM3A in human trophoblast is limited. KDM3A can be 
localized in the first trimester trophoblast samples, particularly strong immunostaining was 
observed in the extravillous trophoblast columns (Chapter 3; Fig 3.8C). Its expression can also 
be observed in the Bewo cell line and upregulation of Kdm3a can be observed on hypoxia 
exposure both at transcript and protein levels (Chapter 3; Fig 3.8 A&B). Thorough investigations 
are needed to evaluate the role of KDM3A in human trophoblast cells. First trimester trophoblast 
may be the best choice to understand the role of KDM3A in the process of low oxygen signaling 
dependent trophoblast invasion. Although the potential for mechanistic studies on role of 
KDM3A in human placentation is limited, KDM3A expression, activity and polymorphisms can 
be investigated in normal as well as complicated pregnancy outcomes. 
V. Overview of the importance of the work 
We have identified the importance of maternal environment on development of 
placentation. Our work identified uterine NK cells as regulators of placentation, particularly fine 
tuning oxygen availability at the developing placentation site. Availability of oxygen acted as a 
developmental cue for the organization of chorioallantoic placentation and the process of 
invasive trophoblast lineage development. In the later part of the work, we have identified 
mechanisms underlying hypoxia signaling. These efforts started with gene profiling experiments 
in rat TS cells and led to the identification of KDM3A, a key mediator of hypoxia dependent 
epigenetic reorganisation and development of the invasive trophoblast lineage. This knowledge 
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derived from the rat placentation model can be utilized to elucidate specific mechanisms 
underlying regulation of hemochorial placentation in normal and pathologic pregnancies. 
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Table A1.1. Genes associated with the biopathways analyzed by Ingenuity Pathway Analysis 
Category Functions 
annotations 
p- value Predicted  
activation 
state 
Activation 
Z score 
Molecules 
Cell Cycle segregation of 
chromosomes 
3.66E-06 Decreased -2.138 BUB1 (includes 
EG:100307076),CCNA2,CCNB1,CCNB
2,CIT,DDX11/DDX12P,EBNA1BP2,EC
T2,ESPL1,GPSM2,KIF2C,NCAPD2,NC
APD3,PLK1,PTTG1,SKA2,SPC25 
(includes 
EG:100144563),SYCP3,TOP2A,ZW10 
Cellular Assembly 
and Organization 
segregation of 
chromosomes 
3.66E-06 Decreased -2.138 BUB1 (includes 
EG:100307076),CCNA2,CCNB1,CCNB
2,CIT,DDX11/DDX12P,EBNA1BP2,EC
T2,ESPL1,GPSM2,KIF2C,NCAPD2,NC
APD3,PLK1,PTTG1,SKA2,SPC25 
(includes 
EG:100144563),SYCP3,TOP2A,ZW10 
DNA Replication, 
Recombination, 
and Repair 
segregation of 
chromosomes 
3.66E-06 Decreased -2.138 BUB1 (includes 
EG:100307076),CCNA2,CCNB1,CCNB
2,CIT,DDX11/DDX12P,EBNA1BP2,EC
T2,ESPL1,GPSM2,KIF2C,NCAPD2,NC
APD3,PLK1,PTTG1,SKA2,SPC25 
(includes 
EG:100144563),SYCP3,TOP2A,ZW10 
Cellular Growth 
and Proliferation 
proliferation of 
cells 
3.01E-05 Decreased -2.553 AATF,ACACA,ACTN1,ADAM15,AD
M,AFAP1L1,AK4,AKT1S1,ALKBH1,A
NP32A,APBB2,APEX1,APPL1,ARID5
B,ARIH2,ATF4,ATF6,ATIC,AURKA,B
4GALT6,BARX1,BBC3,BCAT1,BCCIP
,BCL3,BCL6,BCR,BHLHE40,BHLHE4
1,BMP4,BMPR1A,BMPR2,BNIP3,BSG
,BTG2,BUB1 (includes 
EG:100307076),BYSL,C10orf54,C14orf
169,CASP6,CBLB,CCDC92,CCNA2,C
CNB1,CCNG1,CCNG2,CCNI,CD164,C
D82,CDC20 (includes 
EG:107995),CDCA8,CDCP1,CDH1,CD
KN1B,CHCHD6,CHEK1,CITED2,CLD
N15,CLDN4,CLK1,CLTC,COMMD5,C
OMT,CREM (includes 
EG:12916),CTSF,CUL7,CYP20A1,DD
B1,DDIT3,DDX11/DDX12P,DDX21,D
DX56,DHPS,DNAJB1,DNAJB2,DNAJ
B6,DNM1L,DUSP1,E2F5,E2F8,EBNA1
BP2,ECT2,EFEMP2,EFNA1,EFS,EGLN
1,EGLN3,EGR1,EIF2AK4,EIF2B1,EIF4
EBP1,EIF4G2,ELF3,ELL,EMP3,EOME
S,EPS8,ERO1L,ERRFI1,ESPL1,ETV5,
EXOSC2,EXOSC4,EXOSC9,F11R,FAB
P3,FASLG,FASN,FBLN1,FKBP5,FLOT
2,FOXO4,FRMD6,FRS2,FTSJ3,GADD4
5A,GADD45B,GCAT,GCLC,GFER,GIP
C1,GNG2,GNL3,GPI,GPNMB,GRB2,G
SS,GTPBP4,H2AFX,H2AFY,HAND1,H
BP1,HDAC5,HDAC6,HELLS,HES6,HE
XB,HIF1A,HK1,HK2,HNRNPAB,HS6S
T1,HSP90B1,HSPA1A/HSPA1B,HYAL
2,ID1,ID2,ID3,IER3,IGF2BP3,IGFBP2,I
L11RA,IL23A,IL33,IL6ST,INSIG1,IRF
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2,ITGA3,ITGA7,IVNS1ABP,JUN,KIA
A0101,KIF20A,KIF2C,KLF4,KPNA2,K
SR1,LAMC1,LIN28A,LMNB1,LMNB2,
LTBP1,MAD1L1,MAFF,MAGED2,MA
P3K1,MAP3K7 (includes 
EG:26409),MAP3K8,MAPK14,MAPT,
MFSD12,MGAT1,MIF,MLLT3,MMP12
,MMP9,MN1,MSX1,MT1E,MT1H,MT
HFD1,MYBBP1A,MYC,MYCL1,NAE1
,NAMPT,NASP,NCOA3,NDE1 
(includes 
EG:54820),NDUFAF4,NF2,NOA1,NOL
8,NOLC1,NOP2,NOTCH2,NPDC1,NPY
,NQO1,NRF1,NTAN1,NUB1,NUBP1,N
UDC,OSTF1,PAK1IP1,PAWR,PDCD4,
PDGFA,PDIA3,PDXK,PGK1,Phb,PHC1
,PHLDA2,PI4KA,PIK3CA,PLAT,PLAU
,PLIN3,PLK1,PNPT1,POLD4,POMGN
T1,PPAN,PPAT,PPM1D,PPP2R1B,PRD
X3,PREB,PRG2,PRKCD,PRMT1,PRPF
4B,PSAP,PSMB10,PSMC4,PSMC5,PS
ME3,PTHLH,PTTG1,Pvr,RAD51,RAF1
,RALB,RASD1,RBBP7,RBM3,RBM38,
Rbpj,RBPJ,RHOB,RNF139,RNF2,RNF4
,RORA,RRM2,S1PR1,SATB1,SCAMP2
,SCPEP1,SDC1 (includes 
EG:20969),SENP1,SERPINH1,SET,SF3
B3,SFN,SHMT1,SLC2A1,SLC9A3R1,S
MAD2,SMARCB1,SMC3,SOS1,SPHK1
,SRC,SREBF1,SRSF2,SRSF3,SRSF5,SS
BP1,SSBP3,STMN1,STRN,SURF4,TA
CC1,TBP,TBRG4,TCOF1,TERF1,TES,
TFAP2A,TFPI,TFRC,TGM2 (includes 
EG:21817),THOC1,TIMELESS,TJP2,T
NFRSF12A,TOB1,TOP2A,TSC22D1,T
SPAN31,TSPO,TTC5,TUSC2,TXNL1,T
YMS,UBE2C,UHRF2,UPP1,USP10,UT
P20,VAMP8,VDAC1,VEGFA,VHL,VL
DLR,WDR12,WDR77,WIPF1,WNK2,
WTAP,WWTR1,YPEL3,ZFP36L2,ZNF
259 
Cellular Growth 
and Proliferation 
cytostasis 1.20E-03 Decreased -2.483 ANP32A,BCL6,BCR,BHLHE40,BMP4,
BMPR1A,BMPR2,CASP6,CDCA8,CD
H1,CDKN1B,EGR1,GPI,HBP1,HDAC6
,HSPA1A/HSPA1B,ID1,ID2,IRF2,JUN,
LTBP1,MAD1L1,MAPK14,MIF,MYC,
NF2,NQO1,PRMT1,RAF1,RBPJ,SMAD
2,SMC3,SRC,TFAP2A,TOP2A,TTC5 
Cellular Growth 
and Proliferation 
proliferation of 
lung cancer cell 
lines 
1.77E-03 Decreased -2.300 BBC3,CDCA8,CDCP1,CHEK1,ECT2,E
RRFI1,H2AFY,HK1,HK2,ID1,MAP3K7 
(includes 
EG:26409),MAPK14,MYC,NASP,NCO
A3,NOTCH2,PIK3CA,PLK1,POLD4,P
RKCD,RAF1,RASD1,RHOB,SET,STM
N1,TSPO,TUSC2,WDR12 
Cellular 
Development 
proliferation of 
lung cancer cell 
lines 
1.77E-03 Decreased -2.300 BBC3,CDCA8,CDCP1,CHEK1,ECT2,E
RRFI1,H2AFY,HK1,HK2,ID1,MAP3K7 
(includes 
EG:26409),MAPK14,MYC,NASP,NCO
A3,NOTCH2,PIK3CA,PLK1,POLD4,P
RKCD,RAF1,RASD1,RHOB,SET,STM
N1,TSPO,TUSC2,WDR12 
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Cellular Growth 
and Proliferation 
proliferation of 
tumor cell lines 
2.71E-03 Decreased -2.431 AATF,ACACA,ADAM15,ADM,AKT1
S1,APEX1,ARIH2,AURKA,BBC3,BCC
IP,BCL6,BCR,BMP4,BMPR1A,BMPR2
,BNIP3,BSG,BTG2,BUB1 (includes 
EG:100307076),C14orf169,CCNA2,CC
NG2,CDCA8,CDCP1,CDH1,CDKN1B,
CHCHD6,CHEK1,CREM (includes 
EG:12916),CUL7,DDX21,DUSP1,E2F5,
E2F8,ECT2,EFNA1,EGR1,ELF3,EPS8,
ERRFI1,FASN,FKBP5,FRMD6,GADD
45A,GCAT,GRB2,GTPBP4,H2AFY,HA
ND1,HBP1,HDAC5,HES6,HIF1A,HK1,
HK2,ID1,ID2,IER3,IGF2BP3,IGFBP2,I
L23A,IL6ST,ITGA7,JUN,KIAA0101,KI
F20A,KLF4,KPNA2,MAD1L1,MAP3K
7 (includes 
EG:26409),MAPK14,MFSD12,MIF,ML
LT3,MMP9,MYBBP1A,MYC,NASP,N
COA3,NDUFAF4,NF2,NOTCH2,NPY,
NUB1,NUBP1,PDCD4,PDIA3,PHC1,PI
K3CA,PLAT,PLAU,PLK1,PNPT1,POL
D4,PRKCD,PRMT1,PRPF4B,PTHLH,P
TTG1,RAD51,RAF1,RALB,RASD1,RH
OB,RNF4,RORA,RRM2,SENP1,SET,S
FN,SLC2A1,SLC9A3R1,SMARCB1,SP
HK1,SRC,SREBF1,SRSF2,SRSF3,SRS
F5,SSBP1,STMN1,TERF1,TES,TFAP2
A,THOC1,TSPO,TUSC2,TYMS,UBE2
C,VEGFA,VHL,WDR12,WWTR1 
Cellular 
Development 
proliferation of 
tumor cell lines 
2.71E-03 Decreased -2.431 AATF,ACACA,ADAM15,ADM,AKT1
S1,APEX1,ARIH2,AURKA,BBC3,BCC
IP,BCL6,BCR,BMP4,BMPR1A,BMPR2
,BNIP3,BSG,BTG2,BUB1 (includes 
EG:100307076),C14orf169,CCNA2,CC
NG2,CDCA8,CDCP1,CDH1,CDKN1B,
CHCHD6,CHEK1,CREM (includes 
EG:12916),CUL7,DDX21,DUSP1,E2F5,
E2F8,ECT2,EFNA1,EGR1,ELF3,EPS8,
ERRFI1,FASN,FKBP5,FRMD6,GADD
45A,GCAT,GRB2,GTPBP4,H2AFY,HA
ND1,HBP1,HDAC5,HES6,HIF1A,HK1,
HK2,ID1,ID2,IER3,IGF2BP3,IGFBP2,I
L23A,IL6ST,ITGA7,JUN,KIAA0101,KI
F20A,KLF4,KPNA2,MAD1L1,MAP3K
7 (includes 
EG:26409),MAPK14,MFSD12,MIF,ML
LT3,MMP9,MYBBP1A,MYC,NASP,N
COA3,NDUFAF4,NF2,NOTCH2,NPY,
NUB1,NUBP1,PDCD4,PDIA3,PHC1,PI
K3CA,PLAT,PLAU,PLK1,PNPT1,POL
D4,PRKCD,PRMT1,PRPF4B,PTHLH,P
TTG1,RAD51,RAF1,RALB,RASD1,RH
OB,RNF4,RORA,RRM2,SENP1,SET,S
FN,SLC2A1,SLC9A3R1,SMARCB1,SP
HK1,SRC,SREBF1,SRSF2,SRSF3,SRS
F5,SSBP1,STMN1,TERF1,TES,TFAP2
A,THOC1,TSPO,TUSC2,TYMS,UBE2
C,VEGFA,VHL,WDR12,WWTR1 
Cellular Growth 
and Proliferation 
cytostasis of 
tumor cell lines 
5.90E-03 Decreased -2.587 BCL6,BCR,BHLHE40,BMP4,BMPR1A
,CDCA8,CDH1,CDKN1B,EGR1,GPI,IR
F2,LTBP1,MAPK14,NQO1,PRMT1,RB
PJ,SMAD2,TOP2A,TTC5 
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Cell Death and 
Survival 
cell death of 
cancer cells 
9.40E-03 Increased 2.102 AKT1S1,BIK,BMP4,BOK,CASP6,CDH
1,CDKN1B,CHEK1,DDIT3,EGLN3,EIF
2AK3,FASLG,FASN,FOXO4,HIF1A,JU
N,MAP3K1,MAPK14,MMP9,MYC,NC
OA3,PAWR,PLK1,PRKCD,RAF1,RAL
B,SPHK1,TFAP2A,VEGFA,VHL 
Tumor 
Morphology 
cell death of 
cancer cells 
9.40E-03 Increased 2.102 AKT1S1,BIK,BMP4,BOK,CASP6,CDH
1,CDKN1B,CHEK1,DDIT3,EGLN3,EIF
2AK3,FASLG,FASN,FOXO4,HIF1A,JU
N,MAP3K1,MAPK14,MMP9,MYC,NC
OA3,PAWR,PLK1,PRKCD,RAF1,RAL
B,SPHK1,TFAP2A,VEGFA,VHL 
Post-Translational 
Modification 
ubiquitination of 
protein 
1.06E-02 Increased 2.213 ARIH1,ARIH2,BAG5,CDC34,DDB1,D
NAJB2,FBXO22,FBXO6,GCLC,GTPB
P4,HDAC6,HSPBP1,MAP3K1,MAPT,N
DFIP2,NUB1,PLK1,PSMC4,RLIM,RNF
13,RNF139,RNF4,UBE2C,UBE2T,UBE
4B,UBR1 (includes EG:197131),UBR2 
(includes 
EG:224826),UHRF2,VHL,WWP1 
Cardiovascular 
Disease 
damage of artery 1.12E-02 Decreased -2.000 EFEMP2,PLAT,PLAU,PLOD1 
Cell Cycle contact growth 
inhibition of 
tumor cell lines 
1.25E-02 Decreased -2.287 BMP4,BMPR1A,CDH1,EGR1,GPI,LTB
P1,MAPK14,SMAD2,TOP2A,TTC5 
Cellular Growth 
and Proliferation 
contact growth 
inhibition of 
tumor cell lines 
1.25E-02 Decreased -2.287 BMP4,BMPR1A,CDH1,EGR1,GPI,LTB
P1,MAPK14,SMAD2,TOP2A,TTC5 
Cell-To-Cell 
Signaling and 
Interaction 
contact growth 
inhibition of 
tumor cell lines 
1.25E-02 Decreased -2.287 BMP4,BMPR1A,CDH1,EGR1,GPI,LTB
P1,MAPK14,SMAD2,TOP2A,TTC5 
Developmental 
Disorder 
craniofacial 
abnormality 
1.40E-02 Decreased -2.402 ALKBH1,BMPR1A,CITED2,GADD45
A,GDF1,HSD17B2,INSIG1,INSIG2,JM
JD6,LAMC1,LMNB1,LMNB2,MSX1,O
RC1 (includes EG:18392),ORC6 
(includes 
EG:23594),PDGFA,RAF1,RBPJ,RGMA
,SMAD2,SOS1,SPHK1,TCOF1,TFAP2
A 
Connective Tissue 
Disorders 
craniofacial 
abnormality 
1.40E-02 Decreased -2.402 ALKBH1,BMPR1A,CITED2,GADD45
A,GDF1,HSD17B2,INSIG1,INSIG2,JM
JD6,LAMC1,LMNB1,LMNB2,MSX1,O
RC1 (includes EG:18392),ORC6 
(includes 
EG:23594),PDGFA,RAF1,RBPJ,RGMA
,SMAD2,SOS1,SPHK1,TCOF1,TFAP2
A 
Skeletal and 
Muscular 
Disorders 
craniofacial 
abnormality 
1.40E-02 Decreased -2.402 ALKBH1,BMPR1A,CITED2,GADD45
A,GDF1,HSD17B2,INSIG1,INSIG2,JM
JD6,LAMC1,LMNB1,LMNB2,MSX1,O
RC1 (includes EG:18392),ORC6 
(includes 
EG:23594),PDGFA,RAF1,RBPJ,RGMA
,SMAD2,SOS1,SPHK1,TCOF1,TFAP2
A 
Cellular 
Development 
differentiation 
of stem cells 
1.86E-02 Decreased -2.263 BHLHE41,BMP4,EIF4G2,HIF1A,HSP9
0B1,ID2,ID3,IL6ST,JUN,KLF4,LIN28A
,MLLT11,MSX1,MYC,RBPJ,RNF2,S1P
R1,SFN,SMARCB1,VEGFA,WNT4,W
WTR1 
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Cell Cycle cytokinesis 2.71E-02 Decreased -2.534 AURKA,CCNB1,CCNG1,CDC20 
(includes 
EG:107995),CIT,ECT2,GADD45A,IVN
S1ABP,KIF20A,KIF23,PLK1,RALB,R
HOB,SETD8,SRC,SSRP1,TOP2A 
Cellular 
Movement 
cytokinesis 2.71E-02 Decreased -2.534 AURKA,CCNB1,CCNG1,CDC20 
(includes 
EG:107995),CIT,ECT2,GADD45A,IVN
S1ABP,KIF20A,KIF23,PLK1,RALB,R
HOB,SETD8,SRC,SSRP1,TOP2A 
Cell Death and 
Survival 
apoptosis of 
keratinocyte 
cancer cell lines 
3.04E-02 Increased 2.186 BCL3,FASLG,IER3,NQO1,RHOB 
Cellular 
Movement 
invasion of 
epithelial cell 
lines 
3.04E-02 Increased 2.201 CDH1,IER3,ITGA3,MMP9,PLAU 
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Fig.A1.1 Selective canonical pathways  analyzed by Ingenuity Pathway Analysis. The bar 
graph represents a subset of significantly represented canonical signaling pathways when rat TS 
cells are exposed to 0.5% O2analyzed by Ingenuity Pathway analysis. 
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Table A1.2. Genes represented in canonical pathways by Ingenuity Pathway Analysis. 
Ingenuity Canonical 
Pathways  -log(p-value) Ratio Molecules 
Glycolysis I 4.33E00 2E-01 
PGK1,Eno1/Eno1-ps1,GPI,PGAM1,ENO2,ALDOA,PFKL,Tpi1 
(includes others),ALDOC 
Protein Ubiquitination 
Pathway 3.01E00 1.23E-01 
USP24,PSMA3,ANAPC1/LOC100286979,CDC20 (includes 
EG:107995),HSPA1A/HSPA1B,PSMB10,UBR2 (includes 
EG:224826),UBR1 (includes 
EG:197131),DNAJC3,DNAJB2,PSMB8,USP39,PSMC5,USP48,HSP9
0B1,PSMC6,USP10,DNAJB1,USP15,UBE4B,USP27X,PSMC4,THOP
1,USP1,DNAJB9,DNAJC11,PSME1,DNAJC5,PSMD12,CDC34,DNA
JB6,VHL,UBE2C 
Gluconeogenesis I 2.85E00 1.4E-01 PGK1,Eno1/Eno1-ps1,GPI,PGAM1,ENO2,ALDOA,ALDOC 
Mouse Embryonic Stem 
Cell Pluripotency 2.49E00 1.52E-01 
IL6ST,RAF1,ID2,PIK3CA,BMP4,GRB2,RRAS,BMPR2,ID3,MYC,ID
1,MAPK14,MAP3K7 (includes EG:26409),BMPR1A,SOS1 
Renal Cell Carcinoma 
Signaling 2.39E00 1.62E-01 
VEGFA,RAF1,PIK3CA,JUN,SLC2A1,GRB2,RRAS,SOS1,EGLN3,HI
F1A,RAP1A,VHL 
ATM Signaling 2.37E00 1.8E-01 
RAD51,SMC3,JUN,GADD45B,MAPK14,GADD45A,H2AFX,CCNB2
,ATF4,CHEK1,CCNB1 
Glycogen Biosynthesis II 
(from UDP-D-Glucose) 2.25E00 2.5E-01 GYS1,GYG1,GBE1 
Endoplasmic Reticulum 
Stress Pathway 2.16E00 2.78E-01 DNAJC3,ATF4,ATF6,EIF2S1,EIF2AK3 
Estrogen Receptor 
Signaling 2.05E00 1.32E-01 
RAF1,SRC,TAF11 (includes 
EG:309638),GRB2,GTF2F2,RRAS,TBP,MED21,GTF2F1,TAF13 
(includes EG:310784),NCOA3,MED27,THRAP3,SOS1,POLR2I,TAF2 
(includes EG:170844),MED10,GTF2H3 
HIF1α Signaling 2.05E00 1.39E-01 
PIK3CA,SLC2A1,RRAS,HIF1A,SLC2A3,VEGFA,EGLN1,JUN,MAP
K14,EGLN3,MMP12,APEX1,MMP9,MMP17,VHL 
p53 Signaling 2.04E00 1.35E-01 
PIK3CA,GADD45B,C12orf5,CHEK1,CCNG1,CASP6,JUN,MAPK14,
GADD45A,STAG1,BBC3,GNL3,SFN 
NRF2-mediated 
Oxidative Stress 
Response 1.97E00 1.2E-01 
RAF1,PIK3CA,RRAS,MAP3K1,NQO1,DNAJC3,GCLC,DNAJB2,DN
AJB9,MAFF,DNAJC11,JUN,DNAJC5,MAPK14,MAP3K7 (includes 
EG:26409),PRKCD,ATF4,CDC34,DNAJB6,DNAJB1,GCLM,FKBP5,
EIF2AK3 
PDGF Signaling 1.84E00 1.41E-01 
MYC,RAF1,SRC,PIK3CA,JUN,GRB2,RRAS,PDGFA,MAP3K1,SOS1
,SPHK1,INPP5K 
Assembly of RNA 
Polymerase III Complex 1.8E00 2.5E-01 GTF3C4,GTF3C3,TBP,GTF3A 
Regulation of eIF4 and 
p70S6K Signaling 1.8E00 1.03E-01 
RAF1,PIK3CA,GRB2,RRAS,EIF2B3,EIF4G3,PAIP2,ITGA3,EIF2S1,
EIF4EBP1,RPS24,MAPK14,EIF4G2,EIF1AX,PPM1J,SOS1,EIF2B1,P
PP2R1B 
Oleate Biosynthesis II 
(Animals) 1.76E00 1.58E-01 SCD,UFSP2,Scd2 
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Hypoxia Signaling in the 
Cardiovascular System 1.74E00 1.52E-01 
VEGFA,P4HB,HSP90B1,JUN,NQO1,ATF4,HIF1A,CDC34,VHL,UBE
2C 
VEGF Signaling 1.72E00 1.31E-01 
RAF1,PIK3CA,GRB2,RRAS,EIF2B3,HIF1A,EIF2S1,VEGFA,EIF1A
X,SOS1,EIF2B1,SFN,ACTN1 
Role of Oct4 in 
Mammalian Embryonic 
Stem Cell Pluripotency 1.55E00 1.56E-01 CASP6,KDM5B,TDH,PCGF6,PHC1,SH3GLB1,FBXO15 
Cell Cycle Regulation by 
BTG Family Proteins 1.46E00 1.67E-01 PRMT1,PPM1J,BTG2,E2F5,PPP2R1B,CCRN4L 
Cardiomyocyte 
Differentiation via BMP 
Receptors 1.45E00 2E-01 BMP4,BMPR1A,MAP3K7 (includes EG:26409),BMPR2 
PI3K/AKT Signaling 1.41E00 1.04E-01 
RAF1,PIK3CA,GRB2,RRAS,ITGA3,EIF4EBP1,HSP90B1,GYS1,PPM
1J,SOS1,MAP3K8,CDKN1B,INPP5K,SFN,PPP2R1B 
ERK/MAPK Signaling 1.29E00 9.71E-02 
SRC,RAF1,PIK3CA,PLA2G12A,GRB2,RRAS,PPP1R3C,ITGA3,RAP
1A,EIF4EBP1,KSR1,MYC,ELF3,PPP1R10,DUSP1,PRKCD,PPM1J,S
OS1,ATF4,PPP2R1B 
ErbB2-ErbB3 Signaling 1.28E00 1.33E-01 MYC,RAF1,PIK3CA,JUN,GRB2,RRAS,SOS1,CDKN1B 
Cell Cycle: G2/M DNA 
Damage Checkpoint 
Regulation 1.27E00 1.46E-01 GADD45A,TOP2A,CCNB2,PLK1,SFN,CHEK1,CCNB1 
BMP signaling pathway 1.25E00 1.25E-01 
RAF1,JUN,BMP4,MAPK14,BMPR1A,GRB2,RRAS,MAP3K7 
(includes EG:26409),SOS1,BMPR2 
TGF-β Signaling 1.24E00 1.24E-01 
SMAD2,RAF1,JUN,BMP4,MAPK14,BMPR1A,GRB2,RRAS,MAP3K
7 (includes EG:26409),SOS1,BMPR2 
AMPK Signaling 1.21E00 9.64E-02 
CAB39,SRC,PIK3CA,CPT1A,PFKL,PPM1D,EIF4EBP1,GYS1,MAPK
14,PPM1J,FASN,AK4,ACACA,HLTF,PPP2R1B,PPAT 
Cyclins and Cell Cycle 
Regulation 1.18E00 1.12E-01 
HDAC6,CCNA2,RAF1,PPM1J,E2F5,CCNB2,CDKN1B,PPP2R1B,HD
AC5,CCNB1 
Assembly of RNA 
Polymerase II Complex 1.13E00 1.25E-01 
TAF11 (includes EG:309638),TBP,GTF2F1,TAF13 (includes 
EG:310784),TAF2 (includes EG:170844),POLR2I,GTF2H3 
tRNA Charging 1.11E00 7.41E-02 TARS2,MARS2,DARS,HARS,HARS2,FARSB 
Fatty Acid β-oxidation I 1.1E00 1.11E-01 ECI2,AUH (includes EG:11992),SLC27A1,SLC27A3,ECI1 
Ceramide Signaling 1.08E00 1.14E-01 
RAF1,PIK3CA,JUN,RRAS,PPM1J,MAP3K1,SPHK1,S1PR1,PPP2R1
B,KSR1 
Hereditary Breast Cancer 
Signaling 9.95E-01 1.02E-01 
PIK3CA,GADD45B,RRAS,HDAC5,CHEK1,CCNB1,RAD51,HDAC6,
GADD45A,H2AFX,SFN,HLTF,POLR2I 
p38 MAPK Signaling 9.8E-01 1.03E-01 
IL33,IL1R2,MYC,MAPK14,PLA2G12A,DDIT3,DUSP1,MAP3K7 
(includes EG:26409),MAPT,ATF4,FASLG,IRAK2 
Aldosterone Signaling in 
Epithelial Cells 9.76E-01 9.52E-02 
RAF1,PIK3CA,HSPA1A/HSPA1B,PDIA3,DNAJC3,DNAJB2,DNAJB
9,DNAJC11,HSP90B1,DNAJC5,DUSP1,PRKCD,SOS1,DNAJB6,DN
AJB1,PI4KA 
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Endometrial Cancer 
Signaling 9.67E-01 1.23E-01 MYC,RAF1,PIK3CA,CDH1,GRB2,RRAS,SOS1 
Paxillin Signaling 9.66E-01 9.91E-02 
SRC,ITGAE,PIK3CA,MAPK14,GRB2,RRAS,SOS1,ITGA3,ITGA7,A
CTN1,GIT2 
Glioblastoma Multiforme 
Signaling 9.58E-01 9.15E-02 
RAF1,SRC,PIK3CA,GRB2,RRAS,PDGFA,PDIA3,NF2,MYC,RHOB,
PRKCD,SOS1,E2F5,WNT4,CDKN1B 
PTEN Signaling 9.46E-01 9.63E-02 
FOXO4,RAF1,PIK3CA,SHARPIN,GRB2,RRAS,BMPR2,ITGA3,BMP
R1A,SOS1,INPP5K,CDKN1B,FASLG 
Glucose and Glucose-1-
phosphate Degradation 9.3E-01 9.09E-02 HK1,PGM1 
Role of NANOG in 
Mammalian Embryonic 
Stem Cell Pluripotency 9.13E-01 9.65E-02 
IL6ST,RAF1,PIK3CA,RIF1 (includes 
EG:295602),BMP4,BMPR1A,GRB2,RRAS,SOS1,BMPR2,WNT4 
14-3-3-mediated 
Signaling 9.04E-01 1.03E-01 
RAF1,SRC,PIK3CA,JUN,GRB2,RRAS,PDIA3,PRKCD,MAPT,CDKN
1B,SFN,AKT1S1 
Transcriptional 
Regulatory Network in 
Embryonic Stem Cells 8.58E-01 1.25E-01 RIF1 (includes EG:295602),KAT6A,HAND1,EOMES,SET 
Glycogen Degradation II 8.3E-01 1.25E-01 PGM1,PYGL 
Sertoli Cell-Sertoli Cell 
Junction Signaling 8.19E-01 8.72E-02 
RAF1,SRC,TJP2,CLDN15,RRAS,MAP3K1,ITGA3,MPP6 (includes 
EG:35343),F11R,CDH1,JUN,MAPK14,CLDN4,MAP3K7 (includes 
EG:26409),MAP3K8,ACTN1,PVRL2 
Cell Cycle: G1/S 
Checkpoint Regulation 7.97E-01 1.06E-01 HDAC6,MYC,PAK1IP1,E2F5,GNL3,CDKN1B,HDAC5 
Chronic Myeloid 
Leukemia Signaling 7.95E-01 9.52E-02 
HDAC6,MYC,RAF1,PIK3CA,GRB2,RRAS,SOS1,E2F5,CDKN1B,H
DAC5 
VEGF Family Ligand-
Receptor Interactions 7.83E-01 9.52E-02 VEGFA,RAF1,PIK3CA,PLA2G12A,GRB2,RRAS,PRKCD,SOS1 
FLT3 Signaling in 
Hematopoietic Progenitor 
Cells 6.8E-01 1.05E-01 RAF1,PIK3CA,MAPK14,GRB2,RRAS,SOS1,ATF4,EIF4EBP1 
Molecular Mechanisms 
of Cancer 6.14E-01 7.69E-02 
RAF1,PIK3CA,BMP4,APH1B,BMPR2,HIF1A,CHEK1,MYC,CASP6,
JUN,RHOB,BBC3,BMPR1A,MAP3K7 (includes 
EG:26409),SOS1,E2F5,FASLG,SMAD2,SRC,RRAS,GRB2,RALB,A
URKA,RAP1A,CDH1,MAPK14,PRKCD,RBPJ,CDKN1B 
Lipid Antigen 
Presentation by CD1 6.1E-01 8.7E-02 PDIA3,PSAP 
Fatty Acid Activation 6.1E-01 1.05E-01 SLC27A1,SLC27A3 
Leukocyte Extravasation 
Signaling 5.48E-01 8.12E-02 
SRC,PIK3CA,CLDN15,RAP1A,F11R,WIPF1,MAPK14,CLDN4,PRK
CD,FER,MMP12,CTTN,ACTN1,MMP9,MMP17,ARHGAP8/PRR5-
ARHGAP8 
Glioma Signaling 5.38E-01 8.04E-02 
RAF1,PIK3CA,Calm1 (includes 
others),GRB2,RRAS,PDGFA,PRKCD,SOS1,E2F5 
FAK Signaling 5.29E-01 7.92E-02 RAF1,SRC,PIK3CA,GRB2,RRAS,SOS1,ITGA3,GIT2 
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Arsenate Detoxification I 
(Glutaredoxin) 5.17E-01 5E-02 GLRX2 
Prostate Cancer Signaling 5.1E-01 8.16E-02 RAF1,PIK3CA,HSP90B1,GRB2,RRAS,SOS1,ATF4,CDKN1B 
LPS-stimulated MAPK 
Signaling 4.8E-01 8.54E-02 
RAF1,PIK3CA,JUN,MAPK14,RRAS,MAP3K7 (includes 
EG:26409),PRKCD 
Germ Cell-Sertoli Cell 
Junction Signaling 4.75E-01 7.93E-02 
SRC,PIK3CA,RRAS,MAP3K1,ITGA3,CDH1,MAPK14,RHOB,MAP3
K7 (includes EG:26409),FER,MAP3K8,ACTN1,PVRL2 
ErbB Signaling 4.74E-01 9.2E-02 RAF1,PIK3CA,JUN,MAPK14,GRB2,RRAS,PRKCD,SOS1 
Breast Cancer Regulation 
by Stathmin1 4.73E-01 7.73E-02 
RAF1,PIK3CA,Calm1 (includes 
others),GRB2,RRAS,PPP1R3C,GNB4,STMN1,PPP1R10,PPM1J,PRK
CD,SOS1,E2F5,GNG2,CDKN1B,PPP2R1B 
Colorectal Cancer 
Metastasis Signaling 4.73E-01 7.39E-02 
IL6ST,SMAD2,SRC,PIK3CA,GRB2,RRAS,MYC,VEGFA,GNB4,APP
L1,CDH1,JUN,RHOB,SOS1,WNT4,GNG2,MMP12,MMP9,MMP17 
Mechanisms of Viral Exit 
from Host Cells 4.69E-01 8.89E-02 PRKCD,SH3GLB1,LMNB2,LMNB1 
Acute Myeloid Leukemia 
Signaling 4.62E-01 8.54E-02 MYC,RAF1,PIK3CA,GRB2,RRAS,SOS1,EIF4EBP1 
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Table A2.1.  Genes upregulated on hypoxia exposure 
Affymetrix ID Gene Title Gene Symbol 
Ave 
amb sig 
int 
Ave 
hypox 
sig int hypox/ amb 
1373108_at 
protein phosphatase 1, 
regulatory (inhibitor) subunit 
3C Ppp1r3c 40 1668 41.298 
1373685_at ankyrin repeat domain 37 Ankrd37 177 4762 26.832 
1380804_at --- --- 44 709 16.012 
1368530_at matrix metallopeptidase 12 Mmp12 76 937 12.277 
1372897_at 
procollagen lysine, 2-
oxoglutarate 5-dioxygenase 2 Plod2 186 2100 11.303 
1377190_at --- --- 370 3196 8.635 
1395153_at claudin 15 Cldn15 207 1698 8.219 
1369415_at 
basic helix-loop-helix family, 
member e40 Bhlhe40 71 580 8.198 
1389659_at 
cytotoxic T lymphocyte-
associated protein 2 alpha Ctla2a 1720 13531 7.867 
1379483_at 
Basic helix-loop-helix family, 
member e40 Bhlhe40 77 588 7.654 
1370975_at 
lysine (K)-specific demethylase 
3A Kdm3a 559 4013 7.180 
1371824_at adenylate kinase 3-like 1 Ak3l1 327 2303 7.042 
1368674_at phosphorylase, glycogen, liver Pygl 1668 11366 6.813 
1368025_at 
DNA-damage-inducible 
transcript 4 Ddit4 1434 9702 6.766 
1386998_at 
aldolase C, fructose-
bisphosphate Aldoc 533 3501 6.572 
1391640_at --- --- 177 1158 6.545 
1387455_a_at 
very low density lipoprotein 
receptor Vldlr 144 940 6.514 
1394948_at --- --- 151 975 6.445 
1394259_at claudin 15 Cldn15 85 550 6.444 
1398350_at 
hypothetical protein 
LOC100364588 
LOC10036458
8 709 4468 6.300 
1398120_at --- --- 81 505 6.213 
1389265_at 
glucan (1,4-alpha-), branching 
enzyme 1 Gbe1 724 4437 6.125 
1389611_at 
very low density lipoprotein 
receptor Vldlr 145 881 6.061 
1370954_at 
prolyl 4-hydroxylase, alpha 
polypeptide I P4ha1 2424 13537 5.584 
1370341_at enolase 2, gamma, neuronal Eno2 689 3838 5.571 
1376845_at 
interferon, alpha-inducible 
protein 27 like 2B Ifi27l2b 2412 13329 5.526 
1389230_at --- --- 794 4342 5.466 
1376850_a_at 
chemokine (C-C motif) ligand 
27 Ccl27 176 954 5.421 
1375455_at 
guanylate cyclase activator 1a 
(retina) Guca1a 171 924 5.396 
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1373554_at --- --- 225 1213 5.380 
1369961_at 
phosphatidic acid phosphatase 
type 2A Ppap2a 665 3550 5.335 
1367507_at 
nudix (nucleoside diphosphate 
linked moiety X)-type motif 22 Nudt22 825 4315 5.230 
1397918_at --- --- 592 3095 5.225 
1391458_at 
N-myc downstream regulated 
gene 1 Ndrg1 310 1600 5.165 
1378930_a_at --- --- 500 2584 5.165 
1391932_at 
similar to hypothetical protein 
MGC47256 RGD1308694 137 702 5.139 
1368079_at 
pyruvate dehydrogenase 
kinase, isozyme 1 Pdk1 1139 5832 5.119 
1389581_at interleukin 33 Il33 1643 8300 5.052 
1394548_at carboxypeptidase M Cpm 106 522 4.926 
1367950_at 
solute carrier family 22 
(organic cation/carnitine 
transporter), member 5 Slc22a5 143 699 4.883 
1387908_at 
RAS, dexamethasone-induced 
1 Rasd1 621 3030 4.882 
1371434_at 
hypothetical protein 
LOC691807 LOC691807 3601 16897 4.692 
1382475_at --- --- 156 727 4.674 
1376653_at 
putative homeodomain 
transcription factor 1 Phtf1 483 2249 4.654 
1390502_at 
similar to RIKEN cDNA 
1700025G04 gene RGD1309104 438 2015 4.596 
1379611_at --- --- 121 548 4.520 
1390943_at 
similar to chromosome 1 open 
reading frame 63 RGD1359529 118 526 4.453 
1391756_at 
rCG54026-like /// rCG54026-
like 
LOC10036239
4 /// 
LOC10036599
1 7829 34762 4.440 
1369670_at Cd200 molecule Cd200 4598 20384 4.434 
1378006_at --- --- 361 1577 4.365 
1393690_at insulin induced gene 2 Insig2 529 2268 4.285 
1393240_at 
EGF-containing fibulin-like 
extracellular matrix protein 2 Efemp2 136 584 4.280 
1373970_at interleukin 33 Il33 1373 5741 4.182 
1373558_at --- --- 133 554 4.164 
1387964_a_at ERO1-like (S. cerevisiae) Ero1l 516 2149 4.162 
1369006_at hexokinase 2 Hk2 452 1838 4.063 
1373291_at --- --- 184 741 4.029 
1396239_at 
similar to RIKEN cDNA 
2310008H04 RGD1566036 812 3265 4.022 
1373979_at --- --- 549 2198 4.004 
1370081_a_at 
vascular endothelial growth 
factor A Vegfa 150 595 3.976 
1376593_at --- --- 394 1561 3.960 
1384002_at ATPase, class VI, type 11B Atp11b 165 653 3.946 
1372341_at solute carrier family 25, Slc25a36 655 2540 3.878 
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member 36 
1392603_at --- --- 358 1380 3.853 
1375182_at --- --- 175 673 3.846 
1373807_at 
vascular endothelial growth 
factor A Vegfa 463 1777 3.841 
1371953_at cyclin G2 Ccng2 353 1336 3.779 
1367966_at 
dipeptidylpeptidase 3 /// similar 
to Dipeptidyl-peptidase 3 
(Dipeptidyl-peptidase III) (DPP 
III)  
Dpp3 /// 
LOC678760 2133 8034 3.766 
1370884_at 
sepiapterin reductase (7,8-
dihydrobiopterin:NADP+ 
oxidoreductase) Spr 473 1766 3.737 
1382476_x_at --- --- 155 578 3.723 
1384098_at ring finger protein 125 Rnf125 1023 3798 3.712 
1394940_at 
family with sequence similarity 
46, member A Fam46a 178 657 3.687 
1367942_at 
acid phosphatase 5, tartrate 
resistant Acp5 869 3157 3.633 
1387805_at 
BCL2/adenovirus E1B 
interacting protein 3 Bnip3 2779 10006 3.600 
1389207_at 
EGL nine homolog 1 (C. 
elegans) Egln1 1659 5967 3.596 
1368254_a_at sphingosine kinase 1 Sphk1 176 622 3.541 
1367894_at insulin induced gene 1 Insig1 831 2942 3.541 
1389075_at --- --- 613 2161 3.525 
1387180_at interleukin 1 receptor, type II Il1r2 898 3143 3.499 
1367789_at 
solute carrier family 27 (fatty 
acid transporter), member 1 Slc27a1 690 2409 3.490 
1369310_at 
brain abundant, membrane 
attached signal protein 1 Basp1 275 959 3.489 
1392706_at --- --- 208 723 3.482 
1376642_at 
XK, Kell blood group complex 
subunit-related family, member 
8 Xkr8 187 640 3.417 
1369473_at phosphoglucomutase 1 Pgm1 338 1143 3.378 
1388634_at phosphoglucomutase 1 Pgm1 1096 3679 3.356 
1386721_at zinc finger protein 503 Znf503 473 1585 3.354 
1374544_at platelet receptor Gi24 MGC112715 1655 5543 3.349 
1387769_a_at inhibitor of DNA binding 3 Id3 214 717 3.344 
1369393_at 
mitogen-activated protein 
kinase kinase kinase 8 Map3k8 370 1227 3.320 
1379368_at B-cell CLL/lymphoma 6 Bcl6 228 755 3.311 
1374224_at 
eukaryotic translation initiation 
factor 2 alpha kinase 4 Eif2ak4 1545 5035 3.258 
1389789_at Max dimerization protein 1 Mxd1 300 977 3.257 
1375230_at --- --- 3341 10854 3.249 
1371692_at 
myeloid/lymphoid or mixed-
lineage leukemia (trithorax 
homolog, Drosophila); 
translocated to, 11 Mllt11 483 1568 3.247 
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1374004_at prolyl endopeptidase-like Prepl 824 2657 3.225 
1370517_at neuronal pentraxin 1 Nptx1 381 1227 3.222 
1383519_at Hexokinase 2 Hk2 5174 16532 3.195 
1379057_at 
hypothetical protein 
LOC683460 LOC683460 484 1547 3.192 
1376941_at 
Williams-Beuren syndrome 
chromosome region 16 
homolog (human) Wbscr16 897 2849 3.176 
1376030_at 
ArfGAP with coiled-coil, 
ankyrin repeat and PH domains 
1 Acap1 366 1161 3.169 
1374310_at protein phosphatase 1J Ppm1j 392 1239 3.163 
1372652_at forkhead box O4 Foxo4 306 966 3.159 
1390391_at --- --- 635 1989 3.130 
1389530_at 
solute carrier family 35, 
member E1 Slc35e1 1189 3705 3.117 
1390203_at --- --- 298 925 3.110 
1392905_at 
Guanine nucleotide binding 
protein (G protein), gamma 2 Gng2 632 1951 3.088 
1387587_at 
Fas ligand (TNF superfamily, 
member 6) Faslg 1033 3183 3.083 
1389986_at --- --- 625 1902 3.041 
1388440_at 
anterior pharynx defective 1 
homolog B (C. elegans) Aph1b 672 2041 3.038 
1376877_at 
CUB domain containing 
protein 1 Cdcp1 927 2792 3.010 
1368305_at caspase 6 Casp6 3361 9936 2.957 
1379251_at --- --- 602 1779 2.955 
1396737_at 
structural maintenance of 
chromosomes flexible hinge 
domain containing 1 Smchd1 235 694 2.955 
1368247_at 
heat shock 70kD protein 1A /// 
heat shock 70kD protein 1B 
(mapped) 
Hspa1a /// 
Hspa1b 2104 6216 2.954 
1382255_at --- --- 778 2286 2.939 
1372610_at 
prolyl 4-hydroxylase, alpha 
polypeptide II P4ha2 1655 4819 2.911 
1381335_at --- --- 1094 3130 2.860 
1372328_at kinesin light chain 4 Klc4 374 1068 2.859 
1374105_at 
HIG1 hypoxia inducible 
domain family, member 1A Higd1a 348 984 2.832 
1370912_at heat shock 70kD protein 1A Hspa1a 761 2149 2.825 
1389377_at insulin induced gene 2 Insig2 657 1856 2.823 
1390433_at 
regulator of chromosome 
condensation (RCC1) and BTB 
(POZ) domain containing 
protein 1 Rcbtb1 280 789 2.816 
1371394_x_at --- --- 7377 20683 2.804 
1387389_at 
receptor (G protein-coupled) 
activity modifying protein 3 Ramp3 321 901 2.803 
1368871_at 
mitogen activated protein 
kinase kinase kinase 1 Map3k1 269 754 2.803 
1393246_at zinc finger, MYND-type Zmynd10 329 921 2.799 
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containing 10 
1374446_at 
TCDD-inducible poly(ADP-
ribose) polymerase Tiparp 505 1396 2.766 
1397247_at 
CUB domain containing 
protein 1 Cdcp1 472 1304 2.762 
1393214_at --- --- 3193 8814 2.760 
1368012_at telomerase associated protein 1 Tep1 308 846 2.752 
1380682_at mex3 homolog B (C. elegans) Mex3b 265 727 2.748 
1372844_at ephrin A1 Efna1 448 1229 2.746 
1377869_at 
CCR4 carbon catabolite 
repression 4-like (S. cerevisiae) Ccrn4l 724 1983 2.739 
1374693_at 
poly (ADP-ribose) polymerase 
family, member 16 Parp16 1128 3075 2.725 
1376481_at 
a disintegrin-like and 
metalloprotease (reprolysin 
type) with thrombospondin 
type 1 motif, 9 Adamts9 254 690 2.713 
1385168_at 
similar to receptor-interacting 
factor 1 RGD1306520 510 1379 2.702 
1389615_at 
Der1-like domain family, 
member 1 Derl1 2203 5936 2.695 
1384080_at --- --- 293 788 2.689 
1378800_at --- --- 224 600 2.681 
1368641_at 
wingless-type MMTV 
integration site family, member 
4 Wnt4 318 850 2.676 
1388714_at 
elongation factor RNA 
polymerase II Ell 1382 3698 2.675 
1369874_at G protein-coupled receptor 1 Gpr1 323 862 2.669 
1395268_at 
WW domain containing E3 
ubiquitin protein ligase 1 Wwp1 790 2108 2.668 
1367912_at 
latent transforming growth 
factor beta binding protein 1 Ltbp1 240 640 2.663 
1372691_at uridine phosphorylase 1 Upp1 826 2198 2.662 
1384164_at --- --- 479 1274 2.662 
1376076_at 
hypoxia-inducible protein 2-
like 
LOC10036156
8 5202 13829 2.658 
1369166_at matrix metallopeptidase 9 Mmp9 2703 7183 2.657 
1398706_at --- --- 2818 7462 2.648 
1387017_at squalene epoxidase Sqle 525 1385 2.639 
1387201_at ring finger protein 138 Rnf138 1162 3049 2.625 
1371360_at 
N-myc downstream regulated 
gene 1 Ndrg1 8284 21738 2.624 
1371392_at glucose phosphate isomerase Gpi 8155 21272 2.608 
1379397_at 
RAR-related orphan receptor 
alpha Rora 260 677 2.607 
1373812_at 
cyclin-dependent kinase 
inhibitor 1B Cdkn1b 1488 3880 2.607 
1398273_at ephrin A1 Efna1 283 737 2.600 
1385068_at --- --- 238 615 2.583 
1393252_at --- --- 286 737 2.583 
1389439_at --- --- 563 1452 2.579 
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1376990_at --- --- 655 1688 2.577 
1398364_at 
similar to chromosome 1 open 
reading frame 63 RGD1359529 1438 3691 2.567 
1384743_at --- --- 347 888 2.563 
1370062_at 
HIG1 hypoxia inducible 
domain family, member 1A Higd1a 6757 17284 2.558 
1383498_at --- --- 364 922 2.530 
1389297_at ERO1-like (S. cerevisiae) Ero1l 10334 26140 2.529 
1389652_at --- --- 771 1947 2.526 
1373494_at breakpoint cluster region Bcr 1932 4879 2.526 
1370264_at 
spectrin repeat containing, 
nuclear envelope 1 Syne1 242 602 2.489 
1372295_at 
nuclear prelamin A recognition 
factor Narf 281 700 2.486 
1380547_at chloride channel 3 Clcn3 540 1335 2.474 
1371624_at 
zinc finger CCCH-type 
containing 7B Zc3h7b 377 926 2.459 
1380229_at 
v-maf musculoaponeurotic 
fibrosarcoma oncogene 
homolog F (avian) Maff 730 1796 2.459 
1388471_at t-complex 11 (mouse) like 2 Tcp11l2 239 587 2.457 
1368146_at dual specificity phosphatase 1 Dusp1 3861 9486 2.457 
1377719_a_at --- --- 948 2327 2.454 
1369628_at 
synaptic vesicle glycoprotein 
2b Sv2b 1213 2966 2.446 
1382325_at 
glycine C-acetyltransferase (2-
amino-3-ketobutyrate-
coenzyme A ligase) Gcat 938 2294 2.445 
1386888_at 
eukaryotic translation initiation 
factor 4E binding protein 1 Eif4ebp1 4417 10788 2.443 
1397179_at similar to DIP13 alpha RGD1309388 368 898 2.440 
1384082_at --- --- 702 1714 2.440 
1383302_at 
DnaJ (Hsp40) homolog, 
subfamily B, member 1 Dnajb1 893 2169 2.430 
1390688_at 
DEAD (Asp-Glu-Ala-Asp) box 
polypeptide 50 Ddx50 1401 3400 2.427 
1392453_at chloride channel 3 Clcn3 576 1388 2.408 
1368899_at 
bone morphogenetic protein 
receptor, type IA Bmpr1a 322 774 2.399 
1389138_at --- --- 2746 6557 2.388 
1378232_at chloride channel 3 Clcn3 361 860 2.386 
1390394_at similar to CG3570-PA LOC500034 549 1308 2.381 
1393131_at FLT3-interacting zinc finger 1 Fiz1 1497 3555 2.376 
1392516_a_at 
StAR-related lipid transfer 
(START) domain containing 4 Stard4 341 807 2.366 
1370848_at 
solute carrier family 2 
(facilitated glucose 
transporter), member 1 Slc2a1 11103 26256 2.365 
1368965_at 
solute carrier family 16, 
member 3 (monocarboxylic 
acid transporter 4) Slc16a3 3530 8336 2.361 
1386978_at 
BCL2/adenovirus E1B 
interacting protein 3-like Bnip3l 3293 7749 2.353 
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1367898_at 
BCL2/adenovirus E1B 
interacting protein 3-like Bnip3l 3917 9209 2.351 
1393887_at choline phosphotransferase 1 Chpt1 850 1989 2.341 
1376965_at --- --- 467 1091 2.335 
1368147_at dual specificity phosphatase 1 Dusp1 250 583 2.331 
1371993_at copine III Cpne3 351 817 2.328 
1373533_at --- --- 2315 5386 2.327 
1398275_at matrix metallopeptidase 9 Mmp9 4525 10473 2.314 
1374296_at --- --- 1424 3290 2.310 
1370249_at translocator protein Tspo 3253 7442 2.287 
1369737_at 
cAMP responsive element 
modulator Crem 224 512 2.284 
1368826_at catechol-O-methyltransferase Comt 330 752 2.279 
1377029_at --- --- 402 916 2.279 
1388409_at 
zinc finger CCCH-type 
containing 7B Zc3h7b 296 673 2.276 
1372179_at hippocalcin-like 1 Hpcal1 3553 8080 2.274 
1379601_at 
alkB, alkylation repair homolog 
5 (E. coli) Alkbh5 547 1245 2.274 
1374610_at --- --- 1288 2929 2.273 
1379676_a_at deoxyribonuclease 1-like 1 Dnase1l1 273 621 2.270 
1399154_at 
lysine (K)-specific demethylase 
2A Kdm2a 742 1675 2.257 
1383161_a_at --- --- 1516 3421 2.256 
1372518_at fibulin 1 Fbln1 589 1328 2.255 
1383447_at ets variant 5 Etv5 511 1151 2.254 
1391935_at 
eukaryotic translation initiation 
factor 4E member 3 Eif4e3 678 1525 2.250 
1368174_at 
EGL nine homolog 3 (C. 
elegans) Egln3 859 1930 2.246 
1368488_at 
nuclear factor, interleukin 3 
regulated Nfil3 344 769 2.232 
1379680_at --- --- 511 1140 2.231 
1370220_at serine carboxypeptidase 1 Scpep1 4913 10941 2.227 
1370719_a_at chloride channel CLIC-like 1 Clcc1 365 813 2.225 
1390830_at 
hypothetical protein 
LOC499602 LOC499602 266 591 2.224 
1394576_at --- --- 247 548 2.222 
1380130_at --- --- 256 569 2.221 
1372340_at 
methionine adenosyltransferase 
II, beta Mat2b 1387 3076 2.218 
1393373_at opsin 3 Opn3 243 539 2.217 
1398981_at 
TP53 regulated inhibitor of 
apoptosis 1 Triap1 2156 4771 2.213 
1393990_at zinc finger protein 503 Znf503 292 645 2.207 
1367900_at glycogenin 1 Gyg1 379 837 2.206 
1387361_s_at phosphoglycerate kinase 1 Pgk1 14135 31173 2.205 
1382802_x_at --- --- 1225 2700 2.205 
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1372006_at --- --- 3265 7176 2.198 
1392221_at --- --- 453 994 2.196 
1396051_at --- --- 325 711 2.192 
1378400_at 
family with sequence similarity 
122B Fam122b 1079 2364 2.190 
1398287_at 
plasminogen activator, 
urokinase Plau 3427 7506 2.190 
1380855_at --- --- 586 1277 2.181 
1372140_at 
coiled-coil domain containing 
28A Ccdc28a 330 719 2.177 
1386909_a_at 
voltage-dependent anion 
channel 1 Vdac1 3544 7691 2.170 
1394479_at arylformamidase Afmid 426 921 2.162 
1389580_at 
helicase-like transcription 
factor Hltf 312 673 2.156 
1383224_at 
par-6 (partitioning defective 6) 
homolog beta (C. elegans) Pard6b 1196 2578 2.156 
1373023_at --- --- 290 622 2.147 
1385405_at 
ADAM metallopeptidase 
domain 23 Adam23 270 579 2.147 
1379649_at 
glycosyltransferase 8 domain 
containing 3 Glt8d3 490 1048 2.139 
1378204_at --- --- 239 512 2.138 
1375673_at --- --- 682 1458 2.137 
1369590_a_at 
DNA-damage inducible 
transcript 3 Ddit3 639 1366 2.137 
1380410_at --- --- 420 898 2.136 
1385925_at --- --- 359 767 2.135 
1387614_at 
synaptonemal complex protein 
3 Sycp3 645 1374 2.130 
1374478_at 
similar to RIKEN cDNA 
2610528J11 RGD1305347 270 574 2.125 
1388874_at metastasis suppressor 1 Mtss1 949 2016 2.124 
1383228_at --- --- 932 1981 2.124 
1383306_at --- --- 1233 2608 2.115 
1388532_at similar to hypothetical protein RGD1310571 1791 3786 2.114 
1389857_at WW domain binding protein 5 Wbp5 2154 4539 2.107 
1396099_at tetraspanin 33 Tspan33 279 589 2.106 
1370845_at 
ectonucleoside triphosphate 
diphosphohydrolase 2 Entpd2 794 1669 2.104 
1367650_at 
tubulointerstitial nephritis 
antigen-like 1 Tinagl1 4653 9784 2.103 
1377042_at polycomb group ring finger 5 Pcgf5 2606 5465 2.097 
1396300_at arylformamidase Afmid 270 566 2.096 
1379703_at 
DENN/MADD domain 
containing 3 Dennd3 366 766 2.096 
1387249_at 
BCL2-interacting killer 
(apoptosis-inducing) Bik 253 529 2.095 
1376996_at --- --- 472 987 2.091 
1398294_at actinin, alpha 1 Actn1 544 1135 2.086 
1391450_at lysyl oxidase-like 2 Loxl2 1232 2567 2.084 
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1376304_at --- --- 3218 6701 2.082 
1388464_at similar to cullin 7 LOC680835 3510 7309 2.082 
1368279_at 
myeloid/lymphoid or mixed-
lineage leukemia (trithorax 
homolog, Drosophila); 
translocated to, 3 Mllt3 1343 2797 2.082 
1367601_at 
Cbp/p300-interacting 
transactivator, with Glu/Asp-
rich carboxy-terminal domain, 
2 Cited2 2659 5519 2.075 
1389539_at Similar to DIP13 alpha RGD1309388 772 1600 2.073 
1390192_at 
solute carrier family 27 (fatty 
acid transporter), member 3 Slc27a3 354 730 2.064 
1376159_at 
GDNF-inducible zinc finger 
protein 1 Gzf1 998 2059 2.063 
1383034_at 
RING1 and YY1 binding 
protein Rybp 2331 4807 2.062 
1383227_at 
similar to ADP-ribosylation 
factor-like 1 LOC688311 1754 3615 2.061 
1377720_x_at --- --- 1949 4008 2.057 
1387116_at 
DnaJ (Hsp40) homolog, 
subfamily B, member 9 Dnajb9 880 1808 2.053 
1373673_at --- --- 1019 2086 2.047 
1376436_at 
lysM and putative 
peptidoglycan-binding domain-
containing protein 3-like  
LOC10036017
4 /// Lysmd3 632 1292 2.043 
1391148_at --- --- 332 678 2.043 
1375916_at 
protein-L-isoaspartate (D-
aspartate) O-methyltransferase 
domain containing 2 Pcmtd2 302 614 2.038 
1389544_at 
translocase of outer 
mitochondrial membrane 7 
homolog (yeast) Tomm7 7907 16095 2.035 
1371791_at surfeit 4 Surf4 1021 2077 2.035 
1383910_at --- --- 1739 3533 2.032 
1386934_at 
solute carrier family 6 
(neurotransmitter transporter, 
creatine), member 8 Slc6a8 738 1498 2.030 
1372822_at --- --- 1566 3173 2.027 
1398247_at lon peptidase 1, mitochondrial Lonp1 3779 7659 2.026 
1395745_at --- --- 484 980 2.024 
1372706_at hexosaminidase B Hexb 2257 4567 2.023 
1379462_at kinase suppressor of ras 1 Ksr1 617 1246 2.020 
1368689_at gap junction protein, beta 5 Gjb5 1719 3466 2.016 
1390423_at MYC binding protein 2 Mycbp2 1399 2813 2.011 
1389419_at --- --- 1561 3137 2.009 
1376522_at --- --- 260 522 2.004 
1381400_at --- --- 296 593 2.003 
1382400_at rearranged L-myc fusion Rlf 594 1189 2.002 
1376724_at --- --- 269 538 2.002 
1391253_at --- --- 343 686 1.999 
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1389169_at 
progesterone receptor 
membrane component 2 Pgrmc2 259 518 1.997 
1383110_at kelch-like 24 (Drosophila) Klhl24 329 657 1.997 
1395973_at --- --- 482 961 1.995 
1378925_at 
cAMP responsive element 
modulator Crem 843 1682 1.995 
1391183_at 
golgi associated PDZ and 
coiled-coil motif containing Gopc 315 627 1.990 
1374625_at 
hairy and enhancer of split 6 
(Drosophila) Hes6 406 806 1.987 
1367602_at 
Cbp/p300-interacting 
transactivator, with Glu/Asp-
rich carboxy-terminal domain, 
2 Cited2 6718 13346 1.987 
1375011_at --- --- 585 1160 1.983 
1372016_at 
growth arrest and DNA-
damage-inducible, beta Gadd45b 1453 2879 1.982 
1375368_at phosphoglycolate phosphatase Pgp 1251 2478 1.982 
1390396_at 
eukaryotic translation initiation 
factor 4E member 3 Eif4e3 916 1808 1.974 
1367796_at 
mannosyl (alpha-1,3-)-
glycoprotein beta-1,2-N-
acetylglucosaminyltransferase Mgat1 341 673 1.973 
1388945_at 
similar to 1300014I06Rik 
protein RGD1311307 1423 2805 1.971 
1395267_at --- --- 332 655 1.971 
1371027_at 
Cas-Br-M (murine) ecotropic 
retroviral transforming 
sequence b Cblb 506 998 1.970 
1388038_at attractin Atrn 452 890 1.970 
1399166_a_at B-cell CLL/lymphoma 7B Bcl7b 426 839 1.969 
1398411_at --- --- 18739 36896 1.969 
1382404_at --- --- 1674 3294 1.968 
1391346_at 
transcription factor 25 (basic 
helix-loop-helix) Tcf25 256 503 1.967 
1394012_at --- --- 633 1243 1.964 
1388539_at plakophilin 2 Pkp2 3225 6334 1.964 
1374722_at 
C1q and tumor necrosis factor 
related protein 1 C1qtnf1 306 599 1.961 
1388900_at RGD1566118 RGD1566118 2412 4729 1.961 
1367706_at 
voltage-dependent anion 
channel 1 Vdac1 7131 13980 1.960 
1370073_at 
DnaJ (Hsp40) homolog, 
subfamily C, member 3 Dnajc3 1323 2593 1.959 
1383058_at --- --- 409 800 1.958 
1371988_at 
mannosidase, alpha, class 1A, 
member 1 Man1a1 533 1042 1.956 
1374254_a_at transmembrane protein 205 Tmem205 571 1115 1.951 
1381470_at --- --- 2058 3993 1.940 
1389196_at 
hypothetical protein 
LOC681367 LOC681367 1018 1974 1.939 
1375910_at 
CDC42 effector protein (Rho 
GTPase binding) 3 Cdc42ep3 573 1112 1.939 
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1367609_at 
macrophage migration 
inhibitory factor Mif 8516 16503 1.938 
1390792_a_at --- --- 434 838 1.931 
1371094_at LIM homeobox 2 Lhx2 332 640 1.930 
1398561_at interferon regulatory factor 2 Irf2 363 701 1.930 
1369562_at hippocalcin-like 1 Hpcal1 1071 2065 1.928 
1387747_at gap junction protein, beta 3 Gjb3 2664 5126 1.924 
1375341_at transmembrane protein 189 Tmem189 589 1133 1.923 
1375723_at --- --- 874 1679 1.922 
1388705_at selenoprotein M Selm 947 1819 1.921 
1396199_at 
hypothetical protein 
LOC690326 LOC690326 326 626 1.920 
1373624_at --- --- 1728 3318 1.920 
1377043_at --- --- 274 526 1.920 
1392475_at activating transcription factor 6 Atf6 1704 3271 1.919 
1371113_a_at transferrin receptor Tfrc 3361 6450 1.919 
1379770_at choline phosphotransferase 1 Chpt1 447 858 1.919 
1375948_at 
AlkB, alkylation repair 
homolog 5 (E. coli) Alkbh5 1215 2332 1.919 
1375652_at 
signal sequence receptor, 
gamma Ssr3 2294 4393 1.915 
1383631_at 
similar to Oligosaccharyl 
transferase 3 CG7748-PA RGD1311563 1948 3730 1.915 
1387130_at 
solute carrier family 39 (iron-
regulated transporter), member 
1 Slc40a1 1263 2417 1.914 
1389189_at actinin, alpha 1 Actn1 7382 14123 1.913 
1376415_at 
mitochondrial ribosome 
recycling factor Mrrf 671 1284 1.912 
1374581_at 
Der1-like domain family, 
member 1 Derl1 2295 4384 1.911 
1370199_at nucleobindin 1 Nucb1 3104 5921 1.908 
1371467_at 
similar to RIKEN cDNA 
0610007P06 LOC293103 4963 9463 1.907 
1389648_at 
receptor-interacting serine-
threonine kinase 4 Ripk4 411 782 1.906 
1392923_at --- --- 274 522 1.906 
1372136_at Tetraspanin 14 Tspan14 7648 14573 1.905 
1374632_at jumonji domain containing 6 Jmjd6 1473 2804 1.903 
1374204_at 
WD repeat and SOCS box-
containing 1 Wsb1 2139 4066 1.901 
1399012_at transmembrane protein 59 Tmem59 3130 5951 1.901 
1383327_at programmed cell death 4 Pdcd4 799 1520 1.901 
1390982_at 
chromatin assembly factor 1, 
subunit B (p60) Chaf1b 953 1812 1.900 
1372950_at 
blocked early in transport 1 
homolog (S. cerevisiae) like Bet1l 387 734 1.896 
1393823_at 
polymerase (DNA directed), 
eta Polh 267 506 1.896 
1368407_at heparanase Hpse 265 503 1.895 
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1389528_s_at Jun oncogene Jun 1635 3085 1.887 
1368549_at 
HMG-box transcription factor 
1 Hbp1 484 913 1.886 
1372029_at 
mannose-6-phosphate receptor 
binding protein 1 M6prbp1 3084 5815 1.885 
1376501_at 
Rho GTPase activating protein 
8 Arhgap8 738 1390 1.884 
1369813_at 
DnaJ (Hsp40) homolog, 
subfamily C, member 5 Dnajc5 378 711 1.884 
1389023_at 
Similar to Oligosaccharyl 
transferase 3 CG7748-PA RGD1311563 6919 13006 1.880 
1371635_at 
transmembrane protein, 
adipocyte asscociated 1 Tpra1 435 817 1.879 
1373600_at 
glycosyltransferase 8 domain 
containing 3 Glt8d3 3690 6931 1.878 
1383183_at --- --- 369 694 1.878 
1387798_a_at 
complement component 
(3b/4b) receptor 1-like Cr1l 3838 7202 1.876 
1383028_at 
carnitine deficiency-associated 
gene expressed in ventricle 3 
homolog (mouse) Cdv3 607 1139 1.876 
1387675_at 
plasminogen activator, 
urokinase Plau 12417 23261 1.873 
1393492_at --- --- 467 875 1.873 
1367807_at 
procollagen-lysine 1, 2-
oxoglutarate 5-dioxygenase 1 Plod1 2507 4694 1.873 
1374911_at 
oxidative stress responsive 
gene RGD1303142 1008 1886 1.871 
1389787_at PTK7 protein tyrosine kinase 7 Ptk7 3019 5648 1.871 
1391494_at --- --- 549 1025 1.869 
1388662_at --- --- 375 701 1.866 
1377022_at 
abhydrolase domain containing 
10 Abhd10 1266 2363 1.866 
1391481_at --- --- 4582 8547 1.865 
1372863_at MYC binding protein 2 Mycbp2 2688 5010 1.864 
1372364_a_at N-terminal asparagine amidase Ntan1 2458 4580 1.863 
1369986_at 
hydroxyacyl glutathione 
hydrolase Hagh 809 1508 1.863 
1380265_at 
small nuclear RNA activating 
complex, polypeptide 1 Snapc1 1375 2560 1.862 
1381969_at --- --- 2549 4743 1.861 
1369220_at dynamin 1-like Dnm1l 417 774 1.859 
1388404_at RNA polymerase 1-3 Rpo1-3 4934 9165 1.857 
1389973_a_at surfeit 4 Surf4 1161 2157 1.857 
1378032_at 
nuclear factor of kappa light 
polypeptide gene enhancer in 
B-cells inhibitor, zeta Nfkbiz 5190 9639 1.857 
1374404_at Jun oncogene Jun 320 593 1.855 
1367743_at phosphofructokinase, liver Pfkl 356 660 1.854 
1387081_at 
reticulocalbin 2, EF-hand 
calcium binding domain Rcn2 15287 28280 1.850 
1373590_at stomatin Stom 441 816 1.850 
1373373_at --- --- 2214 4091 1.847 
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1383167_at --- --- 424 784 1.847 
1373376_at --- --- 2049 3783 1.846 
1371981_at 
Down syndrome critical region 
gene 3 Dscr3 2300 4245 1.846 
1382534_at --- --- 757 1396 1.844 
1388772_at 
LSM8 homolog, U6 small 
nuclear RNA associated (S. 
cerevisiae) Lsm8 1125 2075 1.844 
1388680_at 
C1GALT1-specific chaperone 
1 C1galt1c1 313 576 1.840 
1379283_at --- --- 2513 4618 1.837 
1367635_at 
prolyl 4-hydroxylase, beta 
polypeptide P4hb 18538 34058 1.837 
1374121_at --- --- 5986 10997 1.837 
1367914_at epithelial membrane protein 3 Emp3 2265 4154 1.834 
1395248_at 
ER degradation enhancer, 
mannosidase alpha-like 1 Edem1 597 1095 1.834 
1399022_at CDC-like kinase 1 Clk1 2414 4426 1.833 
1379347_at --- --- 837 1532 1.831 
1383019_at --- --- 297 544 1.831 
1383226_at zinc finger protein X-linked Zfx 1375 2518 1.831 
1370957_at interleukin 6 signal transducer Il6st 1295 2371 1.831 
1389258_at ring finger protein 138 Rnf138 723 1323 1.829 
1388370_at cyclin I Ccni 4894 8933 1.825 
1382024_at 
DnaJ (Hsp40) homolog, 
subfamily B, member 6 /// 
similar to DnaJ homolog 
subfamily B member 6 (Heat 
shock protein J2) (HSJ-2) 
(MRJ) (mDj4) 
Dnajb6 /// 
LOC690183 7774 14185 1.825 
1372739_at tetraspanin 31 Tspan31 2477 4516 1.823 
1369738_s_at 
cAMP responsive element 
modulator Crem 295 538 1.822 
1382128_at --- --- 382 695 1.822 
1377345_at --- --- 1880 3424 1.821 
1376230_at transmembrane protein 82 Tmem82 283 516 1.821 
1373810_at phospholipase A2, group XIIA Pla2g12a 1299 2360 1.817 
1387521_at programmed cell death 4 Pdcd4 656 1193 1.817 
1373499_at growth arrest specific 5 Gas5 7819 14192 1.815 
1376878_at 
similar to RIKEN cDNA 
2310022B05 RGD1559896 419 760 1.814 
1385426_at 
coiled-coil domain containing 
109B Ccdc109b 290 525 1.812 
1386886_at CD164 molecule, sialomucin Cd164 14031 25426 1.812 
1371819_at histone deacetylase 5 Hdac5 566 1026 1.811 
1389780_at 
tissue factor pathway inhibitor 
(lipoprotein-associated 
coagulation inhibitor) Tfpi 1926 3488 1.811 
1373106_at 
zinc finger protein 36, C3H 
type-like 2 Zfp36l2 1335 2411 1.806 
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1392547_at hypothetical LOC302884 MGC105649 716 1291 1.804 
1371854_at --- --- 2905 5241 1.804 
1395980_at --- --- 282 509 1.803 
1392937_at cyclin I Ccni 665 1197 1.800 
1372244_at calcium binding protein 39 Cab39 3599 6477 1.800 
1372717_at --- --- 1722 3098 1.799 
1373781_a_at suprabasin Sbsn 15415 27714 1.798 
1376410_at matrix metallopeptidase 17 Mmp17 526 945 1.796 
1378180_at dCMP deaminase Dctd 913 1640 1.796 
1367519_at oxysterol binding protein-like 2 Osbpl2 904 1622 1.794 
1383080_at --- --- 2671 4789 1.793 
1383328_x_at programmed cell death 4 Pdcd4 1190 2132 1.792 
1373459_at 
serine/threonine kinase 11 
interacting protein Stk11ip 670 1200 1.791 
1389014_at 
nicotinamide 
phosphoribosyltransferase Nampt 2117 3789 1.790 
1398961_at similar to ring finger protein 13 LOC681578 442 792 1.790 
1373759_at --- --- 344 616 1.790 
1372379_at --- --- 672 1202 1.789 
1391723_at --- --- 552 985 1.785 
1394614_at 
glucosamine (N-acetyl)-6-
sulfatase Gns 311 554 1.780 
1376805_at --- --- 2719 4839 1.780 
1378010_at --- --- 282 500 1.772 
1392627_x_at --- --- 23574 41740 1.771 
1390420_at 
carboxypeptidase X (M14 
family), member 1 Cpxm1 307 543 1.770 
1367603_at triosephosphate isomerase 1 Tpi1 13223 23397 1.769 
1372980_at tetraspanin 33 Tspan33 693 1223 1.766 
1388426_at 
sterol regulatory element 
binding transcription factor 1 Srebf1 447 788 1.765 
1369788_s_at Jun oncogene Jun 647 1142 1.765 
1388789_at 
Similar to hypothetical protein 
MGC17943 RGD1563325 1353 2386 1.764 
1383099_at 
GC-rich promoter binding 
protein 1 Gpbp1 290 512 1.764 
1389558_at similar to CG3570-PA LOC500034 760 1337 1.760 
1373149_at yippee-like 3 (Drosophila) Ypel3 606 1065 1.759 
1399039_at 
similar to DnaJ (Hsp40) 
homolog, subfamily B, member 
10 isoform 2 LOC689593 674 1184 1.757 
1377704_at 
male-specific lethal 2 homolog 
(Drosophila) Msl2 343 602 1.756 
1389681_at poliovirus receptor-related 2 Pvrl2 985 1730 1.756 
1387770_at 
interferon, alpha-inducible 
protein 27 Ifi27 945 1659 1.756 
1393730_at 
ADAM metallopeptidase with 
thrombospondin type 1 motif, 4 Adamts4 686 1204 1.756 
1389710_at Son of sevenless homolog 1 Sos1 2517 4418 1.756 
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(Drosophila) 
1367529_at 
Der1-like domain family, 
member 1 Derl1 1897 3329 1.755 
1382415_at 
arginine/serine-rich coiled-coil 
2 Rsrc2 963 1689 1.754 
1383357_a_at RELT-like 1 Rell1 1596 2798 1.754 
1368080_at 
response gene to complement 
32 Rgc32 456 800 1.753 
1368235_at CDC-like kinase 3 Clk3 748 1309 1.751 
1369725_at 
ArfGAP with dual PH domains 
2 Adap2 1616 2827 1.749 
1393345_at --- --- 1398 2445 1.749 
1371926_at --- --- 2436 4254 1.747 
1385668_at 
hypothetical protein 
LOC683460 LOC683460 413 720 1.744 
1389077_at 
Golgi transport 1 homolog B 
(S. cerevisiae) Golt1b 392 684 1.743 
1368881_at 
blocked early in transport 1 
homolog (S. cerevisiae) Bet1 445 775 1.742 
1383840_at 
chondroitin sulfate N-
acetylgalactosaminyltransferase 
1 Csgalnact1 571 994 1.741 
1372733_at --- --- 491 854 1.739 
1390524_at ring finger protein 12 Rnf12 2736 4752 1.737 
1390145_at Dmx-like 2 Dmxl2 401 697 1.736 
1389435_at 
Family with sequence 
similarity 114, member A1 Fam114a1 458 795 1.735 
1383474_at 
interleukin-1 receptor-
associated kinase 2 Irak2 347 600 1.731 
1398906_at sedlin-like LOC287274 3911 6768 1.731 
1396128_at 
GC-rich promoter binding 
protein 1 Gpbp1 938 1623 1.730 
1382199_at --- --- 730 1262 1.730 
1377948_at 
ankyrin repeat and zinc finger 
domain containing 1 Ankzf1 394 679 1.725 
1372243_at calcium binding protein 39 Cab39 2460 4242 1.724 
1398596_at 
natural killer tumor recognition 
sequence-like 
LOC10036416
5 1129 1946 1.723 
1384584_at --- --- 636 1095 1.723 
1392118_at --- --- 296 508 1.719 
1383730_at 
Tetratricopeptide repeat 
domain 9C Ttc9c 734 1262 1.719 
1383162_at --- --- 1425 2447 1.718 
1391271_at neuron navigator 2 Nav2 297 510 1.717 
1367729_at 
ornithine aminotransferase 
(gyrate atrophy) Oat 1305 2238 1.715 
1374174_at --- --- 305 523 1.713 
1388388_at male-enhanced antigen 1 Mea1 4334 7421 1.712 
1381124_at --- --- 1451 2482 1.711 
1388777_at 
signal sequence receptor, 
gamma Ssr3 4558 7794 1.710 
1391505_x_at --- --- 20110 34383 1.710 
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1370381_at 
proline-rich nuclear receptor 
coactivator 1 Pnrc1 1706 2917 1.709 
1390926_at 
zinc finger, SWIM-type 
containing 3 Zswim3 328 561 1.709 
1383326_a_at programmed cell death 4 Pdcd4 1028 1755 1.707 
1367648_at 
insulin-like growth factor 
binding protein 2 Igfbp2 1252 2135 1.705 
1398601_at spire homolog 1 (Drosophila) Spire1 525 896 1.705 
1374541_at glycogen synthase 1, muscle Gys1 1583 2698 1.704 
1380077_at --- --- 316 538 1.703 
1383624_at 
similar to hypothetical protein 
LOC284018 isoform b RGD1565033 421 717 1.702 
1367800_at plasminogen activator, tissue Plat 3064 5213 1.702 
1394815_at 
Similar to RIKEN cDNA 
9030409E16 RGD1559505 1014 1723 1.699 
1374185_at 
thioredoxin domain containing 
11 Txndc11 901 1530 1.699 
1395662_at --- --- 486 826 1.699 
1371894_at 
Glucosamine (N-acetyl)-6-
sulfatase Gns 3003 5096 1.697 
1370318_at 
phosphatidylinositol 4-kinase, 
catalytic, alpha Pi4ka 1056 1791 1.696 
1373983_at 
arginine/serine-rich coiled-coil 
2 Rsrc2 3790 6425 1.695 
1389840_at splicing factor 3b, subunit 1 Sf3b1 2734 4634 1.695 
1392508_at exoribonuclease 1 Eri1 326 552 1.694 
1385959_at 
Son of sevenless homolog 1 
(Drosophila) Sos1 449 761 1.694 
1382993_at Bcl-2 binding component 3 Bbc3 728 1233 1.694 
1386394_at --- --- 7503 12705 1.693 
1374232_at 
phosphoinositide-3-kinase, 
catalytic, alpha polypeptide Pik3ca 367 621 1.693 
1370820_at F-box protein 6 Fbxo6 3096 5234 1.690 
1390117_at --- --- 413 698 1.690 
1367617_at 
aldolase A, fructose-
bisphosphate Aldoa 21018 35465 1.687 
1374884_at 
protein phosphatase 1D Mg-
depend.  isoform Ppm1d 610 1030 1.687 
1388750_at transferrin receptor Tfrc 13186 22237 1.686 
1382379_at ring finger protein 138 Rnf138 1325 2232 1.685 
1373519_at --- --- 597 1005 1.685 
1368206_at acyl-CoA thioesterase 8 Acot8 654 1102 1.684 
1383213_at 
epidermal growth factor 
receptor pathway substrate 8 Eps8 600 1010 1.684 
1383829_at 
bobby sox homolog 
(Drosophila) Bbx 1971 3319 1.684 
1372246_at osteoclast stimulating factor 1 Ostf1 3268 5501 1.683 
1373950_at zinc finger protein 496 Znf496 1178 1983 1.683 
1387135_at 
a disintegrin and 
metallopeptidase domain 15 
(metargidin) Adam15 413 694 1.680 
1388628_at transmembrane emp24 protein Tmed3 539 906 1.680 
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transport domain containing 3 
1376779_at forkhead box O1 Foxo1 302 506 1.678 
1372171_at 
polyhomeotic-like 1 
(Drosophila) Phc1 438 735 1.678 
1367764_at cyclin G1 Ccng1 8705 14605 1.678 
1386995_at BTG family, member 2 Btg2 6275 10522 1.677 
1389742_at --- --- 1786 2991 1.675 
1390938_at 
Rho GTPase activating protein 
28 Arhgap28 573 960 1.674 
1380474_at Lysyl oxidase-like 2 Loxl2 389 651 1.674 
1390769_at 
Ribose-phosphate 
pyrophosphokinase I -like LOC314140 5057 8462 1.673 
1383724_at 
heparan sulfate 2-O-
sulfotransferase 1 Hs2st1 463 774 1.673 
1382721_at 
gametogenetin binding protein 
2 Ggnbp2 2551 4266 1.673 
1384323_at 
proteasome (prosome, 
macropain) 26S subunit, 
ATPase, 6 Psmc6 5487 9177 1.672 
1388618_at nidogen 2 Nid2 2069 3457 1.671 
1386976_at Cd82 molecule Cd82 1983 3312 1.671 
1374800_at --- --- 2712 4528 1.670 
1373569_at --- --- 1083 1808 1.669 
1388468_at CDC42 small effector 1 Cdc42se1 2280 3805 1.669 
1384452_at 
Zinc finger, CCHC domain 
containing 7 Zcchc7 777 1296 1.668 
1382891_at 
Ubiquitin specific peptidase 27, 
X-linked Usp27x 404 674 1.667 
1367699_at SH3-domain GRB2-like 1 Sh3gl1 1298 2161 1.665 
1392789_at 
solute carrier family 25, 
member 36 Slc25a36 313 520 1.664 
1370355_at 
stearoyl-Coenzyme A 
desaturase 1 Scd1 715 1189 1.663 
1374252_at centrosomal protein 110kDa Cep110 343 570 1.662 
1373887_at --- --- 1439 2389 1.660 
1385829_at obscurin-like 1 Obsl1 602 997 1.657 
1388271_at metallothionein 2A Mt2A 12994 21519 1.656 
1374948_at transmembrane protein 106A Tmem106a 735 1217 1.656 
1383667_at RUN domain containing 1 Rundc1 491 813 1.655 
1390109_at --- --- 5993 9917 1.655 
1373258_at cathepsin F Ctsf 742 1227 1.653 
1395346_at 
angio-associated, migratory 
cell protein Aamp 1565 2587 1.653 
1367575_at enolase 1, (alpha) Eno1 16782 27706 1.651 
1367516_at distrobrevin binding protein 1 Dtnbp1 847 1396 1.649 
1373775_at 
Negative regulator of ubiquitin-
like proteins 1 Nub1 310 511 1.647 
1376994_at --- --- 360 593 1.646 
1386229_at 
corepressor interacting with 
RBPJ, 1 Cir1 578 952 1.646 
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1399069_at --- --- 1187 1952 1.644 
1375421_a_at 
praja 2, RING-H2 motif 
containing Pja2 1668 2742 1.644 
1370859_at 
protein disulfide isomerase 
family A, member 6 Pdia6 11161 18340 1.643 
1368947_at 
growth arrest and DNA-
damage-inducible, alpha Gadd45a 611 1004 1.643 
1392887_at --- --- 549 901 1.643 
1372569_at four and a half LIM domains 3 Fhl3 1322 2171 1.642 
1389248_at galactokinase 1 Galk1 7308 11996 1.641 
1384312_at iroquois homeobox 1 Irx1 508 833 1.640 
1373844_at 
protein phosphatase 
methylesterase 1 Ppme1 1073 1758 1.639 
1367810_at 
solute carrier family 6 
(neurotransmitter transporter, 
creatine), member 8 Slc6a8 461 756 1.639 
1398768_at 
retinoblastoma binding protein 
7 Rbbp7 15188 24883 1.638 
1384423_at 5-nucleotidase, cytosolic II-like 
LOC10036459
7 546 895 1.638 
1390412_at 
solute carrier family 39 (iron-
regulated transporter), member 
1 Slc40a1 661 1083 1.637 
1372846_at 
cytochrome b, ascorbate 
dependent 3 Cybasc3 889 1454 1.636 
1376862_at ubiquitination factor E4B Ube4b 3818 6246 1.636 
1390209_at synaptogyrin 3 Syngr3 697 1139 1.635 
1383222_at --- --- 740 1209 1.635 
1377213_at --- --- 1176 1922 1.634 
1385436_at transmembrane channel-like 4 Tmc4 312 510 1.634 
1392575_at Zinc finger protein 654 Znf654 447 731 1.634 
1383543_at 
golgi transport 1 homolog B (S. 
cerevisiae) Golt1b 357 583 1.634 
1392985_at 
ariadne ubiquitin-conjugating 
enzyme E2 binding protein 
homolog 1 (Drosophila) Arih1 768 1255 1.633 
1397224_at 
ATPase, Ca++ transporting, 
plasma membrane 1 Atp2b1 429 700 1.632 
1392754_at 
ADAM metallopeptidase 
domain 8 Adam8 1458 2379 1.632 
1382007_at 
SH3-domain GRB2-like 
endophilin B1 Sh3glb1 3005 4901 1.631 
1379260_at headcase homolog (Drosophila) Heca 503 820 1.630 
1385314_at --- --- 606 987 1.629 
1391051_at --- --- 8981 14626 1.629 
1390249_at 
similar to human chromosome 
15 open reading frame 39 RGD1305464 1301 2118 1.628 
1368751_at 
potassium voltage-gated 
channel, delayed-rectifier, 
subfamily S, member 3 Kcns3 482 785 1.627 
1389565_at --- --- 367 597 1.627 
1390205_at --- --- 830 1349 1.626 
1382466_at small nuclear ribonucleoprotein Snrnp48 914 1485 1.624 
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48k (U11/U12) 
1383239_at 
zinc finger, CCHC domain 
containing 7 Zcchc7 952 1546 1.623 
1368076_at 
von Hippel-Lindau tumor 
suppressor Vhl 3218 5222 1.623 
1373902_at 
ribosomal modification protein 
rimK-like family member B Rimklb 789 1280 1.621 
1395928_at --- --- 355 576 1.621 
1374863_at 
retinol binding protein 7, 
cellular Rbp7 2391 3874 1.620 
1398975_at 
angio-associated, migratory 
cell protein Aamp 4809 7787 1.619 
1382348_at dihydroorotate dehydrogenase Dhodh 346 561 1.618 
1373225_at --- --- 4190 6777 1.617 
1387156_at 
hydroxysteroid (17-beta) 
dehydrogenase 2 Hsd17b2 3090 4995 1.616 
1383894_at --- --- 339 548 1.616 
1375548_at 
similar to RIKEN cDNA 
4732418C07 RGD1310351 2561 4137 1.616 
1374543_at --- --- 1508 2436 1.615 
1377167_at --- --- 885 1430 1.615 
1383361_at 
DnaJ (Hsp40) homolog, 
subfamily B, member 6 Dnajb6 17171 27730 1.615 
1371237_a_at metallothionein 1a Mt1a 15874 25632 1.615 
1387001_at 
v-ral simian leukemia viral 
oncogene homolog B (ras 
related; GTP binding protein) Ralb 4096 6613 1.615 
1391205_at HEAT repeat containing 2 Heatr2 1002 1617 1.614 
1373996_at gene trap locus F3b Gtlf3b 1015 1638 1.613 
1382020_at sperm associated antigen 9 Spag9 654 1055 1.612 
1371547_at C10 protein 
LOC10036200
5 4685 7553 1.612 
1387114_at protein kinase C, delta Prkcd 904 1458 1.612 
1398359_at ring finger protein 181 Rnf181 1627 2621 1.611 
1372710_at 
blocked early in transport 1 
homolog (S. cerevisiae) Bet1 1260 2030 1.610 
1372377_at 
DEAD (Asp-Glu-Ala-Asp) box 
polypeptide 41 Ddx41 736 1184 1.610 
1393342_at --- --- 1749 2814 1.609 
1376763_at --- --- 349 561 1.609 
1391167_at --- --- 2305 3707 1.608 
1371540_at 
keratinocyte associated protein 
2 Krtcap2 2393 3848 1.608 
1375640_at FK506 binding protein 9 Fkbp9 1757 2824 1.607 
1391422_at 
DnaJ (Hsp40) homolog, 
subfamily B, member 6 Dnajb6 1036 1664 1.607 
1371766_at --- --- 958 1540 1.607 
1370427_at 
platelet-derived growth factor 
alpha polypeptide Pdgfa 2835 4547 1.604 
1392541_at 
gamma-glutamyl 
cyclotransferase Ggct 571 915 1.602 
1372551_at Fas-activated serine/threonine Fastk 489 783 1.602 
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kinase 
1371666_at --- --- 2418 3871 1.601 
1382385_at 
proteasome (prosome, 
macropain) 26S subunit, 
ATPase, 6 Psmc6 1344 2150 1.600 
1372773_at 
neural proliferation, 
differentiation and control, 1 Npdc1 496 793 1.600 
1386540_at --- --- 548 877 1.600 
1369929_at prosaposin Psap 10514 16815 1.599 
1371648_at 
damage-specific DNA binding 
protein 1 Ddb1 8886 14206 1.599 
1398795_at aspartyl-tRNA synthetase Dars 3838 6136 1.599 
1389705_at 
recombination activating gene 
1 activating protein 1 Rag1ap1 692 1106 1.598 
1371373_at ring finger protein 181 Rnf181 2519 4024 1.597 
1370347_at PDZ and LIM domain 7 Pdlim7 1308 2090 1.597 
1382556_a_at similar to DIP13 alpha RGD1309388 684 1092 1.597 
1384478_at 
myeloid/lymphoid or mixed-
lineage leukemia (trithorax 
homolog, Drosophila); 
translocated to, 3 Mllt3 473 755 1.595 
1374144_at --- --- 639 1020 1.595 
1388503_at 
EP300 interacting inhibitor of 
differentiation 1 Eid1 1061 1692 1.594 
1375003_at 
serine (or cysteine) peptidase 
inhibitor, clade B, member 6a Serpinb6a 4303 6857 1.594 
1370331_at 
interleukin 11 receptor, alpha 
chain 1 Il11ra1 633 1008 1.593 
1389409_at testis derived transcript Tes 1638 2605 1.591 
1374572_at GATS protein-like 3 Gatsl3 1651 2626 1.591 
1376797_at CSRP2 binding protein Csrp2bp 496 788 1.590 
1395147_at --- --- 413 657 1.590 
1376352_at --- --- 1339 2127 1.589 
1367643_at basigin Bsg 15648 24857 1.588 
1389570_at 
inositol polyphosphate-5-
phosphatase K Inpp5k 452 717 1.588 
1368321_at early growth response 1 Egr1 1067 1691 1.585 
1374560_at proline-rich coiled-coil 1 Prrc1 325 515 1.585 
1388391_at 
NADH dehydrogenase 
(ubiquinone) 1 alpha 
subcomplex, 1 Ndufa1 8209 13003 1.584 
1382056_at 
splicing factor, arginine/serine-
rich 11 Sfrs11 1932 3059 1.584 
1373454_at 
similar to RIKEN cDNA 
0610037P05 RGD1305823 2103 3331 1.584 
1378705_at SET domain containing 5 Setd5 1615 2557 1.584 
1383596_at 
ISY1 splicing factor homolog 
(S. cerevisiae) Isy1 736 1165 1.583 
1392598_at --- --- 2161 3420 1.582 
1383269_at ring finger protein 2 Rnf2 2186 3458 1.582 
1374507_at ubiquitination factor E4B Ube4b 1754 2771 1.580 
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1382797_at 
similar to 1500019C06Rik 
protein RGD1560433 409 647 1.580 
1393136_at transmembrane protein 57 Tmem57 718 1135 1.579 
1379497_at --- --- 21766 34372 1.579 
1390201_at 
RAP1A, member of RAS 
oncogene family Rap1a 592 935 1.579 
1374622_at --- --- 1984 3132 1.579 
1387085_at 
phosphoribosyl pyrophosphate 
synthetase 1 Prps1 688 1085 1.577 
1376848_at --- --- 575 907 1.577 
1385252_at tripartite motif-containing 6 Trim6 485 764 1.576 
1369963_at 
platelet-activating factor 
acetylhydrolase, isoform 1b, 
subunit 3 Pafah1b3 679 1071 1.576 
1373922_at --- --- 334 526 1.576 
1372093_at 
Max interactor 1-like /// MAX 
interactor 1 
LOC10036089
8 /// Mxi1 724 1141 1.576 
1390234_at splicing factor 3b, subunit 1 Sf3b1 10929 17208 1.575 
1387367_at golgi apparatus protein 1 Glg1 526 829 1.574 
1368326_at 
eukaryotic translation initiation 
factor 2 alpha kinase 3 Eif2ak3 579 912 1.574 
1386929_at hexokinase 1 Hk1 786 1237 1.574 
1384489_at 
lysine (K)-specific demethylase 
2A Kdm2a 458 720 1.573 
1384163_at --- --- 2117 3328 1.572 
1390842_at transcription factor AP-2, alpha Tcfap2a 2545 3998 1.571 
1398641_at 
pleckstrin homology domain-
containing, family A 
(phosphoinositide binding 
specific) member 3 Plekha3 1999 3139 1.570 
1388722_at 
DnaJ (Hsp40) homolog, 
subfamily B, member 1 Dnajb1 1492 2341 1.569 
1382312_at 
AT rich interactive domain 5B 
(Mrf1 like) Arid5b 1729 2712 1.568 
1388942_at --- --- 874 1371 1.568 
1388563_at 
GC-rich promoter binding 
protein 1 Gpbp1 4241 6645 1.567 
1384272_at --- --- 368 577 1.567 
1382283_at 
WAS/WASL interacting 
protein family, member 1 Wipf1 968 1516 1.566 
1372552_at 
acyl-Coenzyme A binding 
domain containing 3 Acbd3 1793 2807 1.566 
1372509_at 
hypothetical protein 
LOC687192 LOC687192 443 694 1.566 
1373977_at Kinesin family member 5C Kif5c 714 1117 1.565 
1373141_at 
ariadne homolog 2 
(Drosophila) Arih2 677 1059 1.565 
1377649_at --- --- 342 535 1.564 
1398788_at 
protein disulfide isomerase 
family A, member 3 Pdia3 10329 16149 1.563 
1394854_at 
telomeric repeat binding factor 
(NIMA-interacting) 1 Terf1 487 761 1.563 
1374052_at 
Family with sequence 
similarity 160, member B1 Fam160b1 429 670 1.562 
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1389298_at --- --- 1341 2094 1.561 
1369879_a_at 
transmembrane BAX inhibitor 
motif containing 6 Tmbim6 5353 8350 1.560 
1374670_at 
Similar to hypothetical protein 
MGC20700 RGD1307722 472 737 1.560 
1372769_at ligatin Lgtn 1079 1683 1.559 
1385953_at 
myeloid/lymphoid or mixed-
lineage leukemia (trithorax 
homolog, Drosophila); 
translocated to, 3 Mllt3 1146 1785 1.558 
1368101_at calmodulin 3 Calm3 2375 3698 1.557 
1378294_at 
F-box and leucine-rich repeat 
protein 12 Fbxl12 1260 1961 1.557 
1368936_at thioredoxin-like 1 Txnl1 5705 8881 1.557 
1376006_at --- --- 1356 2110 1.556 
1384122_at --- --- 1171 1823 1.556 
1370937_a_at integrin, alpha 7 Itga7 564 878 1.556 
1383155_at 
family with sequence similarity 
117, member B Fam117b 835 1299 1.556 
1382970_at 
similar to ubiquitin protein 
ligase E3 component n-
recognin 2 LOC363188 465 723 1.555 
1374725_at Moloney leukemia virus 10 Mov10 518 805 1.555 
1387690_at caspase 3 Casp3 351 545 1.555 
1372132_at 
CNDP dipeptidase 2 
(metallopeptidase M20 family) Cndp2 1187 1846 1.555 
1374917_at SEC63 homolog (S. cerevisiae) Sec63 379 588 1.553 
1371616_at --- --- 3483 5407 1.552 
1382743_at 
Intermediate filament family 
orphan 2 Iffo2 682 1058 1.552 
1383201_at --- --- 2626 4069 1.550 
1383687_at --- --- 824 1277 1.549 
1395064_at 
similar to 4930429A08Rik 
protein RGD1564943 747 1156 1.548 
1392785_at --- --- 1482 2294 1.548 
1388587_at immediate early response 3 Ier3 9552 14782 1.548 
1367486_at 
ADP-ribosylation factor 
GTPase activating protein 2 Arfgap2 597 923 1.547 
1398787_at Ras homolog enriched in brain Rheb 6305 9753 1.547 
1384508_at --- --- 491 759 1.546 
1391012_at 
family with sequence similarity 
83, member F Fam83f 1346 2081 1.546 
1390134_at --- --- 717 1109 1.546 
1390141_at 
methylenetetrahydrofolate 
dehydrogenase (NADP+ 
dependent) 1-like Mthfd1l 855 1322 1.546 
1390347_at --- --- 336 519 1.545 
1379315_at 
Ras association (RalGDS/AF-
6) domain family (N-terminal) 
member 7 Rassf7 669 1033 1.544 
1389444_at 
Zinc finger, DHHC-type 
containing 20 Zdhhc20 922 1423 1.544 
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1371611_at exostoses (multiple) 2 Ext2 1050 1620 1.543 
1371579_at 
Similar to signal peptidase 
complex subunit 3 homolog LOC680782 4904 7564 1.543 
1376843_at 
bone morphogenetic protein 
receptor, type II 
(serine/threonine kinase) Bmpr2 1567 2415 1.542 
1389364_at 
Nedd4 family interacting 
protein 2 Ndfip2 2880 4440 1.542 
1370007_at 
protein disulfide isomerase 
family A, member 4 Pdia4 4427 6824 1.542 
1389071_at 
EH domain binding protein 1-
like 1 Ehbp1l1 716 1103 1.540 
1367660_at 
fatty acid binding protein 3, 
muscle and heart Fabp3 14644 22540 1.539 
1368486_at insulin receptor substrate 3 Irs3 331 509 1.538 
1367873_at 
ATPase, H+ transporting, 
lysosomal accessory protein 1 Atp6ap1 2257 3471 1.538 
1393019_at --- --- 334 514 1.538 
1387279_at F11 receptor F11r 4526 6958 1.537 
1399026_at 
poly(A) binding protein 
interacting protein 2 Paip2 6584 10116 1.536 
1377691_at 
SEC22 vesicle trafficking 
protein homolog B (S. 
cerevisiae) Sec22b 3002 4611 1.536 
1371310_s_at 
serine (or cysteine) peptidase 
inhibitor, clade H, member 1 Serpinh1 1280 1965 1.536 
1367668_a_at 
stearoyl-CoA desaturase (delta-
9-desaturase) Scd 2369 3636 1.535 
1373458_at brain expressed gene 4 Bex4 5599 8593 1.535 
1393824_at 
Similar to RIKEN cDNA 
9030409E16 RGD1559505 1215 1864 1.535 
1380445_at --- --- 454 697 1.534 
1370305_at 
Yip1 interacting factor 
homolog (S. cerevisiae) Yif1 774 1188 1.534 
1382873_at CTTNBP2 N-terminal like Cttnbp2nl 478 734 1.534 
1378990_at --- --- 384 589 1.534 
1379724_at 
pleckstrin homology-like 
domain, family B, member 2 Phldb2 405 621 1.533 
1388071_x_at RT1 class Ib, locus EC2 RT1-EC2 1172 1797 1.533 
1389598_at 
ceroid-lipofuscinosis, neuronal 
6 Cln6 3675 5635 1.533 
1390185_at decapping enzyme, scavenger Dcps 615 943 1.533 
1367744_at melanoma antigen, family D, 2 Maged2 453 693 1.532 
1388883_at 
polymerase (DNA-directed), 
delta 4 Pold4 665 1018 1.531 
1376086_at UFM1-specific peptidase 2 Ufsp2 2669 4084 1.530 
AFFX-r2-Bs-thr-3_s_at --- --- 800 1223 1.530 
1382568_at --- --- 550 842 1.529 
1390419_a_at tumor suppressor candidate 3 Tusc3 1044 1596 1.529 
1379850_at 
proteasome (prosome, 
macropain) 26S subunit, 
ATPase, 6 Psmc6 4805 7344 1.528 
1388729_at 
Harvey rat sarcoma virus 
oncogene, subgroup R Rras 1085 1659 1.528 
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1374736_at --- --- 694 1061 1.528 
1383643_at 
similar to UPF0197 protein 
C11orf10 homolog RGD1560328 3475 5308 1.527 
1372237_at --- --- 781 1193 1.527 
1379302_at 
recombination signal binding 
protein for immunoglobulin 
kappa J region Rbpj 720 1100 1.527 
1373208_at --- --- 772 1179 1.527 
1376062_at syndecan 1 Sdc1 1592 2430 1.527 
1398879_at transmembrane protein 66 Tmem66 1987 3028 1.524 
1372149_at 
AU RNA binding 
protein/enoyl-coenzyme A 
hydratase Auh 1552 2364 1.523 
1373117_at 
ubiquitin-like with PHD and 
ring finger domains 2 Uhrf2 2719 4140 1.523 
1376347_at 
lysine (K)-specific demethylase 
5B Kdm5b 1278 1945 1.522 
1378743_at 
similar to Peptidyl-prolyl cis-
trans isomerase NIMA-
interacting 4 (Rotamase Pin4) 
(PPIase Pin4) LOC684441 455 692 1.522 
1390789_at 
acyl-Coenzyme A 
dehydrogenase family, member 
11 Acad11 835 1269 1.521 
1398842_at clathrin, heavy chain (Hc) Cltc 10800 16424 1.521 
1373788_at 
solute carrier family 41, 
member 1 Slc41a1 534 812 1.521 
1398922_at --- --- 1101 1674 1.520 
1391006_at --- --- 363 552 1.520 
1368511_at 
basic helix-loop-helix family, 
member e41 Bhlhe41 2212 3363 1.520 
1389529_at 
Family with sequence 
similarity 168, member A Fam168a 359 545 1.520 
1376200_at hypothetical LOC316976 MGC72974 1136 1727 1.520 
1373250_at --- --- 3497 5312 1.519 
1375184_at --- --- 371 564 1.518 
1370255_at surfactant protein C Sftpc 478 725 1.518 
1386864_at 
phosphoglycerate mutase 1 
(brain) Pgam1 21892 33225 1.518 
1370375_at 
glutaminase 2 (liver, 
mitochondrial) Gls2 646 980 1.517 
1384865_at --- --- 962 1459 1.517 
1371769_at 
secretory carrier membrane 
protein 2 Scamp2 750 1138 1.517 
1371610_at --- --- 1905 2891 1.517 
1374903_at 
glucosaminyl (N-acetyl) 
transferase 2, I-branching 
enzyme Gcnt2 2051 3110 1.517 
1383116_at 
asparagine-linked glycosylation 
13 homolog (S. cerevisiae) Alg13 1202 1823 1.516 
1398776_at ribophorin II Rpn2 6286 9531 1.516 
1388331_at 
heat shock protein 90kDa beta 
(Grp94), member 1 Hsp90b1 11970 18145 1.516 
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1372893_at Yip1 domain family, member 1 Yipf1 1696 2571 1.516 
1388904_at hypothetical protein Dd25 Dd25 749 1135 1.516 
1398909_at hypothetical LOC301124 LOC301124 2272 3441 1.515 
1380095_at 
WAP four-disulfide core 
domain 6A Wfdc6a 956 1448 1.515 
1382427_at 
CGG triplet repeat binding 
protein 1 Cggbp1 986 1493 1.514 
1388531_at 
progesterone receptor 
membrane component 2 Pgrmc2 1081 1633 1.511 
1388407_at 
family with sequence similarity 
195, member B Fam195b 1210 1827 1.511 
1389526_at 
EFR3 homolog A (S. 
cerevisiae) Efr3a 686 1036 1.510 
1373413_at transmembrane protein 128 Tmem128 1656 2499 1.509 
1371780_at 
KDEL (Lys-Asp-Glu-Leu) 
endoplasmic reticulum protein 
retention receptor 2 Kdelr2 4995 7538 1.509 
1367867_at 
growth factor, augmenter of 
liver regeneration Gfer 1916 2892 1.509 
1372804_at 
MMR_HSR1 domain 
containing protein 
RGD1359460 RGD1359460 901 1360 1.509 
1374092_at 
WW domain containing 
transcription regulator 1 Wwtr1 534 806 1.508 
1382317_at 
epidermal growth factor 
receptor pathway substrate 8 Eps8 795 1198 1.507 
1387642_at 
Interleukin 23, alpha subunit 
p19 Il23a 2603 3921 1.506 
1369452_a_at 
phosphatidylinositol binding 
clathrin assembly protein Picalm 450 678 1.505 
1374202_at --- --- 519 782 1.505 
1367783_at 
GABA(A) receptor-associated 
protein like 2 Gabarapl2 2480 3732 1.505 
1383590_at 
chondroitin sulfate N-
acetylgalactosaminyltransferase 
1 Csgalnact1 1752 2635 1.504 
1391880_at --- --- 2970 4464 1.503 
1390032_at 
RNA binding motif, single 
stranded interacting protein 2 Rbms2 2081 3127 1.503 
1387903_at 
praja 2, RING-H2 motif 
containing Pja2 1259 1888 1.500 
1378094_at --- --- 845 1268 1.500 
1372272_at 
Hypothetical protein 
LOC692032 LOC692032 1142 1712 1.500 
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Table A2.2: Genes downregulated by hypoxia 
Affymetrix ID Gene Title Gene Symbol 
Ave 
amb sig 
int 
Ave hypox 
sig int 
amb/  
hypox 
1393128_at G patch domain containing 4 Gpatch4 567 83 -6.843 
1377114_at --- --- 9144 1601 -5.713 
1386947_at cadherin 1 Cdh1 1789 373 -4.792 
1382186_a_at G patch domain containing 4 Gpatch4 580 143 -4.048 
1387988_at 
hydroxy-delta-5-steroid 
dehydrogenase, 3 beta- and steroid 
delta-isomerase 6 Hsd3b6 8204 2183 -3.758 
1388781_at --- --- 663 188 -3.536 
1378958_at coiled-coil domain containing 86 Ccdc86 815 236 -3.456 
1371350_at 
methionine adenosyltransferase II, 
alpha Mat2a 3430 995 -3.446 
1371583_at 
RNA binding motif (RNP1, RRM) 
protein 3 Rbm3 7243 2142 -3.381 
1373536_at --- --- 8159 2567 -3.179 
1374945_at 
tRNA methyltransferase 61 homolog 
A (S. cerevisiae) Trmt61a 565 178 -3.171 
1370288_a_at tropomyosin 1, alpha Tpm1 692 219 -3.165 
1387028_a_at inhibitor of DNA binding 1 Id1 4684 1489 -3.147 
1374777_at hypothetical protein LOC502894 LOC502894 847 269 -3.145 
1382381_at --- --- 2315 751 -3.082 
1388194_at dihydrolipoamide S-acetyltransferase Dlat 727 242 -3.005 
1377461_at --- --- 684 232 -2.951 
1385066_a_at --- --- 617 210 -2.940 
1386586_at PAK1 interacting protein 1 Pak1ip1 1687 578 -2.920 
1378003_at 
leucine rich repeat containing 8 
family, member B Lrrc8b 1673 584 -2.866 
1377627_at 
UTP20, small subunit (SSU) 
processome component, homolog 
(yeast) Utp20 759 265 -2.857 
1389554_at --- --- 1077 378 -2.854 
1382275_at PAK1 interacting protein 1 Pak1ip1 2458 866 -2.840 
1376098_a_at --- --- 2542 899 -2.829 
1379380_at 
sprouty homolog 1, antagonist of FGF 
signaling (Drosophila) Spry1 503 178 -2.818 
1387776_at transglutaminase 2, C polypeptide Tgm2 676 240 -2.816 
1375551_at coiled-coil domain containing 86 Ccdc86 784 279 -2.809 
1372789_at zinc finger protein 637 Zfp637 1076 389 -2.763 
1380611_at FK506 binding protein 5 Fkbp5 1318 479 -2.750 
1371840_at sphingosine-1-phosphate receptor 1 S1pr1 1110 404 -2.745 
1388473_at --- --- 521 190 -2.742 
1378106_at 
pleckstrin homology-like domain, 
family A, member 2 Phlda2 6380 2333 -2.735 
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1389690_at similar to RIKEN cDNA 2410146L05 RGD1311103 1531 562 -2.723 
1377021_at 
tRNA methyltransferase 6 homolog 
(S. cerevisiae) Trmt6 783 289 -2.714 
1380523_at F-box protein 15 Fbxo15 4157 1534 -2.711 
1383675_at similar to Protein KIAA0690 LOC679127 1203 444 -2.711 
1375911_at hypothetical protein LK44 RGD735140 528 198 -2.663 
1386910_a_at 
APEX nuclease (multifunctional DNA 
repair enzyme) 1 Apex1 1583 595 -2.660 
1386946_at carnitine palmitoyltransferase 1a, liver Cpt1a 911 343 -2.657 
1372510_at sulfiredoxin 1 homolog (S. cerevisiae) Srxn1 1431 543 -2.638 
1372326_at 
Solute carrier family 2 (facilitated 
glucose transporter), member 3 Slc2a3 1064 405 -2.628 
1371765_at histone cluster 3, H2a Hist3h2a 620 236 -2.628 
1392514_at brix domain containing 1 Bxdc1 2148 818 -2.625 
1373944_at --- --- 654 252 -2.595 
1374857_at 
GAR1 ribonucleoprotein homolog 
(yeast) Gar1 2825 1095 -2.580 
1370287_a_at tropomyosin 1, alpha Tpm1 1858 721 -2.575 
1373068_at 
interferon-related developmental 
regulator 2 Ifrd2 1412 548 -2.575 
1391889_at --- --- 596 232 -2.570 
1391306_at --- --- 1021 399 -2.561 
1374340_at --- --- 1236 483 -2.558 
1383747_at 
epithelial cell transforming sequence 2 
oncogene Ect2 3596 1423 -2.527 
1383301_at hypothetical protein LOC498154 LOC498154 772 307 -2.516 
1386668_a_at similar to Protein KIAA0690 LOC679127 627 250 -2.509 
1391063_at kinesin family member 23 Kif23 965 385 -2.508 
1387232_at bone morphogenetic protein 4 Bmp4 2195 889 -2.468 
1377708_at hypothetical protein LOC499339 LOC499339 2274 925 -2.457 
1390579_at similar to RIKEN cDNA 1810029B16 RGD1305222 2369 967 -2.450 
1370366_at 
translocase of inner mitochondrial 
membrane 10 homolog (yeast) Timm10 2608 1067 -2.444 
1378214_at --- --- 697 287 -2.433 
1370346_at cyclin B1 Ccnb1 3901 1605 -2.431 
1388178_at nuclear receptor coactivator 3 Ncoa3 803 333 -2.414 
1371775_at --- --- 642 266 -2.413 
1379337_at FAST kinase domains 2 Fastkd2 1608 671 -2.396 
1395603_at RGD1565487 RGD1565487 1096 458 -2.394 
1392385_at Nuclear receptor coactivator 3 Ncoa3 1438 601 -2.393 
1389532_at Nebulette Nebl 1420 594 -2.389 
1391905_at 
PWP2 periodic tryptophan protein 
homolog (yeast) Pwp2 678 284 -2.386 
1378112_at MYST histone acetyltransferase Myst3 1291 543 -2.379 
1383685_at HEAT repeat containing 1 Heatr1 1075 452 -2.377 
1376206_at Similar to TSG118.1 RGD1565096 2158 913 -2.364 
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1379526_at --- --- 967 409 -2.363 
1367926_at prohibitin Phb 555 236 -2.348 
1393904_at lin-28 homolog (C. elegans) Lin28 775 331 -2.342 
1388560_at WD repeat domain 77 Wdr77 5005 2143 -2.336 
1377760_at 
nucleolar complex associated 4 
homolog (S. cerevisiae) Noc4l 946 406 -2.333 
1395376_at 
DEAD/H (Asp-Glu-Ala-Asp/His) box 
polypeptide 11 (CHL1-like helicase 
homolog, S. cerevisiae) Ddx11 1583 679 -2.330 
1387268_at polymerase (RNA) I polypeptide B Polr1b 879 377 -2.328 
1374288_at FtsJ homolog 3 (E. coli) Ftsj3 1723 741 -2.325 
1381428_a_at --- --- 574 247 -2.325 
1385020_at hypothetical protein LOC499339 LOC499339 654 282 -2.317 
1374836_at 
ribosomal RNA processing 9, small 
subunit (SSU) processome 
component, homolog (yeast) Rrp9 938 406 -2.314 
1389384_at 
NADH dehydrogenase (ubiquinone) 1 
alpha subcomplex, assembly factor 4 Ndufaf4 2274 983 -2.313 
1381217_at 
tRNA methyltransferase 6 homolog 
(S. cerevisiae) Trmt6 822 356 -2.310 
1391754_at 2 ' -5 ' oligoadenylate synthetase 1I Oas1i 545 236 -2.308 
1392542_at CDC42 small effector 2 Cdc42se2 1703 738 -2.308 
1374716_at 
ribosomal RNA processing 15 
homolog (S. cerevisiae) Rrp15 1048 455 -2.304 
1388804_at --- --- 673 292 -2.302 
1368508_at 
proteasome subunit alpha type-3-like 
/// proteasome (prosome, macropain) 
subunit, alpha type 3 /// proteasome 
subunit alpha type 3-like 
LOC10036106
7 /// Psma3 /// 
Psma3l 735 321 -2.291 
1387154_at neuropeptide Y Npy 1622 710 -2.285 
1377387_a_at 
endothelin-converting enzyme 2 /// 
endothelin converting enzyme 2-like 
Ece2 /// 
LOC10036356
1 570 250 -2.285 
1379719_at --- --- 2483 1089 -2.280 
1372498_at cytokine induced apoptosis inhibitor 1 Ciapin1 2966 1305 -2.273 
1372997_at similar to Protein C22orf13 homolog LOC687713 954 420 -2.272 
1372116_at mitochondrial ribosomal protein S2 Mrps2 2216 978 -2.266 
1369943_at transglutaminase 2, C polypeptide Tgm2 2566 1135 -2.261 
1393817_at --- --- 568 251 -2.261 
1373897_at Lamin B1 Lmnb1 5326 2369 -2.248 
1386669_at similar to Protein KIAA0690 LOC679127 542 241 -2.247 
1368402_at 
dynein, cytoplasmic 1 light 
intermediate chain 2 Dync1li2 2476 1104 -2.243 
1371919_at 
nudix (nucleoside diphosphate linked 
moiety X)-type motif 19 Nudt19 661 295 -2.242 
1382592_at coiled-coil domain containing 99 Ccdc99 818 366 -2.238 
1385073_at mCG146312-like 
LOC10036333
1 5005 2240 -2.235 
1374921_at 
regulator of telomere elongation 
helicase 1 Rtel1 874 392 -2.233 
1390384_at H2A histone family, member X H2afx 1081 484 -2.232 
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1386711_a_at 
DnaJ (Hsp40) homolog, subfamily C, 
member 11 Dnajc11 628 282 -2.231 
1389609_at 
transmembrane 7 superfamily member 
3 Tm7sf3 950 427 -2.228 
1387895_s_at 
cell division cycle 20 homolog (S. 
cerevisiae) Cdc20 1292 581 -2.225 
1387950_at 
nuclear import 7 homolog (S. 
cerevisiae) Nip7 4829 2171 -2.225 
1377166_at 
Amyotrophic lateral sclerosis 2 
(juvenile) homolog (human) Als2 560 253 -2.214 
1387793_at 
solute carrier family 9 
(sodium/hydrogen exchanger), 
member 3 regulator 1 Slc9a3r1 2046 926 -2.211 
1389282_at Integrin, alpha 3 Itga3 957 433 -2.209 
1378120_at 
mRNA turnover 4 homolog (S. 
cerevisiae) Mrto4 744 337 -2.206 
1391461_at similar to hypothetical protein RGD1306576 1063 483 -2.200 
1370177_at poliovirus receptor PVR 3313 1506 -2.200 
1371303_at L-threonine dehydrogenase Tdh 1046 476 -2.199 
1390036_at 
solute carrier family 16, member 6 
(monocarboxylic acid transporter 7) Slc16a6 2160 985 -2.193 
1398333_at --- --- 1484 679 -2.186 
1385086_at 
budding uninhibited by 
benzimidazoles 1 homolog (S. 
cerevisiae) Bub1 2652 1216 -2.180 
1382065_at --- --- 799 368 -2.174 
1387076_at 
hypoxia-inducible factor 1, alpha 
subunit (basic helix-loop-helix 
transcription factor) Hif1a 9614 4424 -2.173 
1375937_a_at centromere protein T Cenpt 565 260 -2.173 
1395595_at 
Mki67 (FHA domain) interacting 
nucleolar phosphoprotein Mki67ip 1692 780 -2.168 
1375895_at rCG34104-like 
LOC10036040
6 4762 2205 -2.159 
1373625_at 
serine hydroxymethyltransferase 1 
(soluble) Shmt1 1045 485 -2.154 
1388136_at 
translocase of inner mitochondrial 
membrane 9 homolog (yeast) Timm9 1277 593 -2.152 
1388582_at 
proteasome (prosome, macropain) 
activator subunit 3 Psme3 1422 661 -2.151 
1376065_at 
RRS1 ribosome biogenesis regulator 
homolog (S. cerevisiae) Rrs1 1172 545 -2.150 
1391415_at 
partner of NOB1 homolog (S. 
cerevisiae) Pno1 2660 1242 -2.141 
1377625_at 
tRNA methyltransferase 6 homolog 
(S. cerevisiae) Trmt6 897 420 -2.135 
1373573_at PP3111 protein Pp3111 1393 653 -2.135 
1368588_at 
DEAD (Asp-Glu-Ala-Asp) box 
polypeptide 52 Ddx52 1089 510 -2.134 
1382972_at 
UTP15, U3 small nucleolar 
ribonucleoprotein, Utp15 503 236 -2.133 
1372467_at heparan sulfate 6-O-sulfotransferase 1 Hs6st1 576 270 -2.129 
1383323_at 
DSN1, MIND kinetochore complex 
component, homolog (S. cerevisiae) Dsn1 505 237 -2.128 
1374501_at --- --- 4575 2153 -2.125 
1376681_at ribosomal RNA processing 8, Rrp8 591 278 -2.123 
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methyltransferase, homolog (yeast) 
1374227_at tetratricopeptide repeat domain 27 Ttc27 825 389 -2.123 
1374415_at 
polymerase (RNA) III (DNA directed) 
polypeptide E Polr3e 585 276 -2.122 
1371622_at 
DPH1 homolog (S. cerevisiae) /// 
candidate tumor suppressor in ovarian 
cancer 2 Dph1 /// Ovca2 1370 646 -2.121 
1367632_at 
glutamate-ammonia ligase (glutamine 
synthetase) Glul 1430 674 -2.120 
1372539_at --- --- 1140 538 -2.118 
1372177_at molybdenum cofactor synthesis 2 Mocs2 2815 1334 -2.111 
1398264_at 
solute carrier family 30 (zinc 
transporter), member 2 Slc30a2 2729 1294 -2.109 
1388482_at 
family with sequence similarity 129, 
member B Fam129b 2302 1092 -2.108 
1388340_at 
NS5A (hepatitis C virus) 
transactivated protein 9 Ns5atp9 1285 610 -2.105 
1370180_at 
nudix (nucleoside diphosphate linked 
moiety X)-type motif 4 Nudt4 2340 1116 -2.097 
1374152_at WD repeat domain 46 Wdr46 553 264 -2.096 
1372629_at coronin, actin binding protein, 2B Coro2b 919 439 -2.095 
1373871_at suppressor of Ty 7 (S. cerevisiae)-like Supt7l 1669 797 -2.093 
1368870_at inhibitor of DNA binding 2 Id2 899 430 -2.092 
1373564_at 
3-hydroxyisobutyryl-Coenzyme A 
hydrolase Hibch 952 455 -2.091 
1391555_at --- --- 537 257 -2.089 
1385344_at --- --- 786 377 -2.087 
1376811_a_at 
cleavage and polyadenylation specific 
factor 6 Cpsf6 1235 594 -2.078 
1383428_at armadillo repeat containing 8 Armc8 655 316 -2.077 
1384922_at --- --- 700 338 -2.072 
1375849_at RGM domain family, member A Rgma 909 440 -2.065 
1376267_at --- --- 1977 961 -2.057 
1393684_at helicase, lymphoid specific Hells 635 309 -2.055 
1372502_at neurofibromin 2 (merlin) Nf2 1309 637 -2.054 
1372966_at 
major facilitator superfamily domain 
containing 2 Mfsd2 2062 1005 -2.052 
1388436_at 
small nuclear ribonucleoprotein 
polypeptide A Snrpa 1996 975 -2.048 
1384149_at coiled-coil domain containing 75 Ccdc75 875 427 -2.048 
1373390_at 
male-specific lethal 1 homolog 
(Drosophila) Msl1 896 439 -2.043 
1377889_at 
URB1 ribosome biogenesis 1 
homolog (S. cerevisiae) Urb1 1089 533 -2.041 
1379406_at 
similar to chromosome 14 open 
reading frame 21 RGD1308396 749 367 -2.039 
1384901_at --- --- 832 408 -2.038 
1383168_at hypothetical protein LOC688298 LOC688298 1386 681 -2.036 
1382076_at 
solute carrier family 37 (glycerol-3-
phosphate transporter), member 1 Slc37a1 1379 678 -2.035 
1373733_at BCL2-related ovarian killer Bok 1603 788 -2.034 
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1393964_at 
reproductive homeobox 9-like /// 
reproductive homeobox 9 
LOC10036400
2 /// Rhox9 733 361 -2.033 
1375686_at 
peptidylprolyl isomerase 
(cyclophilin)-like 3 Ppil3 3930 1939 -2.027 
1367934_at ribosomal protein L39 Rpl39 546 270 -2.026 
1390272_at DPH5 homolog (S. cerevisiae) Dph5 862 426 -2.023 
1370316_at 
HSPA (heat shock 70kDa) binding 
protein, cytoplasmic cochaperone 1 Hspbp1 992 491 -2.021 
1377937_at mitochondrial ribosomal protein S14 Mrps14 1808 895 -2.020 
1368811_at lamin B1 Lmnb1 812 403 -2.016 
1387123_at 
cytochrome P450, family 17, 
subfamily a, polypeptide 1 Cyp17a1 1279 635 -2.015 
1371513_at --- --- 2724 1354 -2.012 
1392981_at iroquois homeobox 4 Irx4 1922 956 -2.011 
1368181_at 
methylenetetrahydrofolate 
dehydrogenase (NADP+ dependent) 
1, methenyltetrahydrofolate 
cyclohydrolase, 
formyltetrahydrofolate synthetase Mthfd1 3308 1645 -2.011 
1388425_at OAF homolog (Drosophila) Oaf 4773 2374 -2.010 
1379699_at --- --- 967 482 -2.005 
1373282_at 
similar to mitochondrial carrier 
protein MGC4399 LOC691431 794 396 -2.004 
1374737_at 
tRNA splicing endonuclease 54 
homolog (S. cerevisiae) Tsen54 1041 520 -2.001 
1373263_at WD repeat domain 74 Wdr74 1382 691 -1.999 
1389983_at 
nucleolar complex associated 2 
homolog (S. cerevisiae) Noc2l 1569 786 -1.997 
1373538_at ubiquitin specific peptidase 1 Usp1 905 453 -1.996 
1373272_at 
pleckstrin homology domain 
containing, family A member 5 Plekha5 604 304 -1.988 
1367911_at 
isocitrate dehydrogenase 3 (NAD+) 
alpha Idh3a 1557 783 -1.988 
1374806_at stratifin Sfn 5271 2652 -1.987 
1373629_at 
solute carrier family 7 (cationic amino 
acid transporter, y+ system), member 
6 Slc7a6 921 464 -1.987 
1372645_at presenilin associated, rhomboid-like Parl 1789 901 -1.986 
1398427_at Myocyte enhancer factor 2D Mef2d 1086 547 -1.983 
1393320_at 
UTP15, U3 small nucleolar 
ribonucleoprotein, homolog (S. 
cerevisiae) Utp15 2191 1105 -1.982 
1375071_at nucleoporin 133 Nup133 1568 791 -1.982 
1372506_at 
proteasome (prosome, macropain) 
activator  Psme3 2483 1254 -1.979 
1389200_at bystin-like Bysl 2101 1064 -1.975 
1382071_at Nuclear respiratory factor 1 Nrf1 601 304 -1.975 
1392454_at zinc finger, HIT type 6 Znhit6 936 474 -1.974 
1374223_at --- --- 677 343 -1.974 
1375908_at myelin protein zero-like 2 Mpzl2 788 400 -1.971 
1367701_at 
receptor (G protein-coupled) activity 
modifying protein 2 Ramp2 561 285 -1.969 
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1372879_at AKT1 substrate 1 (proline-rich) Akt1s1 1156 588 -1.967 
1382903_at zinc finger, ZZ-type containing 3 Zzz3 959 488 -1.966 
1373181_at 
actin filament associated protein 1-
like 1 Afap1l1 1937 986 -1.965 
1379858_at methyltransferase like 2 Mettl2 1080 550 -1.964 
1376214_at 
methylmalonic aciduria (cobalamin 
deficiency) cblC type, with 
homocystinuria Mmachc 1144 583 -1.963 
1389472_at methyltransferase like 13 Mettl13 606 309 -1.962 
1375442_at 
M-phase phosphoprotein 10 (U3 small 
nucleolar ribonucleoprotein) Mphosph10 1491 760 -1.961 
1372043_at 
mRNA turnover 4 homolog (S. 
cerevisiae) Mrto4 2703 1381 -1.957 
1389253_at vanin 1 Vnn1 514 263 -1.957 
1385765_at --- --- 893 457 -1.955 
1374569_at 
glutamate-rich WD repeat containing 
1 Grwd1 1387 710 -1.954 
1379582_a_at cyclin A2 Ccna2 4615 2363 -1.953 
1368308_at myelocytomatosis oncogene Myc 1906 976 -1.952 
1373784_at 
chaperonin containing Tcp1, subunit 8 
(theta) Cct8 1567 803 -1.950 
1371881_at zinc finger, HIT type 2 Znhit2 539 276 -1.949 
1389380_at folylpolyglutamate synthase Fpgs 811 416 -1.948 
1372793_at 
single-stranded DNA binding protein 
1 Ssbp1 1344 690 -1.948 
1374458_at --- --- 1103 566 -1.947 
1399146_at dolichol kinase Dolk 702 361 -1.943 
1393009_at Friend virus susceptibility 1 Fv1 527 272 -1.939 
1372876_at selenophosphate synthetase 2 Sephs2 928 479 -1.937 
1375901_at 
DEAD (Asp-Glu-Ala-Asp) box 
polypeptide 21 Ddx21 7539 3892 -1.937 
1378629_at SATB homeobox 1 Satb1 9707 5011 -1.937 
1371352_at 
high mobility group nucleosomal 
binding domain 2 Hmgn2 3272 1691 -1.935 
1379417_at midasin homolog (yeast) Mdn1 914 473 -1.932 
1378976_x_at --- --- 827 428 -1.931 
1372764_at 
similar to density-regulated protein /// 
similar to density-regulated protein 
LOC687565 /// 
LOC689601 4684 2431 -1.927 
1385089_at Grainyhead-like 1 (Drosophila) Grhl1 582 302 -1.927 
1394639_at CDC42 small effector 2 Cdc42se2 546 284 -1.925 
1373445_at nucleolar protein 8 Nol8 769 399 -1.925 
1373439_at --- --- 3530 1838 -1.921 
1383889_at --- --- 821 428 -1.920 
1378508_at slingshot homolog 1 (Drosophila) Ssh1 627 327 -1.918 
1388668_at --- --- 1368 713 -1.917 
1377287_at 
methionyl-tRNA synthetase 2, 
mitochondrial Mars2 892 466 -1.915 
1398319_at --- --- 3079 1611 -1.912 
1376519_at brain protein 16 Brp16 522 274 -1.907 
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1371839_at splicing factor, arginine/serine-rich 2 Sfrs2 3174 1665 -1.907 
1396191_at 
Eukaryotic translation initiation factor 
5B Eif5b 899 471 -1.906 
1388132_at 
splicing factor proline/glutamine rich 
(polypyrimidine tract binding protein 
associated) Sfpq 2690 1412 -1.905 
1372312_at LTV1 homolog (S. cerevisiae) Ltv1 1797 944 -1.904 
1382290_at methyltransferase like 10 Mettl10 721 379 -1.903 
1393085_at 
MIT, microtubule interacting and 
transport, domain containing 1 Mitd1 662 348 -1.902 
1372302_at 
family with sequence similarity 82, 
member A2 Fam82a2 1071 564 -1.900 
1376018_at Lamin B2 Lmnb2 922 486 -1.898 
1371897_at 
phosphatidic acid phosphatase type 2 
domain containing 3 Ppapdc3 1541 813 -1.895 
1380243_at similar to CG14803-PA RGD1304693 833 440 -1.893 
1383752_at 
NOP2 nucleolar protein homolog 
(yeast) Nop2 1315 695 -1.891 
1369932_a_at v-raf-leukemia viral oncogene 1 Raf1 1176 623 -1.888 
1395044_at Hypothetical protein LOC688832 LOC688832 8653 4597 -1.882 
1367478_at HtrA serine peptidase 2 Htra2 1269 674 -1.882 
1383169_at --- --- 3009 1600 -1.880 
1389391_at solute carrier family 35, member E3 Slc35e3 1206 643 -1.875 
1367525_at 
thyroid hormone receptor associated 
protein 3 Thrap3 2128 1135 -1.874 
1389625_at 
coiled-coil-helix-coiled-coil-helix 
domain containing 4 Chchd4 1325 708 -1.871 
1371035_at general transcription factor III A Gtf3a 2056 1099 -1.870 
1390392_at transmembrane protein 185B Tmem185b 2128 1138 -1.870 
1374920_at --- --- 3161 1692 -1.868 
1368681_at parathyroid hormone-like hormone Pthlh 2683 1437 -1.867 
1390888_a_at 
HemK methyltransferase family 
member 1 Hemk1 789 423 -1.867 
1373001_at 
coiled-coil-helix-coiled-coil-helix 
domain containing 4 Chchd4 2441 1308 -1.866 
1390848_at RNA binding motif protein 19 Rbm19 518 277 -1.866 
1374323_at 
BRCA2 and CDKN1A interacting 
protein Bccip 2984 1600 -1.865 
1384124_at --- --- 1886 1012 -1.863 
1377661_at 
fibroblast growth factor receptor 
substrate 2 Frs2 1236 664 -1.863 
1389162_at 
NFU1 iron-sulfur cluster scaffold 
homolog (S. cerevisiae) Nfu1 1263 678 -1.862 
1382727_at rCG47764-like 
LOC10036234
2 639 343 -1.862 
1367834_at spermidine synthase Srm 1466 787 -1.862 
1388925_at 
sirtuin (silent mating type information 
regulation 2 homolog) 5 (S. 
cerevisiae) Sirt5 879 473 -1.859 
1370940_at tight junction protein 2 Tjp2 1489 802 -1.858 
1388397_at EBNA1 binding protein 2 Ebna1bp2 6076 3271 -1.858 
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1383118_at transmembrane protein 209 Tmem209 1540 830 -1.855 
1381822_x_at rCG32187-like 
LOC10036549
1 609 329 -1.855 
1385727_at FGFR1 oncogene partner 2 Fgfr1op2 955 515 -1.854 
1373452_at 
RNA terminal phosphate cyclase-like 
1 Rcl1 1549 835 -1.854 
1368132_at transducer of ErbB-2.1 Tob1 1127 608 -1.854 
1384230_at 
similar to keratinocytes associated 
protein 3 LOC683980 646 349 -1.854 
1389521_at influenza virus NS1A binding protein Ivns1abp 3293 1779 -1.852 
1390035_at 
similar to hypothetical protein 
MGC29875; novel putative protein 
similar to YIL091C yeast hypothetical 
84 kD protein from SGA1-KTR7 LOC305076 796 430 -1.850 
1387826_at 
similar to pyridoxal (pyridoxine, 
vitamin B6) kinase RGD1566085 595 322 -1.850 
1367987_at 
arginyl aminopeptidase 
(aminopeptidase B) Rnpep 3317 1793 -1.850 
1389862_at nucleolar protein 12 Nol12 693 375 -1.850 
1370191_at antizyme inhibitor 1 Azin1 2018 1093 -1.845 
1383380_at 
ribonuclease P/MRP 38 subunit 
(human) Rpp38 1149 623 -1.845 
1378191_at 
nuclear cap binding protein subunit 1, 
80kDa Ncbp1 586 318 -1.845 
1368517_at 
single stranded DNA binding protein 
3 Ssbp3 853 463 -1.844 
1379488_at TP53 regulating kinase Trp53rk 962 522 -1.843 
1393701_at 
debranching enzyme homolog 1 (S. 
cerevisiae) Dbr1 521 283 -1.843 
1398482_at B-cell CLL/lymphoma 3 Bcl3 1527 829 -1.843 
1398458_at WNK lysine deficient protein kinase 2 Wnk2 2772 1508 -1.838 
1392499_at 
phosphoribosylformylglycinamidine 
synthase Pfas 1490 811 -1.837 
1393848_at ribonucleotide reductase M2 Rrm2 6189 3371 -1.836 
1383632_at --- --- 2563 1398 -1.834 
1367759_at H1 histone family, member 0 H1f0 7282 3975 -1.832 
1389758_at 
transcriptional adaptor 2 (ADA2 
homolog, yeast)-like Tada2l 673 368 -1.831 
1388400_at 
cell division cycle 34 homolog (S. 
cerevisiae) Cdc34 5115 2794 -1.830 
1371503_at nucleotide binding protein 1 Nubp1 1193 652 -1.830 
1392511_at 
TAF2 RNA polymerase II, TATA box 
binding protein (TBP)-associated 
factor Taf2 1709 935 -1.828 
1374063_at splicing factor, arginine/serine-rich 3 Sfrs3 9501 5199 -1.828 
1387206_at 
UDP-Gal:betaGlcNAc beta 1,4-
galactosyltransferase, polypeptide 6 B4galt6 1220 668 -1.827 
1373722_at kinesin family member 20A Kif20a 1409 772 -1.825 
1370886_a_at kinesin light chain 1 Klc1 912 500 -1.824 
1392999_at 
neuropilin (NRP) and tolloid (TLL)-
like 2 Neto2 2593 1423 -1.823 
1378937_at --- --- 511 281 -1.822 
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1372526_at folliculin Flcn 889 488 -1.822 
1394095_at gypsy retrotransposon integrase 1 Gin1 1106 607 -1.822 
1387847_at G protein-coupled receptor 98 Gpr98 591 325 -1.821 
1377268_at 
similar to RIKEN cDNA 
1200014M14 RGD1310597 554 305 -1.820 
1371901_at --- --- 626 344 -1.820 
1388709_at WD repeat domain 43 Wdr43 1058 582 -1.819 
1385522_at 
origin recognition complex, subunit 1-
like (yeast) Orc1l 1254 690 -1.818 
1374005_at coiled-coil domain containing 51 Ccdc51 524 289 -1.816 
1375532_at --- --- 922 508 -1.814 
1368436_at 
nuclear distribution gene C homolog 
(A. nidulans) Nudc 5709 3147 -1.814 
1378264_at 
Nuclear autoantigenic sperm protein 
(histone-binding) Nasp 1964 1083 -1.814 
1373440_at LYR motif containing 2 Lyrm2 1425 786 -1.813 
1377676_at 
nuclear casein kinase and cyclin-
dependent kinase substrate 1 Nucks1 4872 2687 -1.813 
1368187_at glycoprotein (transmembrane) nmb Gpnmb 2280 1258 -1.813 
1369499_at thymidylate synthetase Tyms 912 503 -1.812 
1377658_at 
actin filament associated protein 1-
like 1 Afap1l1 614 339 -1.811 
1374452_at phosphodiesterase 9A Pde9a 570 315 -1.810 
1377060_at 
methylcrotonoyl-Coenzyme A 
carboxylase 2 (beta) Mccc2 1129 624 -1.810 
1391282_at similar to dJ55C23.6 gene product RGD1306962 659 364 -1.809 
1383961_a_at 
DnaJ (Hsp40) homolog, subfamily C, 
member 11 Dnajc11 851 471 -1.809 
1388641_at 
phosphoribosylglycinamide 
formyltransferase Gart 1491 825 -1.808 
1398980_at 
suppressor of Ty 16 homolog (S. 
cerevisiae) Supt16h 2956 1638 -1.805 
1370345_at cyclin B1 Ccnb1 3131 1735 -1.805 
1377833_at 
RAP1 interacting factor homolog 
(yeast) Rif1 874 484 -1.805 
1377383_at embryonal Fyn-associated substrate Efs 2151 1192 -1.804 
1372483_at zinc finger protein 469 Zfp469 627 348 -1.803 
1370311_at 
eukaryotic translation initiation factor 
2B, subunit 1 alpha Eif2b1 1633 907 -1.800 
1389065_at RNA binding motif protein 34 Rbm34 887 493 -1.800 
1367746_a_at flotillin 2 Flot2 571 317 -1.799 
1389041_at Vac14 homolog (S. cerevisiae) Vac14 667 371 -1.799 
1379317_a_at programmed cell death 11 Pdcd11 2816 1566 -1.798 
1390574_at --- --- 852 474 -1.797 
1398809_at 
nudE nuclear distribution gene E 
homolog 1 (A. nidulans) Nde1 1284 715 -1.797 
1399029_at ubiquitin specific peptidase 48 Usp48 780 434 -1.796 
1382886_at --- --- 673 375 -1.794 
1376261_at BCL2-associated athanogene 5 Bag5 1166 650 -1.793 
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1376211_a_at 
potassium channel tetramerisation 
domain containing 6 Kctd6 656 366 -1.792 
1375270_at --- --- 1014 566 -1.792 
1381252_at exoribonuclease 2 Eri2 524 292 -1.792 
1376001_at polymerase (RNA) I polypeptide E Polr1e 1327 741 -1.791 
1382672_a_at 
fer (fms/fps related) protein kinase, 
testis specific 2 Fert2 752 420 -1.791 
1371658_at COX4 neighbor Cox4nb 2265 1265 -1.791 
1374177_at 
TAF13 RNA polymerase II, TATA 
box binding protein (TBP)-associated 
factor Taf13 3434 1918 -1.790 
1370297_at polo-like kinase 1 (Drosophila) Plk1 1235 690 -1.790 
1390481_a_at 
ubiquitin-conjugating enzyme E2T 
(putative) Ube2t 961 538 -1.786 
1392983_at 
proteasome (prosome, macropain) 26S 
subunit, non-ATPase, 12 Psmd12 2688 1505 -1.786 
1370300_at prolactin regulatory element binding Preb 977 548 -1.782 
1383186_at similar to RIKEN cDNA 1600013K19 RGD1307749 620 348 -1.782 
1376690_at mediator complex subunit 21 Med21 3103 1743 -1.780 
1376687_at ubiquitin specific peptidase 1 Usp1 2061 1158 -1.780 
1395652_at glycosyltransferase-like 1B Gyltl1b 589 331 -1.780 
1389800_at PWWP domain containing 2B Pwwp2b 1465 823 -1.779 
1382052_at --- --- 969 545 -1.779 
1382161_at 
M-phase phosphoprotein 10 (U3 small 
nucleolar ribonucleoprotein) Mphosph10 1425 801 -1.778 
1367683_at karyopherin alpha 2 Kpna2 7530 4236 -1.778 
1399077_at Metaxin 1 Mtx1 2840 1598 -1.777 
1384185_at similar to RIKEN cDNA 2410016O06 RGD1307704 1109 625 -1.775 
1382174_at --- --- 2858 1610 -1.775 
1374577_at 
transforming growth factor beta 
regulator 4 Tbrg4 1844 1040 -1.774 
1389197_at 
KTEL (Lys-Tyr-Glu-Leu) containing 
1 Ktelc1 3579 2018 -1.773 
1386928_at 
branched chain aminotransferase 2, 
mitochondrial Bcat2 668 377 -1.773 
1375432_at similar to exosome component 1 LOC679140 2136 1205 -1.772 
1377172_at 
G-protein signaling modulator 2 
(AGS3-like, C. elegans) Gpsm2 1041 588 -1.771 
1386897_at protein arginine methyltransferase 1 Prmt1 6446 3640 -1.771 
1371608_at mitochondrial ribosomal protein S34 Mrps34 1112 628 -1.771 
1383253_at --- --- 1669 944 -1.769 
1376832_at --- --- 1345 760 -1.769 
1377844_at prostaglandin reductase 2 Ptgr2 1419 803 -1.768 
1374886_at BCS1-like (yeast) Bcs1l 1006 569 -1.768 
1370370_at hyaluronoglucosaminidase 2 Hyal2 966 546 -1.768 
1376039_at aurora kinase A Aurka 1703 963 -1.768 
1380009_at vaccinia related kinase 1 Vrk1 2004 1134 -1.767 
1373721_at histidyl-tRNA synthetase 2-like Hars2l 1066 603 -1.767 
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1367659_s_at 
dodecenoyl-Coenzyme A delta 
isomerase (3,2 trans-enoyl-Coenzyme 
A isomerase) Dci 826 468 -1.767 
1394568_at 
similar to DNA segment, Chr 10, 
Wayne State University 102, 
expressed RGD1563365 1237 700 -1.766 
1389073_at receptor accessory protein 4 Reep4 679 385 -1.766 
1397551_at 
DEAD (Asp-Glu-Ala-Asp) box 
polypeptide 27 Ddx27 1048 594 -1.765 
1390558_at 
staufen, RNA binding protein, 
homolog 2 (Drosophila) Stau2 638 361 -1.765 
1369962_at 
5-aminoimidazole-4-carboxamide 
ribonucleotide formyltransferase/IMP 
cyclohydrolase Atic 5142 2914 -1.764 
1374799_at 
non-SMC condensin I complex, 
subunit D2 Ncapd2 529 300 -1.764 
1374538_at 
protein O-linked mannose beta1,2-N-
acetylglucosaminyltransferase Pomgnt1 1200 681 -1.763 
1398916_at aurora kinase A interacting protein 1 Aurkaip1 2439 1383 -1.763 
1376084_a_at 
extra spindle pole bodies homolog 1 
(S. cerevisiae) Espl1 1512 859 -1.761 
1386867_at brain protein 44-like Brp44l 6886 3911 -1.761 
1390151_at hypothetical protein LOC683034 LOC683034 570 324 -1.760 
1372672_at quinolinate phosphoribosyltransferase Qprt 1257 715 -1.759 
1374119_at E74-like factor 3 Elf3 622 354 -1.758 
1369642_at 
platelet-activating factor 
acetylhydrolase, isoform 1b, subunit 2 Pafah1b2 1162 662 -1.757 
1393202_a_at 
Insulin-like growth factor 2 mRNA 
binding protein 3 Igf2bp3 1825 1039 -1.756 
1376869_at --- --- 564 321 -1.756 
1373917_at 
Eukaryotic translation termination 
factor 1 Etf1 4049 2306 -1.756 
1370893_at acetyl-coenzyme A carboxylase alpha Acaca 1330 758 -1.755 
1388985_at hypothetical LOC100361467 
LOC10036146
7 3865 2202 -1.755 
1372414_at --- --- 1047 597 -1.754 
1387633_at proteoglycan 2, bone marrow Prg2 1421 810 -1.754 
1369084_a_at BCL2-related ovarian killer Bok 642 366 -1.753 
1383514_s_at NMDA receptor regulated 1 Narg1 1866 1065 -1.753 
1371838_at splicing factor, arginine/serine-rich 2 Sfrs2 8898 5077 -1.752 
1375540_at 
CDKN2A interacting protein N-
terminal like Cdkn2aipnl 1170 669 -1.750 
1380303_at 
similar to Serine/threonine-protein 
kinase Haspin (Haploid germ cell-
specific nuclear protein kinase) (Germ 
cell-specific gene 2 protein) LOC687827 648 370 -1.750 
1388806_at tetratricopeptide repeat domain 5 Ttc5 649 371 -1.749 
1370294_a_at 
cell division cycle 20 homolog (S. 
cerevisiae) Cdc20 1350 772 -1.749 
1379525_at cardiolipin synthase 1 Crls1 799 457 -1.749 
1383108_at 
TAF13 RNA polymerase II, TATA 
box binding protein (TBP)-associated 
factor Taf13 1814 1038 -1.748 
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1378896_at 
solute carrier family 30 (zinc 
transporter), member 2 Slc30a2 1789 1023 -1.748 
1387779_at MYB binding protein (P160) 1a Mybbp1a 2251 1288 -1.747 
1390839_at PQ loop repeat containing 3 Pqlc3 2614 1497 -1.746 
1372592_at histone deacetylase 6 Hdac6 999 573 -1.744 
1399010_at 
COP9 constitutive photomorphogenic 
homolog subunit 7A (Arabidopsis) Cops7a 1484 851 -1.744 
1373929_at mitochondrial ribosomal protein S7 Mrps7 2343 1344 -1.744 
1371976_at similar to RIKEN cDNA 9530058B02 RGD1311273 1494 857 -1.744 
1372259_at DEK oncogene Dek 2121 1217 -1.743 
1367780_at pituitary tumor-transforming 1 Pttg1 2659 1526 -1.742 
1377624_at GTP-binding protein 10 (putative) Gtpbp10 534 307 -1.742 
1385024_at 
cutC copper transporter homolog 
(E.coli) Cutc 569 327 -1.741 
1376703_at nucleoporin 37 Nup37 3660 2102 -1.741 
1373927_at HMG box domain containing 4 Hmgxb4 801 460 -1.741 
1372271_at RNA binding motif protein 38 Rbm38 1486 855 -1.738 
1373283_at --- --- 611 352 -1.738 
1370128_at 
heart and neural crest derivatives 
expressed 1 Hand1 533 307 -1.737 
1374483_at --- --- 502 289 -1.737 
1375042_at 
asparagine-linked glycosylation 8, 
alpha-1,3-glucosyltransferase 
homolog (S. cerevisiae) Alg8 1008 581 -1.736 
1389038_at 
eukaryotic translation termination 
factor 1 Etf1 4061 2340 -1.736 
1373496_at makorin ring finger protein 1 Mkrn1 1182 682 -1.734 
1376040_at 
signal-induced proliferation-
associated 1 like 2 Sipa1l2 6509 3753 -1.734 
1383290_at 
serine peptidase inhibitor, Kunitz type 
1 Spint1 988 570 -1.734 
1373649_at 
similar to COX10 homolog, 
cytochrome c oxidase assembly 
protein, heme A: farnesyltransferase  
LOC687381 /// 
LOC691853 837 483 -1.734 
1376321_at 
family with sequence similarity 38, 
member A Fam38a 1075 620 -1.733 
1380148_at --- --- 1816 1048 -1.733 
1397708_at hypothetical LOC288978 LOC288978 582 336 -1.732 
1383821_at --- --- 570 329 -1.732 
1374318_at 
BRCA1/BRCA2-containing complex, 
subunit 3 Brcc3 4757 2748 -1.731 
1379626_at SATB homeobox 1 Satb1 11491 6656 -1.726 
1368032_at 
nucleolar and coiled-body 
phosphoprotein 1 Nolc1 3361 1947 -1.726 
1371322_at laminin, gamma 1 Lamc1 1785 1034 -1.726 
1388089_a_at ring finger protein 4 Rnf4 1568 910 -1.724 
1375863_a_at 
similar to Gamma-tubulin complex 
component 4 (GCP-4) RGD1306924 552 320 -1.723 
1394884_s_at 
single-stranded DNA binding protein 
1 Ssbp1 2113 1227 -1.722 
1398383_at cytochrome b-561 Cyb561 814 473 -1.722 
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1372327_at myelin expression factor 2 Myef2 1267 736 -1.721 
1379407_at 
IMP4, U3 small nucleolar 
ribonucleoprotein, homolog (yeast) Imp4 1015 591 -1.718 
1383799_at G protein-coupled receptor 98 Gpr98 969 564 -1.718 
1388484_at ubiquitin-conjugating enzyme E2C Ube2c 2745 1598 -1.718 
1393346_at coiled-coil domain containing 125 Ccdc125 1689 984 -1.717 
1371600_at protein kinase inhibitor, gamma Pkig 923 538 -1.716 
1368522_at timeless homolog (Drosophila) Timeless 1031 601 -1.716 
1368233_at 
general transcription factor IIF, 
polypeptide 2 Gtf2f2 1108 646 -1.716 
1372250_at 
dysbindin (dystrobrevin binding 
protein 1) domain containing 2 Dbndd2 1819 1061 -1.714 
1370353_at 
translocase of inner mitochondrial 
membrane 22 homolog (yeast) Timm22 739 431 -1.713 
1389566_at cyclin B2 Ccnb2 2744 1603 -1.712 
1386971_at 
protein phosphatase 1, regulatory 
subunit 10 Ppp1r10 1011 591 -1.712 
1395144_at adherens junction associated protein 1 Ajap1 524 306 -1.711 
1380448_at 
alkB, alkylation repair homolog (E. 
coli) Alkbh 2998 1754 -1.709 
1374642_at zinc finger protein 64 Zfp64 1238 724 -1.709 
1372348_at AP2 associated kinase 1 Aak1 543 318 -1.706 
1379514_at --- --- 863 506 -1.706 
1389217_at 
RFNG O-fucosylpeptide 3-beta-N-
acetylglucosaminyltransferase Rfng 596 350 -1.703 
1372391_at Ribosomal protein L7-like 1 Rpl7l1 5845 3433 -1.703 
1374597_at cDNA sequence BC034664-like 
LOC10036300
3 565 332 -1.702 
1371717_at mitofusin 1 Mfn1 1424 837 -1.701 
1372916_at Mitochondrial ribosomal protein S27 Mrps27 672 395 -1.701 
1379261_at 
spindle and kinetochore associated 
complex subunit 2 Ska2 526 309 -1.701 
1398931_at similar to CG12935-PA LOC686289 909 535 -1.699 
1387062_a_at 
CHK1 checkpoint homolog (S. 
pombe) Chek1 614 362 -1.699 
1377410_at E2F transcription factor 8 E2f8 1280 754 -1.698 
1385222_at 
eomesodermin homolog (Xenopus 
laevis) Eomes 2016 1187 -1.698 
1386870_at 
glutamate-ammonia ligase (glutamine 
synthetase) Glul 1577 929 -1.698 
1373077_at 
CDKN2A interacting protein N-
terminal like Cdkn2aipnl 1701 1002 -1.697 
1383322_at RAS-like family 11 member B Rasl11b 1454 857 -1.697 
1387260_at Kruppel-like factor 4 (gut) Klf4 1830 1079 -1.696 
1372486_at --- --- 1855 1094 -1.696 
1370323_at thimet oligopeptidase 1 Thop1 813 480 -1.696 
1372522_at arginine and glutamate rich 1 Arglu1 4752 2803 -1.695 
1377797_at 
EMG1 nucleolar protein homolog (S. 
cerevisiae) Emg1 1817 1072 -1.694 
1371928_at cell division cycle associated 8 Cdca8 1873 1105 -1.694 
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1372501_at --- --- 2877 1699 -1.694 
1374892_at 
spermidine/spermine N1-
acetyltransferase family member 2 Sat2 929 549 -1.694 
1371813_at HIRA interacting protein 3 Hirip3 871 514 -1.693 
1387071_a_at microtubule-associated protein tau Mapt 1076 636 -1.693 
1377838_at similar to RIKEN cDNA 0610039J04 RGD1562218 552 326 -1.693 
1396000_at --- --- 656 387 -1.692 
1394005_s_at mediator complex subunit 21 Med21 799 472 -1.692 
1387599_a_at NAD(P)H dehydrogenase, quinone 1 Nqo1 13155 7784 -1.690 
1393729_at 
neuropilin (NRP) and tolloid (TLL)-
like 2 Neto2 926 548 -1.690 
1370030_at 
glutamate cysteine ligase, modifier 
subunit Gclm 1621 959 -1.690 
1398384_at exosome component 9 Exosc9 1009 597 -1.689 
1389056_at 
TRM1 tRNA methyltransferase 1 
homolog (S. cerevisiae) Trmt1 1115 660 -1.689 
1367591_at peroxiredoxin 3 Prdx3 6700 3968 -1.688 
1391220_at 
ESF1, nucleolar pre-rRNA processing 
protein, homolog (S. cerevisiae) Esf1 2465 1460 -1.688 
1385104_at embryonal Fyn-associated substrate Efs 751 445 -1.688 
1388547_at claudin 4 Cldn4 3358 1990 -1.687 
1367708_a_at fatty acid synthase Fasn 1719 1019 -1.687 
1376010_at 
PRP4 pre-mRNA processing factor 4 
homolog B (yeast) Prpf4b 784 465 -1.686 
1389025_at 
TAF11 RNA polymerase II, TATA 
box binding protein (TBP)-associated 
factor Taf11 1054 626 -1.686 
1388182_at DNA primase, p49 subunit Prim1 4291 2546 -1.686 
1370004_at H2A histone family, member Y H2afy 5067 3006 -1.685 
1398902_at similar to mKIAA0664 protein RGD1307222 1459 866 -1.685 
1376219_at 
Probable phospholipid-transporting 
ATPase ID-like 
LOC10036480
0 1467 871 -1.685 
1382923_at 
synaptotagmin binding, cytoplasmic 
RNA interacting protein Syncrip 2128 1264 -1.683 
1381759_at RGD1565975 RGD1565975 741 440 -1.682 
1372058_at --- --- 1244 739 -1.682 
1376451_at KRIT1, ankyrin repeat containing Krit1 1928 1146 -1.682 
1379530_at --- --- 3928 2337 -1.680 
1376407_a_at 
LSM7 homolog, U6 small nuclear 
RNA associated (S. cerevisiae) Lsm7 1628 969 -1.680 
1391921_at 
RNA guanylyltransferase and 5'-
phosphatase Rngtt 1237 736 -1.680 
1372620_at 
acidic (leucine-rich) nuclear 
phosphoprotein 32 family, member E Anp32e 3016 1796 -1.679 
1389279_at --- --- 2968 1769 -1.678 
1389969_at 
translocase of outer mitochondrial 
membrane 40 homolog (yeast) Tomm40 2767 1650 -1.677 
1371565_at 
KTI12 homolog, chromatin associated 
(S. cerevisiae) Kti12 1297 773 -1.677 
1388509_at --- --- 939 560 -1.676 
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1368302_at msh homeobox 1 Msx1 2079 1241 -1.675 
1372454_at 
similar to RIKEN cDNA 2210016L21 
gene RGD1311899 884 528 -1.675 
1372324_at zinc finger, HIT type 3 Znhit3 1000 598 -1.673 
1389015_at FUN14 domain containing 2 Fundc2 1457 871 -1.672 
1372046_at 
general transcription factor IIIC, 
polypeptide 3 Gtf3c3 674 403 -1.672 
1373583_at --- --- 737 441 -1.672 
1382215_at 
similar to Transcription initiation 
factor TFIID 105 kDa subunit (TAFII-
105) RGD1562997 571 342 -1.672 
1376202_at 
UDP-GlcNAc:betaGal beta-1,3-N-
acetylglucosaminyltransferase 1 B3gnt1 753 450 -1.671 
1388158_at HLA-B associated transcript 1 Bat1 1888 1131 -1.670 
1374014_at 
neutral sphingomyelinase (N-SMase) 
activation associated factor Nsmaf 543 325 -1.670 
1372558_at NMDA receptor regulated 1 Narg1 4566 2736 -1.669 
1379652_at 
similar to kinesin-like protein (103.5 
kD) (klp-6) RGD1559696 873 523 -1.668 
1371809_at mitochondrial ribosomal protein S18B Mrps18b 4723 2831 -1.668 
1384224_at --- --- 667 400 -1.666 
1389357_at MORC family CW-type zinc finger 2 Morc2 658 395 -1.664 
1390021_at histone cluster 1, H2bh Hist1h2bh 859 516 -1.664 
1389030_a_at 
V-src sarcoma (Schmidt-Ruppin A-2) 
viral oncogene homolog (avian) Src 1398 841 -1.663 
1387219_at adrenomedullin Adm 10054 6044 -1.663 
1370309_a_at 
heterogeneous nuclear 
ribonucleoprotein A/B Hnrnpab 12760 7674 -1.663 
1383185_at --- --- 1458 877 -1.662 
1399031_at DET1 and DDB1 associated 1 Dda1 761 458 -1.661 
1390494_at ribosomal protein S24 Rps24 579 349 -1.661 
1380490_at 
similar to Importin-8 (Imp8) (Ran-
binding protein 8) (RanBP8) LOC686774 5557 3346 -1.661 
1373682_at 
DEAD (Asp-Glu-Ala-Asp) box 
polypeptide 51 Ddx51 635 383 -1.661 
1388448_at CDC42 small effector 2 Cdc42se2 4291 2584 -1.661 
1381749_at --- --- 1559 939 -1.659 
1395552_s_at ankyrin repeat domain 13C Ankrd13c 724 437 -1.659 
1373451_at ribonuclease H2, subunit B Rnaseh2b 714 431 -1.659 
1371704_at 
DEAD (Asp-Glu-Ala-Asp) box 
polypeptide 23 Ddx23 1636 986 -1.659 
1370327_at COMM domain containing 5 Commd5 977 589 -1.659 
1385856_at RIO kinase 1 (yeast) Riok1 814 491 -1.659 
1382515_at 
cleavage and polyadenylation specific 
factor 2 Cpsf2 760 458 -1.658 
1373080_at poly (A) polymerase alpha Papola 7389 4456 -1.658 
1395642_at nucleolar protein 9 Nol9 1277 770 -1.658 
1386857_at stathmin 1 Stmn1 2712 1638 -1.656 
1372661_at transducin (beta)-like 3 Tbl3 900 543 -1.656 
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1390791_at growth arrest-specific 2 like 1 Gas2l1 577 349 -1.654 
1383652_at jagunal homolog 1 (Drosophila) Jagn1 1510 913 -1.654 
1367624_at 
activating transcription factor 4 (tax-
responsive enhancer element B67) Atf4 9907 5991 -1.654 
1373959_at 
protein phosphatase 2 (formerly 2A), 
regulatory subunit A, beta isoform Ppp2r1b 1426 864 -1.651 
1373516_at 
ribosomal RNA processing 1 homolog 
B (S. cerevisiae) Rrp1b 1717 1040 -1.651 
1390996_at 
zinc finger, FYVE domain containing 
20 Zfyve20 517 313 -1.651 
1367818_at 
coenzyme Q3 homolog, 
methyltransferase (S. cerevisiae) Coq3 1211 734 -1.650 
1398759_at TSC22 domain family, member 1 Tsc22d1 3142 1905 -1.650 
1372415_at 
general transcription factor IIH, 
polypeptide 3 Gtf2h3 737 447 -1.649 
1370008_at PSMC3 interacting protein Psmc3ip 762 463 -1.648 
1372218_at WD repeat domain 12 Wdr12 2052 1246 -1.648 
1396187_at 
DEAD (Asp-Glu-Ala-Asp) box 
polypeptide 21 Ddx21 702 426 -1.648 
1390779_at --- --- 515 313 -1.647 
1387055_at 
NEDD8 activating enzyme E1 subunit 
1 Nae1 1044 635 -1.645 
1372150_at ubiquitin specific peptidase 10 Usp10 2552 1551 -1.645 
1374159_at ALS2 C-terminal like Als2cl 2144 1303 -1.645 
1388990_at 
Mki67 (FHA domain) interacting 
nucleolar phosphoprotein Mki67ip 2181 1326 -1.645 
1389145_at 
CDC42 effector protein (Rho GTPase 
binding) 2 Cdc42ep2 679 413 -1.644 
1369958_at ras homolog gene family, member B Rhob 4390 2671 -1.644 
1376440_at ring finger protein 139 Rnf139 745 453 -1.644 
1374972_at TBC1 domain family, member 2 Tbc1d2 510 310 -1.643 
1370304_at 
translocase of inner mitochondrial 
membrane 17 homolog A (yeast) Timm17a 6773 4123 -1.643 
1373364_at 
eukaryotic translation initiation factor 
4 gamma, 3 Eif4g3 1373 836 -1.643 
1373668_at 
polymerase (RNA) II (DNA directed) 
polypeptide I Polr2i 3532 2150 -1.643 
1398362_at Notch homolog 2 (Drosophila) Notch2 3194 1944 -1.643 
1368992_a_at splicing factor, arginine/serine-rich 5 Sfrs5 2762 1681 -1.642 
1371453_at 
phenylalanyl-tRNA synthetase, beta 
subunit Farsb 2975 1812 -1.642 
1396013_at 
leucine zipper-EF-hand containing 
transmembrane protein 1 Letm1 726 442 -1.642 
1374579_at 
similar to RIKEN cDNA E230015L20 
gene RGD1560873 637 388 -1.640 
1382509_at 
CCR4-NOT transcription complex, 
subunit 6 Cnot6 1926 1174 -1.640 
1382856_at XRCC6 binding protein 1 Xrcc6bp1 741 452 -1.640 
1389471_at 
translocase of outer mitochondrial 
membrane 34 Tomm34 832 508 -1.639 
1389760_at polycomb group ring finger 6 Pcgf6 2185 1333 -1.638 
1399020_at 
family with sequence similarity 40, 
member A Fam40a 968 591 -1.638 
260 
 
1389241_at 
similar to ubiquitin-protein ligase E3-
alpha RGD1562326 1442 880 -1.638 
1368470_at 
gamma-glutamyl hydrolase 
(conjugase, folylpolygammaglutamyl 
hydrolase) Ggh 1488 909 -1.638 
1376567_at 
MAD1 mitotic arrest deficient-like 1 
(yeast) Mad1l1 528 322 -1.638 
1390111_at 
family with sequence similarity 91, 
member A1 Fam91a1 2215 1354 -1.636 
1380062_at 
membrane protein, palmitoylated 6 
(MAGUK p55 subfamily member 6) Mpp6 2045 1250 -1.635 
1372478_at 
CKLF-like MARVEL transmembrane 
domain containing 7 Cmtm7 638 391 -1.633 
1395781_at 
V-myc myelocytomatosis viral 
oncogene homolog 1, lung carcinoma 
derived (avian) Mycl1 721 442 -1.632 
1379300_at carbohydrate sulfotransferase 2 Chst2 577 354 -1.632 
1389525_at ring finger protein 149 Rnf149 521 319 -1.632 
1390918_at 
growth hormone regulated TBC 
protein 1 Grtp1 1210 742 -1.632 
1392161_at 
ATP synthase mitochondrial F1 
complex assembly factor 1 Atpaf1 509 312 -1.631 
1385781_at 
excision repair cross-complementing 
rodent repair deficiency 
complementation group 6 - like Ercc6l 529 325 -1.630 
1374851_at mediator complex subunit 29 Med29 1344 825 -1.629 
1372523_at 
glutamate-cysteine ligase, catalytic 
subunit Gclc 1435 882 -1.627 
1378477_a_at 
formin homology 2 domain containing 
1 Fhod1 604 371 -1.627 
1376201_at 
methyltransferase 10 domain 
containing Mett10d 730 449 -1.627 
1388537_at 
4-nitrophenylphosphatase domain and 
non-neuronal SNAP25-like protein 
homolog 1 (C. elegans) Nipsnap1 740 455 -1.626 
1378110_at --- --- 797 490 -1.626 
1369970_at vesicle-associated membrane protein 8 Vamp8 1165 717 -1.625 
1374905_at --- --- 505 311 -1.625 
1379909_at G kinase anchoring protein 1 Gkap1 4894 3011 -1.625 
1390989_at motile sperm domain containing 2 Mospd2 598 368 -1.625 
1370365_at glutathione synthetase Gss 1648 1014 -1.625 
1371785_at 
tumor necrosis factor receptor 
superfamily, member 12a Tnfrsf12a 1891 1164 -1.625 
1375022_at 
AFG3(ATPase family gene 3)-like 2 
(yeast) Afg3l2 707 435 -1.624 
1373353_at 
bromodomain and PHD finger 
containing, 1 Brpf1 857 528 -1.623 
1377299_at 
nuclear autoantigenic sperm protein 
(histone-binding) Nasp 2841 1750 -1.623 
1375928_at 
SET domain containing (lysine 
methyltransferase) 8 Setd8 2137 1316 -1.623 
1382736_at --- --- 1297 800 -1.623 
1389013_at ribosomal protein L7-like 1 Rpl7l1 4261 2627 -1.622 
1398935_at --- --- 1839 1134 -1.622 
1375970_at --- --- 1057 652 -1.622 
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1380260_at BARX homeobox 1 Barx1 739 456 -1.621 
1389792_at 
small optic lobes homolog 
(Drosophila) Solh 1120 691 -1.621 
1378551_at 
cytochrome P450, family 20, 
subfamily a, polypeptide 1 Cyp20a1 511 315 -1.619 
1389151_at 
a disintegrin and metallopeptidase 
domain 19 (meltrin beta) Adam19 740 457 -1.618 
1395948_at --- --- 1272 786 -1.618 
1382175_at Wilms tumor 1 associated protein Wtap 1067 659 -1.618 
1388901_at FK506 binding protein 5 Fkbp5 1026 634 -1.618 
1392488_at 
AMME chromosomal region gene 1-
like Ammecr1l 895 553 -1.617 
1390020_at 
Oxoglutarate (alpha-ketoglutarate) 
dehydrogenase (lipoamide) Ogdh 1862 1152 -1.617 
1373702_at l(3)mbt-like 2 (Drosophila) L3mbtl2 676 418 -1.617 
1383626_at zinc finger protein 259 Zfp259 579 358 -1.617 
1389897_at 
COP9 constitutive photomorphogenic 
homolog subunit 7A (Arabidopsis) Cops7a 1218 754 -1.616 
1372261_at --- --- 715 443 -1.616 
1398439_a_at 
origin recognition complex, subunit 6 
like (yeast) Orc6l 1152 713 -1.616 
1370460_at ubiquitin specific peptidase 15 Usp15 1036 642 -1.615 
1399075_at 
mitogen activated protein kinase 
kinase kinase 7 Map3k7 1857 1151 -1.613 
1374964_at dipeptidylpeptidase 8 Dpp8 527 327 -1.612 
1373061_at sorting nexin 17 Snx17 515 320 -1.611 
1383240_at --- --- 2664 1654 -1.611 
1389247_at 
polymerase (RNA) III (DNA directed) 
polypeptide A Polr3a 711 442 -1.610 
1389537_at 
Treacher Collins-Franceschetti 
syndrome 1 homolog (human) Tcof1 569 354 -1.609 
1373093_at ERBB receptor feedback inhibitor 1 Errfi1 10183 6336 -1.607 
1367833_at 
proteasome (prosome, macropain) 26S 
subunit, ATPase, 5 Psmc5 3451 2148 -1.607 
1380960_at coronin, actin binding protein 2A Coro2a 967 602 -1.607 
1385268_at coiled-coil domain containing 93 Ccdc93 587 366 -1.605 
1398254_at renin binding protein Renbp 527 329 -1.605 
1375767_at 
pleckstrin homology domain 
containing, family G (with RhoGef 
domain) member 3 Plekhg3 700 436 -1.604 
1387294_at 
SH3-domain binding protein 5 (BTK-
associated) Sh3bp5 2073 1292 -1.604 
1398371_at coiled-coil domain containing 132 Ccdc132 1262 787 -1.604 
1373913_at 
polyribonucleotide 
nucleotidyltransferase 1 Pnpt1 1400 873 -1.604 
1389263_at retinoic acid induced 14 Rai14 2649 1652 -1.604 
1391604_at 
non-SMC condensin II complex, 
subunit D3 Ncapd3 1005 627 -1.603 
1373213_at synaptosomal-associated protein 29 Snap29 997 622 -1.602 
1379656_a_at --- --- 3458 2159 -1.602 
1388609_at 
pleckstrin homology domain 
containing, family M (with RUN Plekhm2 619 387 -1.601 
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domain) member 2 
1372019_at mediator complex subunit 10 Med10 2465 1540 -1.601 
1389616_at --- --- 661 413 -1.601 
1379715_at similar to CG9346-PA RGD1307882 1499 936 -1.600 
1369641_at 
platelet-activating factor 
acetylhydrolase, isoform 1b, subunit 2 Pafah1b2 996 623 -1.600 
1386344_at 
Ankylosis, progressive homolog 
(mouse) Ankh 634 396 -1.600 
1382082_at nuclear transcription factor-Y beta Nfyb 572 357 -1.599 
1379980_at --- --- 763 478 -1.599 
1377400_at HIV-1 Rev binding protein 2 Hrb2 1473 922 -1.598 
1388117_at 
small nuclear ribonucleoprotein 
polypeptides B and B1 Snrpb 5415 3390 -1.598 
1389053_at 
Required for meiotic nuclear division 
1 homolog (S. cerevisiae) Rmnd1 1445 905 -1.596 
1395560_at --- --- 594 372 -1.596 
1395516_at arginine and glutamate rich 1 Arglu1 1113 697 -1.596 
1388567_at THUMP domain containing 1 Thumpd1 1392 872 -1.596 
1371336_at 
hematological and neurological 
expressed 1 Hn1 6328 3967 -1.595 
1372108_at Pentatricopeptide repeat domain 3 Ptcd3 2603 1632 -1.595 
1375979_at --- --- 764 479 -1.595 
1379903_at --- --- 1768 1109 -1.595 
1367720_at aminolevulinate, delta-, dehydratase Alad 2571 1613 -1.594 
1394567_at quiescin Q6 sulfhydryl oxidase 2 Qsox2 792 497 -1.593 
1368612_at integrin, beta 4 Itgb4 532 334 -1.593 
1372540_at 
ubiquitin-like domain containing CTD 
phosphatase 1 Ublcp1 2829 1776 -1.593 
1376930_at mitochondrial ribosomal protein L51 Mrpl51 1655 1039 -1.592 
1387458_at ring finger protein 4 Rnf4 1321 830 -1.592 
1392746_x_at 
La ribonucleoprotein domain family, 
member 1 Larp1 1107 696 -1.592 
1380909_at 
solute carrier family 25 
(mitochondrial carrier, phosphate 
carrier), member 24 Slc25a24 3536 2222 -1.591 
1373744_at 
anaphase promoting complex subunit 
1 Anapc1 895 563 -1.591 
1389137_at Citron Cit 901 567 -1.591 
1393341_at --- --- 639 402 -1.590 
1372808_at 
methylenetetrahydrofolate 
dehydrogenase (NADP+ dependent) 
2, methenyltetrahydrofolate 
cyclohydrolase Mthfd2 3489 2194 -1.590 
1371670_at exosome component 4 Exosc4 1958 1232 -1.590 
1377945_at 
DEAD (Asp-Glu-Ala-Asp) box 
polypeptide 18 Ddx18 1499 943 -1.589 
1398337_at 
Similar to RIKEN cDNA 
9430077D24 gene LOC290341 1423 896 -1.588 
1370869_at 
branched chain aminotransferase 1, 
cytosolic Bcat1 2818 1774 -1.588 
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1374326_at peter pan homolog (Drosophila) Ppan 1382 870 -1.587 
1376316_at 
origin recognition complex, subunit 6 
like (yeast) Orc6l 1375 867 -1.587 
1388790_at 
coenzyme Q5 homolog, 
methyltransferase (S. cerevisiae) Coq5 694 437 -1.587 
1390534_at 
structural maintenance of 
chromosomes 5 Smc5 2099 1322 -1.587 
1392902_at 
ESF1, nucleolar pre-rRNA processing 
protein, homolog (S. cerevisiae) Esf1 1452 916 -1.586 
1370526_at integrin, alpha E Itgae 982 620 -1.586 
1371980_at 
ATPase family, AAA domain 
containing 3A Atad3a 511 322 -1.586 
1372677_at 
deoxyhypusine 
hydroxylase/monooxygenase Dohh 1320 833 -1.585 
1377709_at --- --- 17119 10805 -1.584 
1377506_at 
growth differentiation factor 1 /// 
LAG1 homolog, ceramide synthase 1 Gdf1 /// Lass1 2410 1522 -1.584 
1374687_at --- --- 2672 1688 -1.583 
1372988_at 
CCR4-NOT transcription complex, 
subunit 10 Cnot10 1034 653 -1.583 
1394554_at --- --- 801 506 -1.582 
1370162_at 
protein phosphatase 4, regulatory 
subunit 1 Ppp4r1 1436 907 -1.582 
1380408_at --- --- 1584 1002 -1.581 
1376357_at 
ankyrin repeat and IBR domain 
containing 1 Ankib1 2005 1268 -1.581 
1393142_at centrosomal protein 70kDa Cep70 572 362 -1.581 
1373527_at rCG48622-like 
LOC10036292
0 943 597 -1.580 
1387900_at 
CDP-diacylglycerol--inositol 3-
phosphatidyltransferase 
(phosphatidylinositol synthase) Cdipt 1650 1044 -1.580 
1398342_at tumor suppressor candidate 2 Tusc2 1220 772 -1.580 
1372628_at 
adaptor-related protein complex AP-4, 
sigma 1 Ap4s1 1445 915 -1.579 
1376177_at 
family with sequence similarity 117, 
member A Fam117a 619 392 -1.579 
1390415_at 
thyroid hormone receptor interactor 
13 Trip13 1793 1136 -1.579 
1377868_at 
G protein-coupled receptor associated 
sorting protein 2 Gprasp2 541 343 -1.578 
1370386_at RuvB-like 1 (E. coli) Ruvbl1 1483 940 -1.578 
1368967_at 
eukaryotic translation initiation factor 
2B, subunit 3 gamma Eif2b3 1217 771 -1.577 
1390250_x_at 
Probable phospholipid-transporting 
ATPase ID-like 
LOC10036480
0 933 592 -1.576 
1374568_at similar to mKIAA1737 protein RGD1309492 578 367 -1.576 
1388736_at coiled-coil domain containing 43 Ccdc43 653 414 -1.576 
1384605_at --- --- 977 620 -1.576 
1370437_at nucleoporin like 1 Nupl1 1456 924 -1.576 
1371907_at 
ADP-ribosylation-like factor 6 
interacting protein 4 Arl6ip4 1519 964 -1.575 
1373980_at similar to XPA binding protein 1 LOC688393 708 449 -1.575 
1375506_at aarF domain containing kinase 5 Adck5 934 593 -1.574 
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1371697_at 
patatin-like phospholipase domain 
containing 2 Pnpla2 614 390 -1.573 
1371563_at 
regulator of chromosome 
condensation 2 Rcc2 726 461 -1.573 
1368702_at PRKC, apoptosis, WT1, regulator Pawr 1456 926 -1.573 
1374938_at 
ZW10, kinetochore associated, 
homolog (Drosophila) Zw10 897 570 -1.573 
1378299_at --- --- 815 518 -1.573 
1369063_at 
acidic (leucine-rich) nuclear 
phosphoprotein 32 family, member A Anp32a 8332 5299 -1.572 
1388154_at E2F transcription factor 5 E2f5 1271 808 -1.572 
1395625_at --- --- 2074 1319 -1.572 
1380186_at --- --- 604 384 -1.571 
1389131_at 
cytosolic 5-nucleotidase III-like 
protein-like /// 5'-nucleotidase, 
cytosolic III-like 
LOC10036493
7 /// Nt5c3l 725 462 -1.571 
1375216_at poliovirus receptor-related 2 Pvrl2 1302 829 -1.571 
1398955_at 
COP9 constitutive photomorphogenic 
homolog subunit 8 (Arabidopsis) Cops8 8167 5200 -1.571 
1385118_at 
eukaryotic translation initiation factor 
2, subunit 1 alpha Eif2s1 818 521 -1.570 
1393745_at 
origin recognition complex, subunit 3-
like (yeast) Orc3l 575 367 -1.569 
1373178_at --- --- 3038 1936 -1.569 
1389963_at p55 protein LOC652956 615 392 -1.569 
1371489_at --- --- 6520 4160 -1.567 
1393154_at --- --- 1211 773 -1.567 
1372932_at 
ribosomal RNA processing 1 homolog 
(S. cerevisiae) Rrp1 1373 876 -1.567 
1376298_at 
UPF3 regulator of nonsense 
transcripts homolog B (yeast) Upf3b 896 572 -1.567 
1373389_at 
acyl-Coenzyme A dehydrogenase 
family, member 9 Acad9 956 610 -1.566 
1370421_a_at 
cullin-associated and neddylation-
dissociated 2 (putative) Cand2 710 454 -1.566 
1393106_x_at 
general transcription factor IIF, 
polypeptide 1 Gtf2f1 2230 1425 -1.565 
1373760_at 
threonyl-tRNA synthetase 2, 
mitochondrial (putative) Tars2 717 458 -1.565 
1371914_at 
SWI/SNF related, matrix associated, 
actin dependent regulator of 
chromatin, subfamily b, member 1 Smarcb1 1183 756 -1.564 
1381259_at stromal antigen 1 Stag1 1113 712 -1.564 
1377697_at 
amyloid beta (A4) precursor protein-
binding, family B, member 2 Apbb2 515 329 -1.563 
1389668_at 
SPC25, NDC80 kinetochore complex 
component, homolog (S. cerevisiae) Spc25 2455 1572 -1.562 
1374033_at 
proteasome (prosome, macropain) 
subunit, beta type 10 Psmb10 624 399 -1.562 
1383059_a_at G kinase anchoring protein 1 Gkap1 2012 1289 -1.561 
1392986_at striatin, calmodulin binding protein Strn 977 626 -1.561 
1372462_at 
acetyl-Coenzyme A acetyltransferase 
2 Acat2 780 500 -1.560 
1397508_at 
DEAD (Asp-Glu-Ala-Asp) box 
polypeptide 18 Ddx18 587 376 -1.560 
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1370976_at 
GTPase activating protein (SH3 
domain) binding protein 1 G3bp1 6358 4077 -1.559 
1379659_at BMP-2 inducible kinase Bmp2k 815 523 -1.559 
1390889_at hypothetical protein LOC691543 LOC691543 588 377 -1.559 
1388908_at 
peroxisomal D3,D2-enoyl-CoA 
isomerase Peci 690 442 -1.559 
1370432_at POU class 3 homeobox 1 Pou3f1 1873 1203 -1.558 
1383362_at --- --- 583 374 -1.557 
1371924_at olfactomedin-like 3 Olfml3 974 626 -1.556 
1388954_at 
similar to hypothetical protein 
MGC25461 RGD1306717 520 335 -1.555 
1388773_at 
tumor necrosis factor, alpha-induced 
protein 2 Tnfaip2 864 556 -1.554 
1373241_at Mitochondrial ribosomal protein L49 Mrpl49 3007 1935 -1.554 
1372059_at similar to RIKEN cDNA 2610528E23 RGD1309437 1696 1092 -1.554 
1394597_at DDHD domain containing 1 Ddhd1 1170 753 -1.553 
1367883_at survival motor neuron 1 Smn1 2276 1466 -1.552 
1383625_a_at zinc finger protein 259 Zfp259 2392 1541 -1.552 
1385699_at YTH domain family, member 1 Ythdf1 2544 1640 -1.551 
1388621_at mediator complex subunit 11 Med11 650 419 -1.551 
1392906_at ubiquitin-like 4 Ubl4 1013 654 -1.549 
1388956_at exportin 5 Xpo5 1109 716 -1.548 
1382792_at --- --- 981 634 -1.548 
1389344_at ubiquitin specific peptidase 39 Usp39 1619 1046 -1.548 
1383572_at zinc finger, DHHC-type containing 6 Zdhhc6 2263 1462 -1.547 
1368324_at breast cancer 2 Brca2 607 392 -1.547 
1372547_at 
similar to RIKEN cDNA 2410002O22 
gene RGD1306583 2388 1543 -1.547 
1376701_a_at similar to 5930416I19Rik protein MGC94282 1108 716 -1.547 
1379348_at exosome component 2 Exosc2 653 422 -1.546 
1372186_a_at topoisomerase (DNA) II alpha Top2a 1554 1005 -1.546 
1373194_at LYR motif containing 2 Lyrm2 528 341 -1.546 
1383744_at --- --- 1975 1278 -1.546 
1391584_at --- --- 560 362 -1.546 
1372688_at exosome component 7 Exosc7 2602 1685 -1.545 
1387924_at 
neuronal guanine nucleotide exchange 
factor Ngef 1018 659 -1.545 
1372933_at 
sirtuin 7 (silent mating type 
information regulation 2, homolog) 7 
(S. cerevisiae) Sirt7 510 330 -1.544 
1384456_at ubiquitin specific protease 24 Usp24 795 515 -1.544 
1381986_at Similar to neuron navigator 1 LOC685707 1232 798 -1.544 
1383125_at 
TRM2 tRNA methyltransferase 2 
homolog A (S. cerevisiae) Trmt2a 1166 755 -1.544 
1377232_at 
LIM and calponin homology domains 
1 Limch1 607 393 -1.543 
1367663_at 
proteasome (prosome, macropain) 
activator subunit 1 Psme1 3299 2138 -1.543 
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1376423_at 
F-box and leucine-rich repeat protein 
19 Fbxl19 1435 930 -1.542 
1382679_at WD repeat domain 43 Wdr43 1467 952 -1.542 
1392698_a_at 
general transcription factor IIIC, 
polypeptide 4 Gtf3c4 1083 702 -1.542 
1395533_at histidyl-tRNA synthetase Hars 600 390 -1.540 
1370123_a_at cortactin Cttn 640 416 -1.540 
1391190_at trinucleotide repeat containing 6a Tnrc6a 756 491 -1.540 
1391552_at --- --- 710 462 -1.538 
1373168_at 
Similar to LEYDIG CELL TUMOR 
10 KD PROTEIN LOC288913 726 472 -1.538 
1376149_at --- --- 1084 706 -1.537 
1398977_at --- --- 1040 677 -1.536 
1368065_at 
GIPC PDZ domain containing family, 
member 1 Gipc1 567 369 -1.536 
1371811_at 
Bernardinelli-Seip congenital 
lipodystrophy 2 homolog (human) Bscl2 672 437 -1.535 
1385676_at 
Cd2 (cytoplasmic tail) binding protein 
2 Cd2bp2 524 342 -1.535 
1370144_at 
GTP binding protein 4 /// similar to 
Nucleolar GTP-binding protein 1 
(Chronic renal failure gene protein) 
(GTP-binding protein NGB) /// similar 
to Nucleolar GTP-binding protein 1 
(Chronic renal failure gene protein) 
(GTP-binding protein NGB) /// similar 
to Nucleolar GTP-binding protein 1 
(Chronic renal failure gene protein) 
(GTP-binding protein NGB) /// similar 
to GTP-binding protein NGB 
Gtpbp4 /// 
LOC683324 /// 
LOC689822 /// 
LOC689842 /// 
RGD1563564 1366 890 -1.534 
1373908_at --- --- 1341 874 -1.534 
1375701_at 
methyltransferase 10 domain 
containing Mett10d 1485 968 -1.534 
1382035_at TATA box binding protein Tbp 1261 823 -1.533 
1368330_at 
apoptosis antagonizing transcription 
factor Aatf 600 392 -1.533 
1392467_at 
inositol (myo)-1(or 4)-
monophosphatase 2 Impa2 1112 726 -1.532 
1390171_at 
family with sequence similarity 76, 
member A Fam76a 1639 1070 -1.532 
1383578_at 
RAD51 homolog (RecA homolog, E. 
coli) (S. cerevisiae) Rad51 2883 1882 -1.532 
1371071_at 
guanine nucleotide binding protein (G 
protein), beta polypeptide 4 Gnb4 646 422 -1.532 
1370303_at solute carrier family 35, member A4 Slc35a4 1252 818 -1.531 
1386918_a_at 
sigma non-opioid intracellular 
receptor 1 Sigmar1 842 551 -1.530 
1371889_at solute carrier family 22, member 17 Slc22a17 1392 910 -1.530 
1372014_at mediator complex subunit 27 Med27 857 560 -1.529 
1388108_at 
ELOVL family member 6, elongation 
of long chain fatty acids (yeast) Elovl6 507 332 -1.528 
1376641_at THO complex 1 Thoc1 724 474 -1.528 
1382921_at SDA1 domain containing 1 Sdad1 745 487 -1.528 
1389315_at G protein-coupled receptor kinase Git2 938 614 -1.527 
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interacting ArfGAP 2 
1374161_at importin 11 Ipo11 1589 1040 -1.527 
1368214_at SMAD family member 2 Smad2 1612 1056 -1.526 
1378860_at --- --- 1627 1066 -1.526 
1372619_at mitochondrial ribosomal protein L49 Mrpl49 1583 1037 -1.526 
1383353_at --- --- 2718 1781 -1.526 
1391410_at --- --- 1516 994 -1.525 
1378591_at --- --- 809 531 -1.524 
1388350_at peroxisomal biogenesis factor 19 Pex19 2353 1545 -1.523 
1373935_at 
polymerase (DNA directed), delta 2, 
regulatory subunit Pold2 1243 816 -1.522 
1372460_at --- --- 6929 4551 -1.522 
1372869_at similar to GTP-binding protein NGB RGD1563564 1412 928 -1.522 
1379804_at sorting nexin family member 27 Snx27 1003 659 -1.522 
1367786_at 
proteasome (prosome, macropain) 
subunit, beta type 8 (large 
multifunctional peptidase 7) Psmb8 944 621 -1.521 
1367697_at mitogen activated protein kinase 14 Mapk14 2168 1425 -1.521 
1375918_at zinc finger protein 830 Znf830 998 656 -1.521 
1398772_at NSFL1 (p97) cofactor (p47) Nsfl1c 2606 1715 -1.520 
1390650_at nucleoporin 85 Nup85 1100 724 -1.520 
1389389_at 
DEAD (Asp-Glu-Ala-Asp) box 
polypeptide 56 Ddx56 1132 745 -1.519 
1383051_at 
Synaptotagmin binding, cytoplasmic 
RNA interacting protein Syncrip 1455 958 -1.519 
1376602_a_at F-box protein 22 Fbxo22 1922 1265 -1.519 
1374764_at 
NOP14 nucleolar protein homolog 
(yeast) Nop14 1254 826 -1.518 
1370340_x_at tropomyosin 3, gamma Tpm3 1849 1218 -1.518 
1372076_at hepatitis B virus x interacting protein Hbxip 3257 2146 -1.518 
1373978_at 
nuclear cap binding protein subunit 1, 
80kDa Ncbp1 1567 1033 -1.518 
1398869_at 
proteasome (prosome, macropain) 26S 
subunit, ATPase, 4 Psmc4 2687 1771 -1.517 
1390177_at --- --- 786 518 -1.517 
1397628_at similar to RIKEN cDNA 2900092E17 RGD1305592 978 645 -1.516 
1372015_at 
transforming, acidic coiled-coil 
containing protein 1 Tacc1 943 622 -1.516 
1388837_at solute carrier family 44, member 2 Slc44a2 1114 735 -1.516 
1388953_at 
guanine nucleotide binding protein-
like 3 (nucleolar) Gnl3 5310 3505 -1.515 
1388803_at deoxyhypusine synthase Dhps 1150 759 -1.515 
1383559_at 
DEAD (Asp-Glu-Ala-Asp) box 
polypeptide 19a Ddx19a 776 512 -1.515 
1388570_at coenzyme Q9 homolog (S. cerevisiae) Coq9 3470 2291 -1.515 
1388129_at structure specific recognition protein 1 Ssrp1 4328 2859 -1.514 
1373074_at similar to RIKEN cDNA 2700002I20 RGD1307279 2767 1828 -1.514 
1376212_at programmed cell death 2-like Pdcd2l 1097 725 -1.513 
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1392615_at selenoprotein I Seli 1211 800 -1.513 
1373729_at 
ATP synthase mitochondrial F1 
complex assembly factor 1 Atpaf1 1345 889 -1.513 
1387080_at 
structural maintenance of 
chromosomes 3 Smc3 5299 3504 -1.512 
1397520_at 
eukaryotic translation initiation factor 
4, gamma 2 /// similar to eukaryotic 
translation initiation factor 4 gamma, 
2 
Eif4g2 /// 
LOC678831 1481 980 -1.512 
1376655_at --- --- 869 575 -1.512 
1392618_at --- --- 1010 669 -1.511 
1393098_at 
lethal giant larvae homolog 2 
(Drosophila) Llgl2 883 585 -1.511 
1371351_at RNA polymerase 1-3 Rpo1-3 3461 2293 -1.510 
1384042_at --- --- 923 613 -1.508 
1372134_at 
coiled-coil-helix-coiled-coil-helix 
domain containing 6 Chchd6 658 437 -1.506 
1379476_at nucleoporin 35 Nup35 1910 1268 -1.506 
1389274_at 
dephospho-CoA kinase domain 
containing Dcakd 850 565 -1.505 
1370950_at 
phosphatidic acid phosphatase type 
2B Ppap2b 737 489 -1.505 
1372887_at scavenger receptor class F, member 2 Scarf2 552 367 -1.505 
1389117_at O-sialoglycoprotein endopeptidase Osgep 893 593 -1.504 
1368069_at 
SHANK-associated RH domain 
interactor Sharpin 665 442 -1.504 
1368385_a_at growth factor receptor bound protein 2 Grb2 4882 3247 -1.504 
1374858_at 
DEAH (Asp-Glu-Ala-His) box 
polypeptide 29 
LOC10036232
4 1609 1070 -1.504 
1371887_at high mobility group box 3 Hmgb3 878 584 -1.503 
1373875_at similar to RIKEN cDNA 1190005P17 RGD1308261 1076 716 -1.503 
1390543_at --- --- 818 544 -1.503 
1374912_at kinesin family member 2C Kif2c 977 650 -1.503 
1390509_a_at mitochondrial ribosomal protein L51 Mrpl51 2719 1810 -1.502 
1392417_s_at 
rCG32187-like /// TP53 regulating 
kinase 
LOC10036549
1 /// Trp53rk 700 466 -1.501 
1372331_at 
eukaryotic translation initiation factor 
1A, Y-linked Eif1ay 3636 2423 -1.501 
1369785_at 
phosphoribosyl pyrophosphate 
amidotransferase Ppat 1032 688 -1.501 
1373468_at --- --- 1725 1149 -1.501 
1395421_at 
immunoglobulin superfamily, DCC 
subclass, member 3 Igdcc3 1348 899 -1.500 
1371967_at mitochondrial ribosomal protein L16 Mrpl16 2213 1475 -1.500 
1387918_at tropomyosin 3, gamma Tpm3 1747 1165 -1.500 
1382117_at SET domain containing 6 Setd6 532 354 -1.500 
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